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The spinal cord of vertebrates serves as the conduit for somatosensory
information and motor control, as well as being the locus of neural circuits
that govern fast reflexes and patterned behaviors, such as walking in mammals
or swimming in fish. Consequently, pathologies of the spinal cord –such as
spinal cord injury (SCI)– lead to loss of motor control and sensory perception,
with accompanying decline in life expectancy and quality of life. Despite
the devastating effects of these diseases, few therapies exist to substantially
ameliorate patient outcome.
In part, studies of spinal cord pathology have been limited by the inability
to perform in vivo imaging at the level of cellular processes. The focus of
this thesis is to present the underlying theory for and demonstration of novel
multi-photon microscopy (MPM) and optical manipulation techniques as they
apply to studies the mouse central nervous system (CNS), with an emphasis
on the spinal cord. The scientific findings which have resulted from the
implementation of these techniques are also presented.
In particular, we have demonstrated that third harmonic generation is a dye-
free method of imaging CNS myelin, a fundamental constituent of the spinal
cord that is difficult to label using exogenous dyes and/or transgenic constructs.
Since gaining optical access to the spinal cord is a prerequisite for spinal cord
imaging, we review our development of a novel spinal cord imaging chamber
and surgical procedure which allowed us to image for multiple weeks following
implantation without the need for repeated surgeries. We also have used MPM
to characterize spinal venous blood flow before and after point occlusions. We
review a novel nonlinear microscopy technique that may serve to show optical
interfaces in three dimensions inside scattering tissue. Finally, we discuss a
model and show results of optoporation, a means of transfecting cells with
genetic constructs. Brief reviews of MPM and SCI are also presented.
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CHAPTER 1
INTRODUCTION
The writing of a thesis is, by nature, the woeful attempt to compress several
years of learning, experiments, insights, and frustrations into a small number
of pages in such a way that one reasonably demonstrates all of the above in a
meaningful way. Doubtless, much that could be said has been left out, and there
are perhaps a few items that may have been included that have gotten lost in
the shuffle. However, as a whole, this dissertation captures the essence of my
work over the last 5 years.
My motivation for this thesis dates back to the summer after 6th grade.
A classmate and friend of mine–I shall call her Brianne out of respect for her
privacy–who was athletic, fit (a dancer, as I recall), and good looking had
been swimming at her family’s pool. As is wont for athletic youth, Brianne
decided to dive backwards into the pool, which tragically was not deep enough
sufficiently to slow her descent. We got word that summer that Brianne had
suffered a severe spinal cord injury (SCI) in the cervical spine, resulting in
tetraplegia. I cannot begin to tell you the profound impact that going to school
with a paralyzed friend can have on a 7th grade boy. Six years later, I received
word that a childhood friend and high school classmate had been tackled onto
the ball playing rugby, resulting in a lumbar SCI and subsequent paraplegia.
Both people have continued to face life with optimism, courage, and pride
despite drastically changed lifestyles. Their persistence in the face of difficulty
continues to inspire me.
Nevertheless, as a student fresh out of undergraduate physics, my desire to
help was limited to distant hoping and prayer. After all, my undergraduate
work had focused on di-block copolymer dewetting experiments and Bose-
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Einstein interferometry theory, making any contribution to helping paralytics
an unlikely outcome. It thus came as a great surprise to me when in the spring of
2008, Dr. Chris Schaffer approached me with an offer to join his lab and develop
a project on spinal cord imaging with an immediate application to SCI. The
project was a collaboration with Dr. Joseph Fetcho, who only a few short years
earlier had effectively cured SCI in zebrafish larvae. The project would rely
on my physics background to develop and interpret new imaging techniques,
perform quantitative image analysis, and develop mathematical models of the
observed phenomena, while simultaneously requiring me to enter headlong
into the world of biological sciences, a field that I hadn’t studied since 11th grade.
This thesis summarizes the techniques developed, results observed, and
insights obtained over the last 5 years. This thesis is comprised of 9 chapters,
including this introduction. The first two chapters provide background material
which provide context and serve as a reference for the rest of the thesis. Chapter
2 takes a look at the current state of SCI, including clinical outcome and
pre-clinical animal studies, with a spotlight on in vivo imaging and what it
offers SCI research. Chapter 3 examines multi-photon microscopy, discussing
its value and significance to biology, basic experimental techniques and the
achievement of optical sectioning, as well as a more detailed look at the
individual processes of 2-photon excited fluorescence (2PEF), and second and
third harmonic generation (SHG and THG, respectively). The chapter concludes
with a discussion of optical damage mechanisms.
Chapters 4-7 are formatted as stand-alone papers, whether they are
published as of yet or whether they contain work in progress, including
supplementary files and information. Chapter 4 contains the re-formatted
published manuscript of our work on THG imaging of myelin the mouse CNS.
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Chapter 5 contains the re-formatted published manuscript of our paper on a
novel spinal chamber that allowed for 2PEF imaging of the spinal cord for as
long as 5 months.
Chapters 6-7 are works in progress, and thus will likely be out of date even at
the time of final submission of this thesis. Chapter 6 includes unpublished work
on blood flow and the microvascular network of the spinal cord, consisting both
of theoretical modeling, blood flow measurements, and topographical mapping.
Chapter 7 presents unpublished work on a novel imaging modality that is
designed to map optical interfaces, which we have titled Nonlinear Optical
Reflection Microscopy (NORM).
Chapter 8 contains the prepared manuscript of a project on optimizing laser
parameters for targeted optoporation, a technique for transfecting exogenous
DNA into cells. My contribution to this chapter was primarily through
mathematical modeling, writing custom software to streamline analysis, and
contributing to the intellectual material of the study, while Andrew Davis, a
former undergraduate researcher in the lab, completed the experimental data
taking. It is last in this thesis primarily because I am not the first author on this
work and thus consider it a secondary contribution which stands somewhat
apart from the rest.
Finally, in Chapter 9, we close the thesis with a brief summary of and
reflection on what has been successfully completed in the results of this thesis,
as well as offering some insights for future project directions for whomever
picks this project up where I must inevitably leave off.
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CHAPTER 2
SPINAL CORD INJURY: AN OVERVIEW
In this chapter, we review the current outlook on spinal cord injury (SCI) from a
clinical and scientific perspective. This chapter is divided into three sections. In
the first section, we review the current state of clinical SCI and its economic and
quality of life impact on SCI victims. In the second section, we consider the key
challenges to regeneration in the spinal cord identified through animal studies
and the progress made to date towards overcoming these barriers in pre-clinical
(animal) trials, the vast majority of which have used histological sectioning,
behavioral, and/or in vitro analysis to arrive at their conclusions. Finally,
we examine the growing role of in vivo optical microscopy in understanding
disease mechanisms of SCI and evaluating the therapeutic efficacy of treatment
strategies.
2.1 Clinical Perspective
2.1.1 Epidemiology and Impact
Paralysis affects nearly 6 million people in the United States alone, with SCI
accounting for 23% of known incidents, with the mean age paralytics being
52 years of age [1]. Tragically, current estimates place the number of SCIs at
over 12,000 annually with the mean age at time of injury being 37 years of age,
although the late teens to early twenties age bracket exhibited the highest rate
of injury [2]. According to the National Spinal Cord Injury Statistical Center
(NSCISC), more that 40% of SCI cases occur due to motor vehicle accidents,
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30% due to falls, and 15% due to violence, while sports-related injuries account
only for less than 10% of SCIs [3]. Within the entirety of the four branches
of US military, 5928 servicemembers of approximately 13 million at-risk were
identified with SCI over a 10-year period (43 per-million-persons/year), with
white males being the highest at-risk population [4]. In the overall population
of North America, incidents of SCI occur in males at approximately a 4:1 ration
compared to females [5,6], with Caucasians accounting for 66% of cases [5], with
an estimated 43-51 per-million-persons/year [2, 3, 6]. Curiously, this incidence
rate is less than 20 per-million-persons/year in Europe [6].
Considerable improvements have been realized in post-injury mortality,
with a 40% decrease in the 2-year mortality rate between 1973 and 2004 [7].
In contrast to the 2-year mortality rate, little change has occurred in the life
expectancy of SCI patients, which for a Grade A1 high-level (C1-C3) cervical
injury (tetraplegia; see Fig. 2.1) occurring in one’s twenties is estimated at 25-37
years2 compared to 50.9 years in the general population, while for injuries below
the cervical level the life expectancy rises to ∼ 75% of the general population
[3, 7]. These survival ratings included only patients who were non-ventilator
dependent, while for ventilator-dependent victims the life expectancy drops to
just under 24 years [3]. Incidence of complete (Grade A) SCI is estimated at over
50% of SCI cases [5, 6], with tetraplegia being the clinical outcome in more than
55% [5] in the general population, while within the US military, cervical injury
was present in ∼ 38% of SCIs [4].
SCI costs the health care system an estimated $40.5 billion per year [1], with
1The American Spinal Cord Injury Association (ASIA) has systematized the classification of
spinal cord injury [8], ranging from complete injury resulting in total sensorimotor loss (Grade
A) through (Grade E), wherein sensory and motor control are preserved in totality despite
injury.
2Measured as time post-injury. For for an injury at age 25, the age expected to be attained
would be 50-62 years of age.
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transplantation should reduce ethical concerns (BOX 2) 
and autologous transplants should not be rejected. 
Various adult progenitor cells have been implanted 
in rodent models of SCI, ranging from cells from the 
olfactory system (see above) to bone marrow-derived 
stem cells, cultured spinal cord and brainstem cells and 
dermis-derived stem cells107 (FIG. 5).
Adult bone marrow contains several different 
stem cell populations, including haematopoietic 
stem cells (HSCs) and bone marrow stromal cells 
(BMSCs), also known as mesenchymal stem cells 
(BOX 3). Transplantation of HSCs promotes functional 
recovery after compression-induced SCI in mice108,109 
and transplantation of BMSCs significantly improves 
hindlimb function after SCI in mice and rats109–111. 
However, the potential mechanisms by which BMSCs 
act are currently unclear, although neurotrophic and 
axonal elongation-facilitating actions have been pro-
posed110. Also, the functional outcomes reported must 
be interpreted with caution because many are prima-
rily based on one evaluation protocol without other 
behavioural/electrophysiological assessments. A small-
scale human trial was conducted in which autologous 
BMSCs were intravenously delivered to nine patients 
with SCI88. The improvements observed appeared to fall 
within an expected range of spontaneous recovery, and 
one participant advanced from ASIA category B to D. 
Nevertheless, without controls or some indication of 
cell viability within those lesions, we can conclude only 
that a measure of procedural safety was demonstrated. 
To our knowledge, peer-reviewed results have yet to be 
presented for this study8.
Adult neural progenitor cells (NPCs), isolated from 
the dentate gyrus, the subventricular zone or spinal cord, 
have been shown to self-renew, and to be multipotent 
in vitro and after transplantation into the CNS112,113. 
After transplantation of adult NPCs into the intact 
and injured murine spinal cord, differentiation into 
only astrocytes or oligodendrocytes is observed114–116. 
Recently, mouse brain-derived adult NPCs were 
transplanted into the injured spinal cord of adult rats. 
This treatment was combined with growth factors to 
selectively increase the number of oligodendrocyte pre-
cursors after transplantation. NPCs transplanted 2 weeks 
post-injury survived, migrated, integrated in the injured 
spinal cord tissue, generated mature oligodendrocytes 
that remyelinated the injured axons, and promoted 
some functional recovery. However, NPCs transplanted 
8 weeks post-injury did not survive, and failed to exert 
similar effects117. Therefore, there is a need to find and 
neutralize the inhibitory obstacles present in chronic SCI 
that interfere with NPC survival after transplantation.
Adult neural stem cells also reside in the spinal 
cord118, and the ability to regulate their numbers and 
fate after injury might provide an alternative to trans-
plantation. To regulate their numbers and fate to pro-
mote recovery, it will be necessary to determine which 
molecules are involved in governing neural stem cell 
proliferation, migration and differentiation. Therapies 
using endogenous stem cells would require no exog-
enous stem cell sources and would therefore circumvent 
the obstacle of immune rejection, as well as the ethical 
and moral considerations associated with their use.
Transplantation of engineered stem/progenitor cells. The 
injured adult spinal cord is a poor micro-environment 
for cell survival, neuronal differentiation and maturation. 
Therefore, to enhance the capacity of stem cells in CNS 
repair, researchers have recently begun to engineer stem 
cells to have better survival, and desired differentiation 
and maturation properties110. In an attempt to increase the 
survival of transplanted rat ESCs, ESCs were genetically 
modified to overexpress BCL2, an anti-apoptotic protein. 
This led to tumour-like growth of cells, accompanied by 
increased morbidity and mortality119. More promisingly, 
when transplanted in the compressed mouse spinal cord, 
engineered mouse ESCs expressing the cell adhesion 
molecule L1 survived longer and migrated rostrally and 
caudally from the lesion. Corticospinal axons showed 
interdigitation with L1-transfected ESCs and extended 
into and, in some cases, beyond the lesion site120.
It is apparent that transplantation alone of stem/pro-
genitor cells after SCI will not lead to optimal recovery; 
combination strategies will be necessary for optimum 
return of function. Advances in molecular biology (for 
Box 1 | The ASIA Impairment Scale
Classification of spinal cord injury (SCI) severity using the American Spinal Injury 
Association (ASIA) Impairment Scale. The main categories of the Impairment Scale are as 
follows:
• A (complete): No motor or 
sensory function is preserved 
in the sacral segments S4–S5.
• B (incomplete): Sensory but 
not motor function is 
preserved below the 
neurological level and includes 
the sacral segments S4–S5.
• C (incomplete): Motor 
function is preserved below 
the neurological level, and 
more than a half of key 
muscles below the 
neurological level have a 
muscle grade of <3.
• D (incomplete): Motor 
function is preserved below 
the neurological level, and at 
least a half of key muscles 
below the neurological level 
have a muscle grade of ≥3.
• E (normal): Motor and 
sensory functions are 
normal. 
Extent of injury after damage to 
specific spinal segments is 
illustrated in the figure (see 
American Spinal Injury 
Association in Online links box 
for the complete standard 
neuro logical classification of 
SCI).
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Figure 2.1: Functional impairment correlates with level of spinal cord injury.
The spinal cord is divided up into 7 cervical (C), 12 thoracic (T), 5 lumbar (L),
and 5 sacral (S) vertebrae, terminated at the coccyx. Cervical injury correlate with
quadriplegia while thoracic and lumbar injuries correlate with paraplegia. The spinal
cord ends at the L1-L2 level in humans [9]. Reprinted by permission from Macmillan
Publishers Ltd: Nature Reviews Neuroscience,Thuret, S., Moon, L.D.F. and Gage, F.H.,
Therapeutic interventions after spinal cord injury, 7, 628-643, Copyright 2006. [10]
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estimated lifetime costs ranging from ∼ $1.4-4.4 million, with approximately
20% of costs occurring in the first year following injury [3]. In addition to
the direct cost of health care, SCI also results in a broader economic impact
on the victim. A recent survey in Taiwain [11] showed that less than one
third of previously employed SCI patients had returned to work in a 3-year
follow up study, with only 68% of those returning to the same position.
However, a considerable range of employment statistics have been reported,
with as low as 11% and as high as 75% returning to work (reviewed in [12]).
Differential employment rates were seen when compared across age of injury,
extent of injury, time after injury, and educational background, with favorable
outcomes in each of these comparison groups for younger age, lesser extent of
injury, longer time following injury, and greater education. Other key factors
in employment were the availability of transportation, physical limitations,
architectural difficulties, and recurring health problems [11–13].
In addition to the paralysis, SCI victims face a plethora of related co-
morbidities. For example, in a study [14] of 408 patients, over 65% of SCI
patients were overweight, with approximately 30% being considered obese.
Counterintuitively, Grade A injuries showed the lowest obesity at 22.91%,
while Grade C had the highest obesity (38.3%) and Grade D had the highest
overweight population (74.14%). In turn, being overweight was correlated with
an increased incidence of overuse injuries in the upper limbs, increased fatigue,
and a decline in subjective well-being [15].
Urinary complications have been significantly mitigated by the use of clean
intermittent cauterization (CIC)–the insertion of a temporary cannula to drain
the bladder–over and against traditional methods of indwelling and condom
catheters [16]. Nevertheless, complications are reported to occur at a rate of
7
71% for patients using CIC, compared to 100% in patients using indwelling
catheters [17]. CIC must also be performed as many as 6-7 times per day [17].
Autonomic dysreflexia (AD) results from the loss of supra spinal control of
autonomic reflexes [18–20], resulting in periodic bouts of severe hypertension,
headache, bradycardia, and possible complications including stroke, seizures,
and death [21]. AD presents in 91% of tetraplegic patients with Grade A SCI,
while being absent in paraplegic patients [18]. AD has been seen to occur only in
injuries above T6 [22]. Unfortunately, there is evidence to suggest that the same
mechanisms that give rise to neuroplasticity–and thus functional recovery– may
also be at the root cause of AD [21]. Finally, other complications include
chronic pain [21, 23, 24], pressure ulcers [25], respiratory complications [25–28]
including pneumonia in as many as 50% of patients within the first 30 days
post-SCI [29] , and a significantly increased incidence of suicide [26, 30, 31].
2.1.2 Current Therapies
Despite its devastating effects, no efficacious regenerative therapies exist
[32, 33]. Broadly speaking, most approaches seek to minimize the extent
of direct damage and/or mitigate secondary injury effects (e.g. ischemic
and/or inflammatory insult) [33–35]. Despite numerous trials [35], the
only approved drug therapy is the administration of methylprednisolone
[35]–an anti-inflammatory steroid–within 8 hours following injury, despite
contraindications [36] and recommendations against the practice [36–38]. No
conclusive evidence exists for pharmacological neuroprotective therapies in
clinical trials [33]. Inhibition of the Rho pathway by the drug Cethrin
has recently shown promise in Phase I/IIa clinical trials, with as many as
8
66% of Grade A cervical injuries being downgraded to Grade C or D [39].
Cellular transplantation therapies (reviewed in [33] and [40]) hold promise
in Phase I studies, but definitive improvement remains unclear [40, 41].
Recent evidence [42, 43] also suggests that early (<72 hours following injury)
decompressive spinal stabilization surgery correlates strongly with improved
clinical outcome. Various exercise regimes–both assisted and independent–
appear to have profound effects, both in improving functional recovery and
mitigating secondary complications (for a review, see [44]).
2.2 Key Challenges in SCI Therapy
In spite of the gloomy outlook of current clinical practice and outcome,
considerable and promising advances have been made in animal models,
both in understanding disease mechanisms as well as explorations of possible
therapeutic interventions. The loss of function in SCI owes to disruption and
loss of axonal pathways to and from the brain, in some ways analogous to
destroying an electronic circuit by severing the wires that connect the various
components. While there is, of course, spinal neuron loss, demyelination, and
vascular insult, axon loss lies at the heart of this devastating pathology, and
will form the focus of our review. As such, there are two parallel approaches to
treating axonal loss in SCI: axonal regeneration and/or tissue sparing. In this
section, we shall focus only on the former, since neuroprotective mechanisms
are preventative rather than restorative in nature and do not mitigate the
primary damage (i.e. trauma)3.
3They also range over quite a spectrum of differing effects, from an anti-oxidant raspberry
extract [45] to Omega-3 fatty acids [46].
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Compared to axons in the peripheral nervous system(PNS), which undergo
robust regeneration following nerve damage, axons in the CNS have
greatly reduced regenerative potential. One key difference is the local
microenvironment of the CNS. We begin our review of this microenvironment
with CNS myelin, a fatty lipid sheath produced by the wrapping of
oligodendrocytes around long axons, thereby enabling fast action potential
transmission via saltatory conduction [47]. Myelin is also produced in the
PNS, but the cell type giving rise to it is the Schwann cell, which has salient
differences from CNS myelin. While essential for function, CNS myelin also acts
as a growth-inhibitor, and we will review both the problem and some proposed
solutions.
Furthermore, the CNS is composed of both neurons and glia, the latter
of which play a multi-functional role in the CNS. Once again, there is a
physiological role of these cell types, but their recruitment to the lesion site to
form an aggregate or “scar” has shown to be simultaneously beneficial to tissue
sparing and detrimental to axonal regeneration. We will touch on both aspects
and attempts to mitigate the inhibitory effects of the scar.
Along with external factors in the microenvironment, there are fundamental
differences between the developing CNS in which growth is essential and the
adult CNS in which growth and plasticity are more limited. The intrinsic state
of neurons appears to be governed, in part, by developmental “switches” that
are responsible for developmental growth but turned off in the adult CNS.
Thus, reactivation of these pathways promises to be of benefit to regeneration
in the injured CNS, and we will review some important studies which have
demonstrated the efficacy of this strategy. However, we will also discuss some
caveats of this approach, including organizational differences between the adult
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and developing CNS which affect axonal guidance cues and the establishment
of useful synaptic connections.
Finally, in the vast majority of the above approaches, studies were performed
using plated cells in vitro, or by using fixed-time-point histology and behavioral
analysis in animal models. While much can and has been learned by these
approaches, each has its associated drawbacks. Although in vitro studies allow
for high reproducibility and straightforward analysis, they lack the necessary
context to account for the complicated milieu of the injured CNS. Histology,
on the other hand, while showing multiple tissue constituents, leaves a great
deal of ambiguity in determining regenerative and degenerative dynamics,
since only a single time point can be captured per animal. Behavioral assays
allow for multi-time-point longitudinal studies, but offer little in the way of
elucidating mechanisms and are complicated by spontaneous recovery that
occurs independent of modulation in the target pathway. In contrast to these
assays, a number of time-lapsed in vivo imaging studies have been performed
which circumvent these drawbacks by allowing for repeated imaging of cellular
dynamics, enabling direct and unambiguous visualization of disease progress
and therapeutic efficacy. We will highlight several recent studies using this
approach and offer some concluding thoughts for the value of this approach
for future pre-clinical studies.
2.2.1 Growth Inhibition by CNS Myelin
The developing nervous system, by necessity, must be growth permissive.
However, following early stages of development, large-scale-neurotrophin-
modulated apoptosis [48] and synaptic pruning [49] result in significant loss
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of redundant or ineffective neurons and their processes. Some of these
developmental processes may share common mechanisms with disease (for a
review, see [49]). Somewhere in this complex milieu of neuron proliferation,
pruning, and maturation of the CNS, this growth permissiveness to large
neurite outgrowth is lost. The adult CNS retains plasticity by the rescaling
of synaptic strengths [50, 51], and even learning-associated synapse formation
[52–55]. However, this growth is localized [53] and does not lead to the same
extent of neurite outgrowth necessary for post-injury regeneration or de novo
circuit formation.
One component that has received considerable attention in creating the
semi-static CNS is CNS myelin, in which Nogo, myelin-associated glycoprotein
(MAG), and oligodendrocyte myelin glycoprotein (OMgp) have been identified
as growth-inhibitory substrates (for a recent review see [56]). For example,
Li et al. [57] showed that the growth cone of plated neurons collapsed
upon coming into contact with a MAG coated bead. All three elements
share common receptors [56, 58], namely Nogo Receptor (NgR) and paired
immunoglobulin-like receptor B (PIR-B), which led to the hypothesis that
NgR/PIR-B antagonists would promote axon growth. Conflicting results have
been found [56], especially between the Strittmatter group [59, 60], which
showed robust regeneration after antagonization of the NgR1 receptor using
the peptide NEP1-40, and a subsequent study by Nakamura et al. [61] which
showed that dual NgR/PIR-B knockout mice and NEP1-40 administration in
PIR-B mice failed to induce a robust regenerative response. To complicate
matters further, there is a growing body of evidence that suggests some of
these and other molecules play important physiological functions in preventing
aberrant sprouting in the adult CNS, as well as providing both attractive and
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repulsive guidance cues [62].
However, some research would suggest that the growth-inhibitory role of
myelin is overstated. The research group of Marie Filbin has been particularly
diligent in exploring how the intrinsic state of the neuron may be significant for
how these growth-inhibitory molecules have their effect (for a review of myelin
inhibition and therapeutic approaches, see [63]). Chai et al. [64] showed that
cerebellar neurons co-cultured in the presence of neurotrophins (brain-derived
neurotrophic factor (BDNF) or glial-derived neurotrophic factor (GDNF)) and
plated on a monolayer of MAG-expressing Chinese Hamster Ovary (CHO) cells
or isolated myelin are able to overcome the growth-inhibitory effects of these
substrates. Moreover, they demonstrated that this priming with neurotrophins
resulted in an increase of intracellular cyclic adenosine monophosphate
(cAMP), and that treatment with membrane-permeable cAMP directly–that is,
without neurotrophin incubation–was sufficient to generate the same ability to
overcome myelin-associated growth inhibition. Downstream inhibition of the
protein kinase A (PKA) pathway–one of the primary targets of cAMP–destroyed
the effect of both neurotophin and cAMP treatments, further suggesting that an
elevated intracellular cAMP level is the driving factor in overcoming inhibition.
In subsequent studies [65], they found that immature neurons capable of
sustained growth had increased levels of intracellular cAMP, and that MAG
and myelin are actually growth promoting under these circumstances. Again,
subsequent inhibition of PKA resulted in growth inhibition and artificial cAMP
elevation resulted in growth promotion. Subsequent in vivo studies [66, 67]
in the rat spinal cord have confirmed the efficacy of this treatment strategy,
although this therapy has not constituted a “magic bullet” cure. Similar results
have been seen by Neumann et al. [68]. The exception to these findings of
13
incomplete efficacy is a study by Bhatt et al. [69] in zebrafish larvae, involving
treatment of the Mauthner cell soma following axotomy with cAMP. In this case,
complete axon regeneration with a normal trajectory after treatment with cAMP
was visualized in vivo following injury. Recovery of synaptic connectivity was
determined by performing calcium imaging of spinal interneurons activated
by Mauthner cell axon, with loss of downstream interneuron activation after
injury and return of activation after complete axon regeneration was observed.
Subsequent behavioral testing confirmed functional restoration. This approach
to SCI, which shall be reviewed later in this chapter has much to offer. However,
the inability to reproduce these results in mammals may depend on a number
of factors, including differences between species and the fact that zebrafish
larvae–in contrast to adult zebrafish– may still possess certain directional and
developmental cues that are subsequently abrogated in adults. Nevertheless,
inducing changes to the intrinsic neuronal phenotype remains a promising
therapeutic target. Rho kinase inhibition has also been seen [70, 71] to have
similar effects with respect to myelin-associated inhibition, and has entered
clinical trials as noted above.
2.2.2 The Glial Scar
Following spinal cord injury, microglia and reactive astrocytes invade the lesion
site, forming the so-called “glial scar”, the latter of which was discovered
[72, 73] to secrete growth-inhibitory chondroitin sulfate proteoglycans (CSPGs).
CSPGs play many important physiological roles, including the establishment of
perineuronal nets (PNN) which stabilize synapses and limit neuronal plasticity
in the mature CNS (see Fig. 2.2), but simultaneously restrict regeneration
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following SCI (for a detailed review, see [74]). The efficacy of CSPGs digestion
by the bacterial enzyme chondroitinase ABC (chABC) was demonstrated in the
hallmark study by Bradbury et al. [75]. In this study, intrathecal delivery of
chABC to the injured rat spinal cord led to digestion of CSPGs in vivo, increased
growth into the lesion site, improved motor function, and a nearly two-fold
recovery (compared to controls) of spinal potentials below the lesion site to
supraspinal inputs. These findings were confirmed in a similar study [76] using
a drug delivery method that enabled sustained chABC delivery as opposed
to a single microinjection. To address the concern of aberrant sprouting, a
follow-up study [77] was performed, in which both spared and injured axons
showed aberrant sprouting following chABC treatment in injured, but not
control animals. Despite the failure to develop nociceptive connections–the type
that could potentially contribute to the observation of chronic pain in rat models
of SCI–the aberrant sprouting of these axons is nevertheless a concern for the
use of chABC clinically. Moreover, like myelin, the extent to which CSPGs
inhibit growth depends strongly on neuron age, type, and CSPG concentration
[78].
It is also worth noting that considerable work has been done to investigate
the positive effects of the formation of a glial scar (for a review, see [79]).
For example, the selective ablation of dividing reactive astrocytes [80] led to
increased leukocyte infiltration, loss of myelin, increased neuron degeneration,
and reduced motor score following SCI compared to control mice. Thus,
despite its effects on growth inhibition, it would appear that the glial scar has
a neuroprotective effect, and may substantially mitigate the secondary injury
phase of SCI. Rolls et al. [79] hypothesize that an optimal therapeutic strategy
would aim to strike a balance between early, protective glial scarring and late,
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= synaptogenesis
= CSPGs
= degraded CSPGs
= other PNN components
+ ChABC
Figure 2.2: Illustration of the role of CSPGs in regulating synaptic contacts as PNNs.
In the adult CNS, CSPGs help maintain the mature CNS and protect against aberrant
synapse formation by forming the PNN (left). Subsequent digestion by chABC leads to
increased synaptic plasticity (right) and may be important for regeneration within the
adult CNS. Reprinted from Experimental Neurology, 235, Bartus, K. et al. Chondroitin
sulphate proteoglycans: Key modulators of spinal cord and brain plasticity, 5-17,
Copyright 2012, with permission from Elsevier.
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growth-inhibitory glial microenvironment. In fact, some recent evidence [81,82]
would suggest that the glial scar can promote axonal regeneration, although this
is strongly dependent on astrocyte phenotype.
2.2.3 Fundamental Differences Between the Developing and
Adult CNS
As mentioned previously, the adult CNS, while not static, is decidedly
less plastic than the developing CNS. As a rather striking example of this
phenomenon, Saunders et al. [83] subjected neonatal opossums to spinal cord
crush or complete transection injuries. These animals were then characterized
behaviorally, functionally, and histologically months to years following injury
and found to be substantially normal in both aspects, while similar injuries
in an adult would result in permanent paralysis with drastic differences in
tissue morphology. Although this study showed the importance of innate
differences between the neonatal4 and adult CNS, it did not elucidate key
biological markers or pathways to target.
With respect to bimolecular pathways, promising work [84, 85] has also
been done in studies focused on the PTEN/mTOR pathway. In their ground-
breaking study, Park et al. [84] showed that the mammalian target of rapamycin
(mTOR) pathway is highly active in early neonates but is down-regulated in
the adult CNS by the downstream effects of phosphatase and tension homolog
(PTEN). The mTOR pathway is responsible for promoting cell growth, among
other things (see [86] for a review). Moreover, deletion of PTEN resulted in
4It should be noted that “neonatal” is a qualitative descriptor, as the stage of development at
birth is not conserved across species.
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subsequent up-regulation of the mTOR pathway in retinal ganglion cells and
increased survival and regeneration following axotomy [84]. A subsequent
study by Liu et al. [85] of the corticospinal neurons–neurons projecting axons
into the spinal cord and responsible for voluntary motor function–showed not
only enhanced sprouting of injured and uninjured axons, but evidence for
excitatory synapse formation in many of the regenerating CST axons. However,
as might be guessed by the inhibitory effects of PTEN on a growth-promoting
target, PTEN is a tumor suppressor gene whose inactivation, mutation, or
deletion is common to many cancers, including glioblastoma (reviewed in [87]).
Thus, despite the pro-regenerative effects of PTEN deletion/suppression, its
permanent deletion/suppression is ill-advised.
Studies of the nature just described,combined with the comparisons between
cAMP levels in immature and mature neurons [65] discussed previously,
lend support to the “regeneration recapitulates development” paradigm of
regenerative medicine. However, the scope of this paradigm is not without
bounds. For example, recent work in the Fetcho group [88] demonstrated
that in the hindbrain and spinal cord of zebrafish larvae, neurons are initially
organized into relatively simple “neurotransmitter stripes”, whereby functional
circuits form from simple neuron subtype pools and subsequently migrate to
form nuclei in the more complex mosaic structure of the adult CNS. While
shedding light on developmental biology, the study also reveals the one-way
nature of neural development in complex organisms.
With this limitation in mind, one intriguing possibility for axonal
regeneration focuses on mechanisms of angiogenesis. A growing body of
evidence (reviewed in [89–91]) shows that there is a dynamic interplay between
angiogenesis and axonal guidance. In particular, axonal growth cones and
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endothelial tip cells share common ligands, including vascular endothelial
growth factor (VEGF), which enables a synergistic growth of axons and nerves
[89, 90]. While most of this synergism has been identified in the peripheral
nervous system (PNS), which regenerates robustly, there is reason to think
that angiogenesis may play an important role in CNS regeneration as well
[91, 92]. However, the role of VEGF as a therapy for SCI remains somewhat
controversial, with some studies [93, 94] having showed the positive outcomes
of vascular growth promotion, mitigation of secondary injury, tissue sparing,
and improved behavioral outcome, while others showed the negative outcomes
of leaky vessels [95, 96] and subsequent behavioral and neurological deficits
[95]. Despite the open controversy on the matter, convincing evidence for
axon regeneration along blood vessels has been presented by Dray et al. [97].
They performed repeated in vivo imaging studies of the mouse spinal cord out
to as long as 120 days post-injury, and found that a peak of approximately
50% of endogenously regenerating axons were found to be following blood
vessel trajectories approximately one week after injury, with significantly longer
neurite outgrowth compared to axons not observed to be following vascular
trajectories. This work demonstrates the critical value of in vivo imaging for
eliminating ambiguity and identifying therapeutic targets, a topic to which we
now turn our attention.
2.3 What In Vivo Optical Microscopy Has to Offer
One of the drawbacks to clinical trials is that data is based on either motor skills,
subjective patient self-assessment, or tissue level imaging (e.g. MRI), making
cellular-level mechanistic understandings of any reported efficacy ambiguous,
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at best. Furthermore, spontaneous recovery of sensory and motor skills in the
absence of therapy and/or regeneration, such as spontaneous rewiring of the
propriospinal pathway demonstrated in the mouse spinal cord by Courtine et
al. [98], can further obscure measures of efficacy. Traditional animal studies
allow for the addition of fixed-time-point histology to behavioral assays, adding
tissue characterization at the cellular level to the knowledge base, but fail to
capture information of disease progression. In vivo imaging holds great promise
in providing this missing information.
Axon Degeneration and Sprouting
In addition to providing insights into complex and dynamic inter-cellular
interactions, this information is of critical importance for resolving ambiguities
in therapeutic strategies targeted at axon regrowth, as single time point
images do not allow one to distinguish between axons that are in the
processes of degenerating and regenerating, or between axons that have fully
regenerated and axons that were spared from injury altogether [99, 100] (see
Fig. 2.3a). Similar studies could bring new insights to etiological studies of
neuroinflammatory disorders, such as multiple sclerosis (MS) (see Fig. 2.3b).
In a commentary [100] on setting standards for evaluation of the efficacy of
therapeutic strategies targeted towards axon regeneration, the authors state that
“Obviously, the best solution to this problem would be to develop techniques
to visualize the response of living axons after injury in vivo.” It is this
“obvious solution” that our work presented in this thesis has sought to make
possible, following the pattern of the watershed study by Bhatt et al. discussed
previously [69]. A review of recent work done to this effect is presented in the
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ab
Figure 2.3: Illustration of the advantages of dynamic in vivo imaging in spinal cord
pathology
In contrast to static images, in vivo imaging allows for the capture of important
transients, enabling the identification of axonal phenotypes following injury, whether
spared, regenerating, or dying (a). In the same vein, mechanisms of neuroinflammatory
injury may be distinguished by detecting loss of axonal integrity either in association
with direct immunological attack or by a neurotoxic inflammatory microenvironment
(b). Reprinted by permission from Macmillan Publishers Ltd: Nature Methods, Misgeld,
T. and Kerschensteiner, M., In vivo imaging of the diseased nervous system, 7, 449-463,
Copyright 2006.
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“Introduction” section of later chapters of this thesis containing our published
work on spinal cord imaging. However, we shall here review in greater detail
key scientific5 observations made to date by in vivo optical imaging of the spinal
cord.
The first group to achieve this “best solution” considered afferent axons
of the dorsal root ganglia (DRG), and discovered a new phenomenon known
as acute axonal degeneration (AAD), in which axons of the mouse spinal
cord degenerate up to 100s of micrometers within minutes of traumatic injury
[101]. They also showed that this mechanism was calpain-mediated, and
shared at least some common mechanisms with Wallerian degeneration, the
progressive fragmentation of the distal segment of an axon following axotomy
of a peripheral nerve [47]. Within 24 hours, they saw many injured axons
undergo aberrant growth [101]. We have also seen this response [102], but
observe fewer axons regenerating. Possible resolutions for discrepancy in
growth response include our mechanism of injury and/or the location relative
to the cell bodies, which we did not standardize in our dorsal column lesions.
Our results are in closer agreement with the results in a follow-up paper [103],
reducing the number of regenerating axons from 30% to 9% [101]. While we
observed this growth to occur within the first three days post-injury, we also
noticed that these axons subsequently disintegrated within the first week after
injury [102]. These previous studies had only considered 1-2 days post-injury,
emphasizing the importance of imaging across a range of timescales.
It should also be pointed out that imaging can provide qualitatively
different conclusions on regenerative mechanisms than fixed-point histology.
In the previously-mentioned follow-up study [103], Bareyre et al. demonstrated
5We shall also here omit articles which simply present a new methodology without
presenting scientific findings, though these are reviewed in later chapters
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that the transcription factor, STAT3, is upregulated in peripheral nerve
lesions–which regenerated well–yet is not upregulated in CNS axonal injury,
accompanied by a lack of regenerative capacity. Moreover, inhibition of
STAT3 resulted in failure of peripheral nerves to regenerate. However, one
of the critical findings of this study was that while STAT3 over-expression by
exogenous transduction substantially improved axon sprouting (over 50% of
axons sprouted compared to 9% in controls), it was not able to sustain axon
growth. This latter finding was deduced by repeated imaging of the same
axons in the same animal. Their conclusion rested on (a) the ability to see
key morphological differences between day 0 and day 2 post-injury and (b) the
ability to see that this early response did not result in a regenerative net-gain at
day 10 post-injury. Anecdotally, a similar finding was discovered in our own
work where chABC and cAMP were delivered to the spinal cord via intrathecal
catheter following a laser injury (see Fig. 2.4).
In contrast, traditional histological studies which allow for the examination
of only a single time-point would likely lead to a false conclusion that STAT3
was ineffective on the basis of lack of axonal elongation at later time points, or
else would lead to false conclusion that STAT3 was highly-effective on the basis
of an early sprouting response. Even if it were possible to arrive at the same
conclusion as Bareyre et al. using traditional methods alone, each time point
would require a cohort of animals in both experimental and control groups,
easily tripling the numbers of animals required. Thus, not only does in vivo
imaging allow for findings likely to be missed by traditional studies, but it is
also more humane. Nevertheless, Bareyre et al. were limited in the number of
time-points and longitudinal extent of imaging by the need for invasive surgery
at every time point, a problem that we have attempted to solve with our spinal
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chamber [102].
Microglial Activation and Migration
Moving away from studies of axon dynamics, Dibaj et al. have devoted a
significant amount of effort to understanding the reactions of microglia to
SCI in mouse models [104]. In particular, they have shown [104] that nitric
oxide (NO) and ATP are released following SCI and co-dependently recruit
microglia and alter their phenotype. This study demonstrated the need for in
vivo imaging, since the study was essentially a study of the dynamic process
of chemotaxis–the migration of cells and/or cellular processes in response to a
chemical gradient– in the complex milieu of the injured mouse spinal cord. The
proposed timescales in this study also agree well with our observations [102],
in which the number of microglia at the lesion site were seen to increase by as
much as five-fold within the first 24 hours.
Microglial dynamics are important for therapeutic design since their positive
or negative effects on regeneration depend critically on timing. For example,
neuronal fractalkine (CX3-CL1) binds its receptor (CX3-CR1) expressed on
the surface of microglia [105], and can serve to limit the extent of their
activation and subsequent neurotoxicity [106]. Thus, increasing CX3-CL1 levels
would appear to have a positive effect in down-regulating the release of pro-
inflammatory cytokines, thereby limiting the migration [107] of potentially
destructive immune cells into the spinal cord and preventing axonal loss (Fig.
2.3b). The catch-22 comes from the fact that axon regeneration is inhibited
by axonal fragments [108] which are removed by the resident macrophages,
namely phagocytic microglia. The scenario is further complicated by the
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observation that macrophages (microglia and differentiated monocytes) are
phenotypically diverse. A neurotoxic M1 macrophage will tend to result in
neurotoxicity while M2 macrophages are growth promoting [109]. The precise
determination of a “therapeutic window” and cellular phenotype selection
requires a precise understanding of the temporal profile of mutli-cellular
dynamic interactions, a study for which in vivo microscopy is ideally suited.
Myelin
Loss and/or recovery of CNS myelin in SCI and demyelinating disorders,
like multiple sclerosis (MS), are also dynamic processes whose study has
and will continue to benefit from in vivo imaging. Coherent Anti-Stokes
Raman Scattering (CARS) microscopy has been the predominant source of
myelin contrast [110–112], and we have demonstrated [113] that third harmonic
generation (THG; reviewed in later chapters) is also well-suited to imaging CNS
myelin. As was previously mentioned, chronic pain is a common complication
of SCI, and electrical stimulation of spinal tissues has been observed to cause
significant reduction in pain [114], even though the mechanisms of this relief
remain largely unknown. Huff et al. [112] have shown that this stimulation
in spinal axons results in myelin retraction at the nodes of Ranvier, which
recovers within a few hours post-stimulation. Such an observation would
be next to impossible using immunohistological methods alone. They also
showed that this mechanism was calcium-activated and calpain-dependent.
The authors suggest that one potential mechanism of action is that myelin
retraction exposes voltage-gated potassium channels, whose exposure results
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in a greater polarization of the cell and thereby suppresses hyperactivity.
In Vivo Imaging Beyond SCI
Finally, the value of in vivo imaging in the spinal cord extends beyond studies of
SCI. Amytrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is
a debilitating neurological disease that results in progressive loss of spinal cord
motor neurons, with consequent weakness, paralysis, and death [115]. Familial
ALS (fALS) is genetically linked and accounts for between 5 and 10 % of ALS
cases, while the etiology of the remaining cases remains poorly understood
[115].
In vivo imaging has helped aid progress in our understanding of this
disease. For example, in contrast to microglia, wild-type astrocytes showed
little acute response to axonal injury in healthy animals [116]. Yet in superoxide
dismutase-1 (SOD-1) mutant mice (a leading model of fALS [117]), imaging
revealed rapid astrocyte invasion of the injury site [116]. An analogous study
of microglia [118] in SOD-1 mutant mice showed that pre-clinical ALS (i.e.
limited loss of motor neurons) showed hyper-reactive microglia while clinical
ALS showed hyper-activation of microglia, but with an untargeted response to
injury. In both studies, a hypersensitivity of microglia and astrocytes was seen
in response to injury, consistent with previous studies [119] which showed that
transplanted wild-type glial cells in a SOD-1 mutant mouse do not have the
same immune activation and show diminished neurodegenerative phenotype.
Another in vivo study of ALS [120] has challenged the long-standing assumption
that deficits in axonal transport lead to axon degeneration. In this study,
they used a combination of mice expressing Kaede–a fluorescent protein that
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changes in emission wavelength from green to red upon exposure to UV light
(for a review of photoactivatable color-change proteins, see [121])–in neuronal
mitochondria along with different mouse models of familial ALS. By tracking
of mitochrondrial migration and densities, Marinkovic et al. [120] found that
impaired axonal transport could occur without axonal degeneration and vice
versa. In all cases, these observations required imaging of dynamic processes
inaccessible to traditional methods of study.
2.4 Conclusion
On the face of it, SCI seems like an insurmountable biomedical problem,
with very little improvement in treating the core pathology despite decades
of research. However, as we have considered, new insights as well as
improvements in cellular technologies and gene therapies have led to and
are making possible the identification of new targets and novel therapeutic
strategies. In addition, the availability of transgenic mice and in vivo imaging
platforms create a powerful platform, both for identifying disease mechanisms
and evaluating therapeutic strategies. In most of the imaging studies discussed
above, imaging was performed by the use of one or more modes of nonlinear
laser scanning microscopy. It is this form of microscopy which makes possible
the acquisition of high-resolution optical images inside of highly scattering
tissue, and a good deal of our work has focused on the use and development
of these techniques. The next chapter will focus on the physical mechanisms
underlying this class of microscopy.
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CHAPTER 3
NONLINEAR OPTICAL MICROSCOPY AND TECHNIQUES
In this chapter, we will examine the underlying mechanisms of nonlinear
microscopy in its many forms. Whereas the previous chapter focused on
the biological issues of spinal cord injury, this chapter will be weighted
towards the physics of various microscopy techniques. We begin this chapter
with a very brief description of what nonlinear optical microscopy achieves
in comparison to other imaging modalities and provide some illustrative
examples of how this form of microscopy is a powerful tool for the biological
sciences and neuroscience in particular. We then move into considering the
basic scaling of nonlinear optical signals and how this simple consideration
combined with rudimentary beam geometry is sufficient to demonstrate the
most valuable aspect of nonlinear microscopy: optical sectioning. From
these general considerations, we then discuss the most widely-used form of
nonlinear optical microscopy, two-photon excited fluorescence (2PEF), in terms
of optimal laser parameters for strongly- and weakly-absorbing dyes. We then
consider the processes of second and third harmonic generation (SHG and
THG, respectively), and how these techniques share a common platform but
a different mechanism than 2PEF. Finally, we round out the chapter with a
discussion of optical damage, both in terms of the limits this places on imaging
and as a technique for manipulating tissue.
It should also be noted that in this chapter we shall not attempt to merely
restate what may be found in fuller treatises, such as the useful texts by Robert
Boyd [1] and Jerome Mertz [2]. These texts are highly recommended to the
reader for greater understanding of the topics discussed. However, some
overlap is unavoidable and we will focus on only the most critical aspects of
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these modalities.
3.1 The Significance of Multiphoton Microscopy
Nearly two decades ago, Denk et al. [3] developed nonlinear laser scanning
microscopy (NLSM) or multi-photon microscopy (MPM) as an optical imaging
modality that allows for micrometer-resolution imaging inside highly scattering
tissue. Since that time, MPM has seen considerable use for in vivo studies,
especially in the neurosciences (for reviews, see [4, 5]), where imaging in the
mouse neocortex has reached up to [6] and in excess of [7] 1 mm.
The primary value of MPM is that it achieves optical sectioning–that is,
the ability to construct a 3-dimensional image by imaging successive, axially-
separated planes in isolation from each other–even in the presence of scattering
media. Wide-field fluorescence microscopy achieves fluorescence excitation
by uniform illumination of the sample, which allows for a large field of view
(hence the name) to be imaged simultaneously. This form of microscopy
is useful when examining fluorescently-labeled plated cells or fluorescently-
stained thin (∼ 10 µm) tissue sections. However, since fluorescence signal is
produced everywhere there are fluorophores in the sample, optical sectioning
is not possible. In contrast, confocal microscopy achieves optical sectioning by
using an aperture to reject all light not originating from the focal volume. Thus,
fluorescence is excited everywhere within the focused beam, but only collected
from light originating in the focal plane. By scanning the position of the focus
within a given plane, an image may be built up in a point-by-point fashion.
Translation of the sample or movement of the focus axially shifts the image
plane, allowing for 3-dimensional reconstruction of the specimen. However,
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confocal microscopy requires the trajectory of emitted photons to be ballistic;
that is, to have a return path to the objective devoid of scattering events. In other
words, confocal microscopy provides optical sectioning in transparent media.
In thick tissue, such as the rodent cortex, the assumption of ballistic photon
trajectories is quickly lost and signal becomes washed-out.
The great power of MPM and specifically 2PEF is that it allows for optical
sectioning regardless of scattering of, and hence, the trajectory of emitted
fluorescence1. As we shall see in the next section, optical sectioning is achieved
by exciting fluorescence only in the focal volume. Since we know a priori that
any detected fluorescence could only have arisen within the focal volume, we
need only measure the intensity of fluorescent emissions. By way of contrast,
recall that in wide-field fluorescence we must simultaneously measure position
and intensity of fluorescent emissions by creating an image directly, whereas in
2PEF we know position and only measure intensity.
The value of 2PEF microscopy should not be understated nor seen as an
incremental contribution to biological imaging: it allows for imaging cellular
and sub-cellular processes in vivo with the same resolution as was previously
accessible only to in vitro or in situ2 studies. This ability is useful for at least two
profound reasons. First, in vivo imaging allows for the non-invasive capture
of complex dynamic processes invisible to histological analysis. We discussed
a number of these studies in the spinal cord in the previous chapter, but a
particularly striking example of the relevance of dynamics was seen in the
mouse neocortex in a recent paper by Fuhrmann et al. [8]. In this study,
Fuhrmann et al. examined the interaction between microglia (labeled with
green fluorescent protein (GFP)) and neurons (labeled with yellow fluorescent
1It should be noted that scattering will still exponentially diminish the power of the
excitation beam, resulting in less generated fluorescence.
2For example, brain slice preparations.
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protein (YFP)) in a mouse model of Alzheimer’s disease. In mice containing the
CX3CR1 receptor, microglia were observed to swarm affected neurons, induce
their death, and subsequently disperse (see Fig. 3.1). Microglial density 100 µm
distal to affected neurons did not differ from controls, indicative that uniformly
increased microglial proliferation was not a consequence of gene knockout. In
contrast, double CX3CR1 knockout mice3 failed to show any of the pathological
affects of microglial-mediated neuronal loss. It should be noted that fixed-point
histology would only allow for a single panel to be seen in Fig. 3.1, making it
difficult or impossible to establish microglia as mediators of neuronal death.
Thus, 2PEF allows for the discovery of novel mechanisms–both physiological
and pathological–as well as the monitoring of disease progression at the cellular
and even sub-cellular level in an unprecedented way.
Second, 2PEF allows for studies of structures and processes in vivo for
which there simply is not an in vitro analog. For example, the availability
of calcium indicator fluorophores has extended the value of 2PEF beyond
structural imaging to functional imaging, enabling an understanding of neuron
activity, network structure, and recruitment at the cellular level. Dombeck
et al. [9] have demonstrated the power of this technique by imaging calcium
activity in awake, active mice. Their central hypothesis was that nature has
chosen the most “cost-effective” way of arranging neurons, such that neurons
that are correlated in activity are clustered spatially, thereby reducing the
length of processes necessary for “wiring”. Specifically, Dombeck et al. looked
at the distinct behaviors of grooming and running and found that distinct
3In this strain of mouse, the CX3CR1 receptor protein is replaced (i.e. “knocked out”) by a
green fluorescent protein. Where mice would normally express the CX3CR1 receptor, they now
express a fluorescent reporter protein. In mice that are heterozygous for this knockout, a single
gene copy of CX3CR1 still exists, and the receptor is expressed on the surface of microglia. In
double knockouts, microglia are missing the receptor entirely, and will be unable to bind the
ligand, fractalkine or CX3CL1.
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populations of neurons had strongly correlated firing patterns corresponding to
each behavior. Correlated neurons formed distinct clusters, and these clusters
were often spatially distinct from one another even when associated with the
same behavioral function, which is counterintuitive and opposed the central
hypothesis. Yet, within each cluster, correlations in neuron activity were strongly
linked to neuron spatial separation, with the strongest correlations in activity
corresponding to the smallest distance, in agreement with the hypothesis. This
finding provides a fundamental insight into the organization of neurons in the
mammalian cortex. Moreover, the study explored relations of macroscopic
animal behavior to cellular function and spatial organization at the level of
individual neurons. 2PEF microscopy is the only technique currently available
that can explore these questions on this scale.
Having provided some background on the immense value of MPM, we will
now explore the underlying mechanism of these techniques.
3.2 MPM and Optical Sectioning
3.2.1 Nonlinear Optical Signals
By definition, the intensity of light, INL, produced from a nonlinear process of
order4 m depends on the mth power of the laser intensity, IL:
INL ∝ ImL (3.1)
4We here distinguish the order of the process according to its intensity dependence rather
than the order of the nonlinear susceptibility tensor discussed in later sections, e.g. χ(3) vs. χ(2).
For example, 2PEF is a χ(3) process, but scales with the square of the laser intensity. We thus
consider this to be a second-order process.
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For a pulse with a square temporal profile focused to a spot size of area A, the
laser intensity is given by:
IL =
E
Aτ
(3.2)
where E is the energy per pulse and τ is the pulse duration. The nonlinear
signal, SNL, detected at the microscope is then proportional to INL integrated
over the pulse duration (the amount of signal produced throughout the pulse
duration), the number of pulses per unit time (the signal produced from all the
pulses combined) given by the laser repetition rate, R, and the area of the beam
(the total signal produced everywhere in space), which by (3.1) gives:
SNL ∝
(
E
Aτ
)m
ARτ =
Em
Am−1τm−1
R (3.3)
As we might expect, (3.3) predicts that tight focusing (i.e. using large
numerical aperture (NA) lenses) to a small spot, large pulse energies, short
pulse durations, and large repetition rates will result in large signal, and hence
improved contrast. Alternatively, we may rewrite (3.3) in terms of the average
power, given by:
〈P 〉 = ER (3.4)
which in turn gives:
SNL ∝ 〈P 〉
m
Am−1(τR)m−1
(3.5)
Equation (3.5) is more useful from an experimental viewpoint, as we typically
measure average power from a laser with a fixed repetition rate.
3.2.2 Key Focusing Parameters and Resolution
As could be seen above in (3.3) and (3.5), SNL ∝ A−(m−1). This fact provides
the underlying logic of 2PEF microscopy: signal is only generated at areas of
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high intensity, which for a focused Gaussian beam occurs only to an appreciable
extent within the confocal volume.
To begin, we first note that all our analysis to date has been for a pulse
with a square spatial and temporal profile, while in reality both are Gaussian or
Gaussian-like. For our discussion in this section, it will be necessary to consider
Gaussian beams. It can be shown that [1] the intensity of a Gaussian beam
follows the shape:
IL(r, z) = I0
(
w0
w(z)
)2
exp
(
− 2r
2
w2(z)
)
(3.6)
where
w(z) = w0
√
1 + (2z/kw20)
2 (3.7)
for peak intensity I0, beam waist w0, wave vector k = 2pi/λ for wavelength λ,
radial coordinate r, and axial coordinate z . In a linear process, such as wide-
field fluorescence microscopy, we may integrate (3.6) over the beam area to get
the signal5, S(z):
S(z) =
∫ ∞
0
I(r, z)2pirdr =
piw20
2
I0 (3.8)
Thus, for wide-field fluorescence or any linear excitation technique, the signal is
independent of the position z (and hence lacks optical sectioning capabilities),
as we might have guessed from (3.3).
We now turn our attention to higher order processes. For a process that
scales as ImL , we have:
ImL (r, z) = I0
(
w0
w(z)
)2m
exp
(
− 2mr
2
w2(z)
)
(3.9)
Integrating over the area:
Sm(z) =
∫ ∞
0
I(r, z)2pirdr =
piw20
2m
(
w0
w(z)
)2(m−1)
I0 (3.10)
5Of course, the signal will depend on the sample as well. For fluorescence, we would need
to multiply by concentration and the absorption cross-section to get the true signal.
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or more explicitly
Sm(z) =
piw20
2m
(
1
1 + (2z/kw20)
2
)m−1
I0 (3.11)
As is clear from Sm(z), we now have a signal that depends strongly on the
position z, meaning that even if the sample is uniform, signal will be generated
preferentially at the focus, giving rise to optical sectioning. The confocal
parameter, b, is defined [1] to be:
b ≡ kw20 (3.12)
which gives the approximate z resolution of the process. For an Airy point
spread function (PSF) [2], the beam waist (i.e. diffraction limit) is related to the
numerical aperture of the objective by:
w0 =
λ
2NA
(3.13)
A plot of normalized intensity using (3.11) for m = 2, 3 is shown in Figure 3.2.
3.2.3 Experimental Setup
Since we know the origin of any nonlinear signal to arise from the focal volume
of an objective, we need only move the point of interest and measure the
signal, recording the known location and intensity. We might imagine doing
this by scanning the sample underneath an objective, but this would result
in much slower acquisition than is possible using other techniques. Typically
then, the angle of the beam is scanned using galvanometric mirrors or similar
devices. Figure 3.3 shows a depiction of the microscope used in our studies.
Briefly, femtosecond infrared laser pulses are incident on the scan mirrors,
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Figure 3.2: Signal as a function of position z for a focused Gaussian beam.
For an objective of NA = 1, we show the signal intensity profile for a second- (blue) and
third-order (green) process. A linear process is independent of depth.
50
O
B
J
P
D
C
M
S
D
C
M
S
A
M
P
LE
TL
S
L
S
M IR
L
B
F-
S
B
F-
L
P
M
T1
P
M
T2
Fi
gu
re
3.
3:
M
ul
ti
ph
ot
on
m
ic
ro
sc
op
e
se
tu
p.
A
n
in
fr
ar
ed
la
se
rp
ul
se
(I
R
L)
is
de
fle
ct
ed
of
fo
fr
ap
id
ly
ro
ta
ti
ng
sc
an
m
ir
ro
rs
(S
M
)p
as
si
ng
th
ro
ug
h
a
tu
be
le
ns
(T
L)
an
d
a
sc
an
le
ns
(S
L)
w
hi
ch
va
ry
th
e
an
gl
e
of
th
e
be
am
(t
ho
ug
h
no
t
it
s
po
si
ti
on
)
at
th
e
ba
ck
ap
er
tu
re
of
th
e
ob
je
ct
iv
e
(O
BJ
).
Th
e
ge
ne
ra
te
d
flu
or
es
ce
nc
e
is
de
fle
ct
ed
by
th
e
pr
im
ar
y
di
ch
ro
ic
m
ir
ro
r
(P
D
C
M
)
an
d
th
e
lig
ht
is
su
bs
eq
ue
nt
ly
sp
lit
in
to
2
ch
an
ne
ls
at
th
e
se
co
nd
ar
y
di
ch
ro
ic
m
ir
ro
r
(S
D
C
M
).
Bl
oc
ki
ng
fil
te
rs
BF
-S
an
d
BF
-L
fil
te
r
th
e
sh
or
ta
nd
lo
ng
flu
or
es
ce
nt
w
av
el
en
gt
hs
,r
es
pe
ct
iv
el
y.
Th
e
flu
or
es
ce
nt
lig
ht
is
de
te
ct
ed
by
ph
ot
om
ul
ti
pl
ie
r
tu
be
s
(P
M
T1
an
d
PM
T2
).
51
which vary the azimuthal and planar angle of the light. The scan lens/tube lens
combination works by forming an image of the scan mirrors at the back aperture
of the objective, thus allowing angle to change without varying the position.
This process assures maximal filling of the back aperture (and so maximizes
the effective NA of the objective), while allowing the angle (and thus the xy
position in the sample) to vary rapidly. (For a discussion of some of the finer
details of under-filling or over-filling the back aperture, see [10]). Translation in
z is achieved either by translation of the stage (as in our setup), or by translation
of the objective. Faster z-scanning has been achieved by the use of electronically
tunable lenses [11], where small changes in current can change the focal length
of a lens prior to entry at the back aperture. Alternatively, acoustically tunable
gradient index of refraction lenses (TAG lenses) [12, 13] have also been used.
Fast scanning in the xy plane as well as in z has been achieved using pairs of
acousto-optic deflectors (AODs) [14–16].
3.3 Two-Photon Excited Fluorescence
Since 2PEF was the first modality developed [3], and since the availability
of bright exogenous fluorophores and transgenic mice expressing brilliant
fluorescent proteins continues to improve and expand, 2PEF has dominated the
nonlinear imaging scene. Physically, 2PEF occurs when an electron is promoted
to a higher energy state by the absorption of two photons with individual
photon energies below the energy gap, but whose sum exceeds it. Subsequent
internal conversion and emission of light follows similarly to the more common
single-photon excited fluorescence. However, due to the nonlinearity of 2PEF,
careful analysis of laser parameters to optimize signal while avoiding saturation
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must carefully be determined, which is the subject of this section.
3.3.1 Signal and Saturation
The instantaneous 2PEF power, wf , produced by excitation from a laser with
intensity IL is often expressed as [2]:
wf = σ2PEF I
2
L (3.14)
where σ2PEF is the two-photon excitation fluorescence cross-section6. Due
to internal conversion, σ2PEF is properly distinguished from the two-photon
absorption (2PA) cross-section, σ2PA, and is related by:
σ2PEF = Φσ2PA (3.15)
where Φ is the quantum efficiency which ranges between 0 and 1 and is defined
as:
Φ =
2× number of photons emitted
number of photons absorbed
(3.16)
It is often desirable to talk of power in number of photons rather than the SI
equivalent, which can be achieved by expressing intensities in terms of photons
by dividing by hν, where h is Planck’s constant and ν is the relevant frequency.
This gives the conventional two-photon cross-section in the Go¨ppert-Mayer
(GM) unit7, which is related to the SI equivalent according to [2]:
σ2GM =
( νf
2ν
) 10−58
hν
σ2PEF (3.17)
where νf and ν are the fluorescence and excitation frequencies, respectively. To
see this relation, we first note that the units of σ2PEF are W−1m4. The total
6Technically speaking, σ2PEF is the two-photon excitation fluorescence action cross-section,
since it depends on intensity and has units W−1m4. A true cross-section is thus σ2PEF IL, which
has units of area.
71 GM = 10−50 cm4s/photons
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number of incident photons is given by dividing by the incident photon energy
hν. These photons are converted to fluorescent photons of frequency νf at a
rate of one for every two incident photons at frequency ν. The number of
fluorescent photons is thus the product of the number of incident photons with
the conversion rate. The conversion from m4 to cm4 results in an additional
factor of 10−8.
For a square pulse of duration τ and energy E, the average fluorescence
energy per pulse is simply:
τwf =
σ2PEFE
2
τA(z)2
(3.18)
where A is the cross-sectional area of the pulse at position z, with z = 0
corresponding to the focal plane. For an ensemble of N fluorescent molecules
inside the focal volume, V , with concentrationC, the total fluorescence is simply
N × τwf , which gives:
NτwF = CV τwf = CV
σ2PEFE
2
τA(z)2
(3.19)
Unlike SHG and THG (discussed in the Section 3.4.1) which do not
involve change in the electron populations, 2PEF involves real (as opposed to
virtual) electron transitions and relaxations. Consequently, at sufficiently large
excitation intensities, it is possible to excite all of the dye molecules in the focal
volume, such that any further increase in excitation intensity does not produce
any change in wf . Such an occurrence is undesirable as it changes the shape
of the point spread function (PSF) to a “top hat” shape, resulting in loss of
resolution. Relaxation times, Γ−1f , are on the order of a few nanoseconds [17],
consistent with Fermi’s Golden Rule, so molecules certainly cannot relax within
a pulse duration. To avoid cumulative saturation, we set an upper bound on
pulse repetition rate of approximately R  Γf ∼ 1 GHz. This limit has been
proposed and achieved by Ji et al. [18], and will be examined again later in
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this section. It should also be noted that for τ ∼ 100 fs 1 ns, no molecule is
excited twice by the same pulse, so we restrict our considerations to single pulse
saturation.
Effective imaging is bounded below by fluorescence detection which
requires a minimum of one photon per pixel, which is the product of the
expected number of photons per pulse times the pulse repetition rate, R, and
the pixel dwell time. As a rough guide, let us assume that we are at the limits of
scan speed and this means we need a minimum of 1 photon per pulse. Imaging
is bounded above by dye saturation8. In the first case, we set the left hand
side of (3.19) equal to a single photon energy, and in the second instance, we
naı¨vely set it equal to Nhνf = CV hνf 9. For τ ∼ 100 fs, A ∼ 1µm2, and typical
values for excitation wavelength (∼1 µm) and fluorescence wavelength ( 500
nm), saturation occurs at energy:
E ≈ 10/√σ2GM nJ·GM
1
2 (3.20)
Equation (3.20) gives the appropriate energy scale in the nJ range, and the
scaling gives 2 orders of magnitude change in σ2GM per order of magnitude
change in saturation energy.
This result, however, was based upon a concentration that is uniform for
all time. Of course, this is not true since dye molecules that are in the excited
state can no longer be excited, and the concentration of molecules in the ground
state becomes depleted. In addition, we must take into account two-photon
stimulated emission, which will repopulate the ground state.
8Or by photodamage, which we shall discuss later in this chapter
9This limit assumes a quantum efficiency of unity. It is possible to have all the relevant
molecules in an excited state that does not result in fluorescent decay. For example, hemoglobin
has a quantum efficiency of 0, but σ2PA as high as 150 GM [19]. Conversely, fluorescein has
an efficiency of Φ = 0.9 [20] and at its peak, σ2PA = 37 GM or σ2GM = 33 GM [21]. Thus,
the validity of the approximation of Φ = 1 is dye dependent, although the correction is not a
difficult one to make.
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To deal with this complication, we model our molecule as a two-level system
with a total of N molecules, with Ng molecules in the ground state and Ne in the
excited state. The number of molecules in the ground state is depleted by two-
photon absorption and populated by both spontaneous excited state relaxation,
occuring at a rate Γ−1f , and two-photon stimulated emission, proportional to
the two-photon stimulated emission cross-section, σ2SE , and the square of the
intensity . That is:
dNg
dt
= −σ2GM
(
I(t)
hν
)2
Ng + (Γf + σ2SE
(
I(t)
hν
)2
)Ne (3.21)
Since we have Ng(0) = N or Ne(0) = 0, and since Γf is on the order of GHz,
compared to the femtosecond duration of I(t), we ignore the spontaneous decay
term10. After making the substitution, Ne = N −Ng, this gives:
dNg(t)
dt
= −(σ2GM + σ2SE)
(
I(t)2
(hν)2
)
Ng + σ2SE
(
I(t)
hν
)2
)N (3.22)
This is a linear ODE, which for a square pulse can be solved exactly to give:
Ng(τ)/N = [1− σ2SE
σeff
] exp
(
−σeff (E/hν)
2
A2τ
)
+
σ2SE
σeff
(3.23)
where σeff = σ2GM + σ2SE . By consideration of Fermi’s Golden Rule, we expect
σ2GM = σ2SE , and so we arrive at:
Ng(τ)/N =
1
2
[1 + exp
(
−2σ2PEF (E)
2
A2τ
)
] (3.24)
Appreciable saturation occurs when the argument of the exponential in (3.24)
is of order unity, which agrees to within a factor of 2 with our naı¨ve estimate.
Physically, this requires us to redefine “saturation”, since (3.24) gives a decaying
exponential with increased pulse energy, rather than a hard cut-off. Moreover,
10Put differently, saturation requires the first term in (3.21) to be of order N/τ to excite all
molecules in one pulse. Conversely, at the end of the pulse, N = Ne, and the second term has
order NΓf . Thus, the ratio of the excitation and decay rates amounts to Γ−1f /τ  1.
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(3.24) shows us that even the asymptote corresponds to 1/2 the total number
of molecules being excited, rather than all the molecules as in our previous
estimate. Since a factor of
√
2 is already well within our approximation, we let
(3.20) stand as a guideline. For a bright dye (σ2GM = 100 GM), this happens
at pulse energies as low as 1 nJ, while for a dim dye (σ2GM = 0.5 GM), this
happens at approximately 15 nJ. For a typical Ti:Sapphire laser with a repetition
rate of around 100 MHz, this corresponds to average powers of 100 mW and
1.4 W for the bright and dim dye, respectively, both of which are well above the
average power damage threshold we discuss later. In contrast, for our 1 MHz
fiber laser, these shift to average powers of 1 mW and 14 mW for the bright and
dim dyes, respectively. Since these are experimentally relevant values at 1 MHz,
consideration of saturation cannot be ignored for low repetition rate sources.
We now consider the opposite extreme, where we are signal limited. The
focal volume of interest is V2f = w20b where w0 is the beam waist at the focus and
b is the confocal parameter. Typical values are w0 = b = 1µm and concentrations
of 104 µm−3 11. Plugging these numbers in as before gives a minimum pulse
energy, Emin, of:
Emin =
0.1√
σ2GM
nJ·GM 12 (3.25)
or about a factor of 100 away from the saturation point. Trivially, this gives
a minimum pulse energy of 0.01 nJ and 0.14 nJ for a bright and dim dye,
respectively. Consideration of repetition rate gives average powers of 1 mW
and 14 mW at 100 MHz and 0.01 mW and 0.14 mW at 1 MHz for each dye,
respectively. If we consider imaging of a weak dye at 100 MHz, a maximum
signal of 4 photons per pulse is achieved before the onset of thermal damage
11Based on vascular labeling in mice. A 70 000 MW dextran with 4 dye molecules/dextran
at 5 % weight solution is injected at 0.1 mL into an animal of average blood volume 1.5
mL, for an average fluorophore concentration on the order of 1016 fluorophores/mL or 104
fluorphores/µm3.
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at around 60 mW. In contrast, at 1 MHz, pulse energy can be increased until
the ablative damage threshold at 30 mW is reached, giving a 200 fold per-
pulse increase in signal12. Conversely, if both a weak and a strong dye are
simultaneously excited, the upper bound is set by the saturation of the strong
dye at 1 mW at 1 MHz, limiting the weak dye to a more modest 7-fold signal
increase.
Finally, we must consider that the integrated signal increases linearly with
pulse repetition rate. Thus, by (3.19), the integrated 2PEF power, Wf , is given
by:
Wf = Nτwf ×R = CV σ2PEFE
2
τA(z)2
R (3.26)
or expressed in terms of average power:
Wf = CV
σ2PEF 〈P 〉2
τA(z)2R
(3.27)
in good agreement with (3.3) and (3.5). Figures 3.4 and 3.5 show a summary
of these calculations. In general, curves of constant two-photon power, wf
have slope-1/2 on a log-log plot of E vs R, with increasing two-photon power
moving up to the right. Changing σ2PEF on these plots adjusts only the y-
intercept. Maximum signal without damage is thus obtained at the intersection
of the average power damage threshold and the saturation threshold for a given
dye, or the nonlinear damage threshold for a very weak dye. Since harmonic
generation (which will be discussed in the next section) is a coherent effect13
that does not saturate, the only consideration for SHG and THG is given by
(3.3), making the point of maximum signal for both SHG and THG occur at the
12Damage thresholds and their determination are discussed in Section 3.5
13From a density matrix formalism point of view, 2PEF results in changes in diagonal
(population) terms because there is a real energy transition for the electron, whereas SHG and
THG affect only off-diagonal terms (polarization)
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Figure 3.4: Boundary mapping of 2PEF excitation in pulse energy-repetition rate
space.
Area outside the damage thresholds limit the regime of possible laser parameters.
There is another limit (not shown) at the GHz scale, where the delay between pulses
is shorter than the relaxation time of the dye. Results of boundary calculations for a
100 GM dye (blue) and a 0.5 GM dye (red) are shown, with shaded regions showing the
experimentally relevant regimes. Solid lines mark dye saturation levels, dashed lines
mark the single-photon-production-per-pulse limit, marking the top and bottom of the
regimes, respectively.
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Figure 3.5: 2PEF photon production rate as a function of pulse repetition rate, R, and
pulse energy, E for 100 GM dye.
Signal scales quadratically in E and linearly in R. The black solid line marks the average
power damage threshold.
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intersection of the ablative and thermal damage limits14 (see Figure 3.4). As is
evident from Fig. 3.4, simultaneous imaging of dim and bright dyes will pose
a challenge, as increasing signal-to-noise for a dim dye may push the bright
dye beyond the point of saturation. This concern is not merely theoretical.
For example, 2PEF imaging of metabolic activity in vivo using intrinsic NADH
fluorescence and its relation to microvascular perfusion by FITC (a fluorescein
derivative) dextran [22] were simultaneously assessed at 740 nm excitation in
the context of cortical spreading depression. At this wavelength, NADH has
σ2GM ≈ 0.1 GM [23] while fluorescein has σ2GM ≈ 30 GM [21]. Thus, the high-
repetition rate systems of Ji et al. [18] are not necessarily ideal for every process
of interest, but would enable faster scanning for bright dyes.
3.4 Harmonic Generation
Harmonic generation (HG), is another nonlinear optical phenomenon.
Experimentally, performance of HG imaging is identical to 2PEF, with spectral
isolation of the harmonic of interest achieved by spectral selection filters in the
same way as for fluorescence emission. In light of the similarities, and since
SHG and THG are often generated from contrast arising within the tissue of
interest itself, it is tempting to confuse SHG and THG with endogenous 2PEF
or three-photon excited fluorescence (3PEF). However, this would be a great
mistake, since the physical mechanisms are quite different. One key difference
between HG and 2PEF is that for HG, the electron never enters an excited state,
14To see this limit intuitively, consider that the slope of the thermal damage limit on a log-log
plot of E vs. R is -1, while the slopes for lines of constant SHG and THG signal are -1/2 and
-1/3, respectively. The intersection of the lines of constant harmonic generation signal with the
thermal damage limit is always obtuse, making the intersection with damage limits a unique
maximum.
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while for 2PEF, it does. To understand this distinction, we must consider non-
absorptive material responses to an applied electric field.
3.4.1 Signal Origins
In Section 3.2.1, we found that a simple consideration of the definition of
nonlinear optical signals was sufficient to explain optical sectioning, and we
found that 2PEF followed this analysis closely with the addition of the pre-
factor, σ2PEF . However, this analysis is somewhat misleading because we have
completely ignored the underlying physics giving rise to such a signal. In
reality, nonlinear optical phenomena occur in media that respond to an applied
electric field, E, by giving rise to a material polarization or dipole per unit
volume, P. This polarization may be written in terms of a Taylor expansion
of the electric field:
P = 0[χ
(1)E+ χ(2)E2 + χ(3)E3 + . . .] (3.28)
where 0 is the permittivity of free space15 and the coefficients, χ(n), are the nth
order susceptibility tensors16. Thus, at a given point in the sample, a single
monochromatic field of the form
E(t) = E0 exp(iωt) + E
∗
0 exp(−iωt) = E0 exp(iωt) + c.c. (3.29)
15SI units will be used here and throughout as a matter of convention and for ease of
comparison with experimentally measured values.
16The terms in the expansion (3.28) are properly understood as tensorial products, which we
have written in shorthand as “powers” of the electric field. Of course, the electric field is a
vector, which cannot be simply “squared” as a scalar. However, since we will be treating the
susceptibility tensors as scalars (i.e. working along principal axes in isotropic materials), we
will omit their tensorial nature.
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where ω is the field frequency, E0 the field strength, and c.c. denotes complex
conjugate will give rise to a material response at frequencies:
χ(1) : ω (3.30)
χ(2) : 2ω, 0(DC) (3.31)
χ(3) : 3ω, ω (3.32)
These terms arise straightforwardly from all possible combinations of the given
power of the field in each term. However, it is worth noting that in contrast
to the considerations in Section 3.2.1, we are now working with fields, and not
merely intensities, which as a general rule means that phase is important. To
understand the importance of this aspect, as well as how induced changes in
the medium give rise to new output frequencies, we must turn to the nonlinear
wave equation.
3.4.2 The Nonlinear Wave Equation
Applying Maxwell’s equations to the polarization given in (3.28), along with the
slowly varying envelope approximation and assumption of small divergence
in E [1], we easily arrive at the nonlinear wave equation. For an electric field
propagating in the z direction of the form:
Ej = Aj(r) exp[i(kjz − ωjt)] + c.c. (3.33)
where subscript j denotes the component of the field corresponding to
frequency ωj , the wave equation takes the form:
{∇2TAj + 2ikj
∂Aj
∂z
} exp(i[kjz − ωjt]) = 1
c2
∂2(PNL,j/0)
∂t2
(3.34)
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where ∇2T = ∂2/∂x2 + ∂2/∂y2 is the transverse Laplacian and PNL,j is
the nonlinear polarization at frequency ωj . By the requirements of linear
independence, we take PNL,j to have the form:
PNL,j = Pj(r) exp(i[kjz − ωjt]) (3.35)
which when inserted into (3.34) yields:
{∇2TAj + 2ikj
∂Aj
∂z
} = −ω
2
j
c2
(Pj/0) (3.36)
Equation (3.36) is the nonlinear wave equation. Great insights can be gained in
harmonic generation by consideration of this equation in its plane-wave form
alone, to which we now turn our attention.
3.4.3 Plane Wave Approximation
The simplest consideration is a homogeneous, isotropic material in the plane
wave limit. In this case, the first term in (3.36) vanishes identically. This gives
the simple governing equation:
dAj(z)
dz
= i
ω2j
2kjc2
Pj(z)/0 (3.37)
Since the work in this thesis is focused on THG (see Chapter 4), we consider a
centrosymmetric molecular structure for which χ(2) = 0, though the procedure
for second harmonic generation is completely analogous. We thus have by
(3.28)17:
P = 0χ
(3){A1(z) exp(i[k1z − ω1t]) + A3(z) exp(i[k3z − ω3t]) + c.c.}3 (3.38)
17We drop the notation of the subscript “NL” from hereon in, but it is implicit.
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Noting that ω3 = 3ω1 ≡ 3ω, we collect terms proportional to exp(−i3ωt) to get:
P3 = 0χ
(3)[A31 exp(i3k1z) + A
2
3A
∗
3 exp(ik3z)] exp(−i3ωt) (3.39)
In most applications, the pump beam magnitude, |A1(z)|, is considerably larger
than the harmonic,|A3|, so we neglect those terms of supralinear order in the
third harmonic field, or:
P3 = 0χ
(3)(3ω;ω, ω, ω)A31 exp(i[3k1z − 3ωt]) (3.40)
But by (3.35), we have:
P3 = P3(z) exp(i[k3z − 3ωt]) (3.41)
which is true if and only if:
P3(z) = 0χ
(3)(3ω;ω, ω, ω)A31 exp(i[3k1 − k3]z) = 0χ(3)(3ω;ω, ω, ω)A31 exp(i∆kz)
(3.42)
where
∆k ≡ 3k1 − k3 (3.43)
is the wave-vector mismatch18. Inserting (3.42) into (3.37) then gives:
dA3
dz
=
i(3ω)2
2k3c2
χ(3)(3ω;ω, ω, ω)A31 exp(i∆kz) (3.44)
Since A1 also has a nonlinear component and is coupled to A3 in (3.44), we
perform a similar calculation:
dA1
dz
=
iω2
2k1c2
[χ(3)(ω;ω, ω,−ω)|A1|2A1 + 3χ(3)(ω; 3ω,−ω,−ω)A3A∗21 exp(−i∆kz)]
(3.45)
where the factor of 3 is a result of the combinatorics of cross terms in (3.38).
Since A1  A3, we ignore the second term to get explicitly:
dA1
dz
=
iω2
2k1c2
χ(3)(ω;ω, ω,−ω)|A1|2A1 (3.46)
18This is sometimes referred to as the phase mismatch, which is a misnomer since the phase is
actually the product of the wave-vector mismatch with a length.
65
For a strong pump and weak harmonic generation, |A1|2 ≈ constant, and we are
left with:
A1(z) = A1(0) exp
(
iω2
2k1c2
χ(3)(ω;ω, ω,−ω)|A1|2z
)
(3.47)
Substitution of (3.47) into (3.44) gives:
dA3
dz
=
i(3ω)2
2k3c2
χ(3)(3ω;ω, ω, ω)A1(0)
3 exp(i∆kz) exp
(
i3ω2
2k1c2
χ(3)(ω;ω, ω,−ω)|A1|2z
)
(3.48)
Since ∆k is a linear effect owing to material dispersion, whereas the second
exponential in (3.48) owes to a nonlinear effect, we may ignore the second
exponential as contributing a small effect only. Integrating then gives:
A3(z) =
(3ω)2
2k3c2
χ(3)(3ω;ω, ω, ω)A1(0)
3 exp(i∆kz)− 1
∆k
(3.49)
where we have assumed that no third harmonic exists prior to entering the
material, which we take to be semi-infinite and beginning at z = 0 (i.e. A3(z =
0) = 0). Using the link between the field envelope, A, and intensity:
I = 2nω0c|A|2 (3.50)
where nω is the index of refraction for frequency ω, we have:
I3(z) =
9ω2
16c420n
3
ωn3ω
|χ(3)|2
(
sin(∆kz/2)
∆k/2
)2
I31 (3.51)
Figure 3.6 shows the results of the oscillatory nature of (3.51).
It is worth making a few remarks about (3.51). First, we note that
our intuition based on (3.1) is correct, in that I3 ∝ I31 is verified by explicit
calculation. However, we also see the important role of phase in this process, as
introduced through the existence of a coherence length, Lcoh defined by:
Lcoh ≡ ∆k−1 (3.52)
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Figure 3.6: Plot of THG intensity as a function of length.
The oscillatory nature of the signal shows the importance of phase in this
coherent process. Position is measured in units of coherence length, Lcoh =
∆k−1.
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For ∆k 6= 0, I3 is an oscillatory function of position, reaching a maximum when
z = (2n + 1)piLcoh for integer n, whereas if the exponentials in (3.48) disappear,
we have unbounded quadratic growth in z. Thus, unlike the absorptive χ(3)
process19, THG in a material with a large value of χ(3) will not necessarily give
rise to a large THG signal. This phase dependence is why THG is called a
coherent process. It is also called a parametric process [1], which means that the
electron begins and ends in the same state. In contrast, 2PEF is a non-parametric
process since the electron is promoted to a real energy level.
Another property of THG is that it is forward generated, unlike the isotropic
emission of fluorescence. This property is also clear from (3.51). For example,
for backward generation of TH light (i.e. k3 → −k3), we have that ∆k =
3k1 − k3 = 3ω/c(nω − n3ω)→ 3ω/c(nω + n3ω), which results in a decrease in Lcoh
(∆k) by approximately 3 orders of magnitude. Paraxial focusing (relevant to
microscopy) introduces an additional phase, the Guoy phase [1], which further
restricts efficient production to optical interfaces. In addition, our boundary
condition for paraxial beams is that A3(−∞) = 0, with the precise form of A3
depending on the shape of beam A1. Since this derivation is shown explicitly
in [1] and an example is given in a later chapter on the use of THG for imaging
myelin, we shall not repeat the details here.
3.4.4 SHG and THG: Molecular Ordering
Both SHG and THG are coherent, parametric processes, meaning that they both
depend on phase and involve wave-vector mismatch. Our intuition from (3.1)
19It may seem like the title “two-photon” should suggest a χ(2) process. However, it is
important to keep in mind that a photon corresponds to two powers of the electric field, so
that we might equivalently call 2PEF “four-field-excited fluorescence”. THG also involves four
fields: three at frequency ω and one at frequency 3ω.
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serves us well in that SHG scales as the square of the input field. However,
SHG and THG are fundamentally different in a number of salient ways. First,
SHG can only occur in molecules which lack centrosymmetry, and hence, have
χ(2) 6= 0. To see this property of SHG, consider an electron sitting in a potential
V (x) which has the Taylor expansion:
V (x) ≈ ax2 + bx3 + cx4 + . . . (3.53)
Centrosymmetry is the requirement that V (x) = V (−x). This requirement is
met if and only if b = 0. A straight-forward application of perturbation theory
in the presence of an electric field will show that the electron will only oscillate
(and hence emit) at the second harmonic if b 6= 0. In contrast, THG is ubiquitous
in both centrosymmetric and non-centrosymmetric media.
Another salient difference between SHG and THG is the dependence on
molecular ordering. We shall here follow a toy model proposed by Mertz [2]
that is illustrative of this difference. We considerN molecules ordered along the
z axis, evenly spaced by lattice parameter, L. Analogous to our consideration of
THG in Section 3.4.3, each molecule will emit at the harmonic of interest, with
new harmonic light produced in phase with the fundamental at the location
of each molecule, but with a relative phase between adjacent atoms due to
harmonic wave propagation. However, we will also consider the excitation
beam to be polarized along the x axis, and we will assign the mth molecule
at position xm an angle φm with respect to the x axis. Since the hth harmonic
scales with the hth power of the electric field, the harmonic produced at the
mth molecule will depend on the component of the electric field along the
x axis as (E0 cos(φm))h, for field strength E0. However, by (3.53), we must
have that for even harmonics (odd powers of x in (3.53)) that the susceptibility
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tensor20 of order 2h, h = 1, 2, . . . at molecule m, χ(2h)m , changes sign under the
transformation x→ −x. Formally,
χ(2h)m =

sgn(χ(2h))|χ(2h)|, 0 < φm < pi/2
−sgn(χ(2h))|χ(2h)|, −pi/2 < φm < 0
(3.54)
where sgn denotes the positive or negative sign of χ(2h)m . In contrast, for even
harmonics (2h + 1, h = 1, 2, . . .), (3.53) requires that the sign remains the same,
or
χ(2h+1)m = sgn(χ
(2h+1))|χ(2h+1)m |, −pi/2 < φ < pi/2 (3.55)
The total sum for the harmonic, h, then depends on the sum over all atoms:
HG(h) ∝
∣∣∣∣∣
N−1∑
m=0
exp(i{hk − kh}mL)sgn(χ(h)m ) cosh(φm)
∣∣∣∣∣
2
(3.56)
Here, the first term in the sum comes from the phase-mismatch due to
dispersion within the medium while the second and third terms owe to the
molecular alignment with the field. For a material possessing strong order (i.e.
φm = constant), the last two terms fall out of the expression as a constant and the
dispersion phases contribute to a simple geometric series, giving:
HG(h) ∝ sin
2(∆k(N + 1)L/2)
sin2(∆kL/2)
(3.57)
where ∆k = hk − kh. In the limit of large N and small spacing L, this finding is
in good agreement with our results in (3.51).
Let us now consider a disordered material, such that φm is randomly
and uniformly distributed over the interval [−pi/2, pi/2]. To see the effect of
molecular alignment, we consider phase-matched conditions (i.e. hk − kh = 0),
reducing (3.56) to
HG(h) ∝
∣∣∣∣∣
N−1∑
m=0
sgn(χ(h)m ) cos
h(φm)
∣∣∣∣∣
2
(3.58)
20We will work with the case where χ(h) is real, though it is, in principle, complex
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or alternatively,
HG(h) ∝ N2 ∣∣〈sgn(χ(h)) cosh(φ)〉∣∣2 (3.59)
where 〈. . .〉 denotes the average over all molecules. Since we have assumed that
φm is uniformly distributed, we may approximate the average as an integral,
which gives
HG(h) ∝ N
2
pi2
∣∣∣∣∣
∫ pi/2
−pi/2
sgn(χ(h)) cosh(φ)dφ
∣∣∣∣∣
2
(3.60)
For even harmonics, (3.54) turns the integrand in (3.60) into an odd function of
φ, and the integral evaluates to 0, meaning that disorder destroys the harmonic
signal. In contrast, for odd harmonics, (3.55) gives an even function as our
integrand, and the harmonic remains. For h = 3 (i.e. THG), the integral gives
THG ∝
(
4
3pi
)2
N2 (3.61)
Thus, SHG and THG differ critically in terms of their dependence on molecular
orientation, with THG being more robust to disorder. However, it should
be noted that although THG is not destroyed by the random orientation of
molecules, the THG signal is reduced by more than 50% of its peak value in
disordered systems.
While the dearth of asymmetric molecules exhibiting molecular ordering
restricts SHG in imaging applications, molecular inversion can be used to
create periodically poled materials [24] that switch the sign of χ(2) on the
length-scale of the coherence length, thereby circumventing phase mismatch
problems. Moreover, the scarcity of well-ordered, non-centrosymmetric
biological molecules makes SHG a highly-specific, dye-free imaging source of
image contrast for those non-centrosymmetric molecules which do have regular
order and orientation, such as collagen [25–27]. Finally, while sources of SHG
are less common than THG, χ(2) ∼ 10−11 m•V−1 (e.g [28]) while χ(3) ∼ 10−22
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m2•V−2 (e.g. [29,30]) meaning that SHG will typically give rise to much stronger
signals.
3.5 Damage Considerations
We round out this chapter with a discussion of photodamage or photo
toxicity, the limits of which we have already mentioned in Section 3.3. By
photodamage, we mean injury inflicted on cells or tissue by the application of
light, and so we will exclude the process of photobleaching–the process by
which fluorophores are destroyed–from our discussion. Broadly speaking21,
the topic of photodamage can be divided into three categories: thermal
damage,nonlinear-absorption-mediated damage, and nonlinear ablation.
3.5.1 Thermal Damage
Since the strength of signal increases with the average power according to (3.5)
(although, not indefinitely as we saw in Section 3.3), high-resolution imaging
with a large signal-to-noise ratio will tend to favor the use of large average
power. However, since fluorescence is based on absorption (and quantum
efficiency), equation (3.5) equally governs linear absorption when m = 1. The
absorbed energy (assuming it is not re-emitted) results in tissue heating, which
eventually leads to tissue damage. Straightforwardly from Beer’s Law, the
21Of course, UV or X-ray mediated damage are also a source of photodamage, technically
speaking, and we could add the mutagenic effects of either to the discussion. However, we are
interested in acute photodamage rather than the long-term health effects of imaging.
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power absorbed, Pabs, in the focal volume is, to first order:
Pabs = αb〈P 〉 (3.62)
where α is the extinction coefficient, b is the confocal parameter, and 〈P 〉 is
the average laser power, as before. The onset of thermal damage is gradual
and difficult to define, since the temperatures at which different proteins
denature vary, and the occurrence of damage may not be immediately visible.
Experimentally, we have found that visible tissue disruption occurred in fixed
spinal cord sections at approximately 60 mW using a 10 MHz pulse repetition
rate, 300-fs pulse duration, 1040-nm wavelength laser, while we observed tissue
damage at approximately 35 mW for a 1 MHz repetition rate laser, with similar
wavelength and pulse duration. However, it should be noted that these values
will vary with the tissue under consideration and the wavelengths used, since
different chromophores will absorb to varying degrees. For example, the
absorptivity of hemoglobin can vary as much as 5-fold between 800 nm and
1000 nm, and strongly depends on oxygenation state [31]. Thus, blood-rich
tissues such as the liver will have different damage limits than those we have
observed. Since thermal damage depends only on average power, as can be seen
in (3.62), we should see disparity only if the damage mechanisms differ. As
can be seen from (3.4), these damage thresholds correspond to pulse energies
of 6 nJ and 35 nJ for the 10 MHz and 1 MHz lasers, respectively. Thus, the
higher average power limit corresponds to a lower pulse energy, suggesting
that 60 mW really is the upper bound on thermal damage, while the 35 nJ pulses
correspond to a nonlinear process scaling according to (3.3) with higher values
of m, which we shall discuss in Section 3.5.3.
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3.5.2 Nonlinear-Absorption-Mediated Damage
The onset of damage in our experiments on fixed tissue was characterized
by immediate and visible tissue destruction, either thermal or ablative (see
Section 3.5.3). For biological specimens, however, it has been seen that
phototoxicity can occur for ranges substantially below this threshold. Hopt
et al. have seen phototoxicity after a single scan at 10 mW of average power
at 80 MHz pulse repetition rate, assessed by both changes in indicator dye
intensity and morphological changes [32]. Ko¨nig et al. [33] have seen that
photodamage occurs at 7 mW for 240 fs pulses and follows a scaling of 〈P 〉2/τ ,
which along with wavelength considerations led them to conclude that the
damage mechanism is predominantly two-photon absorption (2PA). Koester et
al. [34] have confirmed this result and verified that the damage is cumulative,
scaling linearly with exposure time. Elsewhere [35], impaired division of cells
and interference with cellular metabolism at 6 mW and 150 fs pulses was
seen. Tirlapur et al. [36] have seen reactive oxygen species damage, DNA
fragmentation, and apoptosis at similar pulse parameters. In each case, pixel
dwell times were 10 µs [32], 60 µs and [33, 36] and 80 µs [35] with sub-micron
pixel sizes.
In contrast, our own dwell time is approximately 1 µs/pixel, which at 1 MHz
gives approximately 1 pulse per pixel, or 80 pulses per pixel with a Ti:Sapph
laser at 80 MHz at a magnification of 3 pixels/µm. This amounts to 3 pulses/µm
and 240 pulses/µm for the 1 MHz and 80 MHz sources, respectively. In [35]
at 80 µs/pixel and approximately 10 pixels/µm , this corresponds to 64000
pulses/µm at 80 MHz. At 6 mW, a cell of area 100 µm2 would receive a total
irradiation dosage of 0.5 mJ/scan. For the same laser parameters, we deliver
a mere 2 µJ. This 100-1000 fold increase in pulse delivery may account for
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the discrepancy between our observed damage thresholds and those of other
groups. In agreement with our observations of thermal damage, Ridsdale et
al. [37] have observed good viability below 50 mW while scanning continuously
for 7 minutes. All of the above measurements were performed in cultured cells,
except for the studies of Koester et al. [34], which examined basal dendrites of
layer V neurons in rat neocortical slice preparations.
Since 10 mW is well below our observed damage threshold, we may rule
out ablative damage (described in Section 3.5.3) as a mechanism of cell death.
Conversely, since 10 mW is also well below thermal damage limits, we rule out
linear absorption as well. However, if 2PA followed by chemical reaction is
the dominant damage mechanism–as the evidence cited above suggests–then it
is reasonable to conclude that cell viability depends on the cumulative number
of photodamaged molecules, as suggested in [34]. In this case, the number of
damaged molecules per scan follows (3.26) for a 1 µm2 focal spot:
Ndamaged ∝ E
2
τ
RT (3.63)
where T is the dwell time in s/µm22. Expressed in terms of average power, we
have by (3.4):
Ndamaged ∝ 〈P 〉
2
Rτ
T (3.64)
Based on these results, we assumed that damage is significant when a critical
number of molecules are destroyed, where this critical number determined by
the results of Konig et al. [35]. Based on this data, we calculated the average
power using our setup and parameters that would be required to give an equal
number of molecules damaged as a function of dwell time using (3.64). The
results are shown in Fig. 3.7. For reference, Konig et al. [35] performed 10
22More properly, it is given in s/µm2, since a diffraction limited spot is actually scanned.
Instead, we consider dwell time in terms of linear scan rate in one direction so as to keep with
convention and simplify calculations.
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Figure 3.7: Average power required to reach critical two-photon mediated damage as
a function of dwell time, T , in one scan.
Shown are results for an 80 MHz (blue) and 1 MHz (green) excitation source. The average
power damage threshold is shown for reference (dashed line). By way of reference, our
typical dwell time is 10−5 s, placing critical 2PA-mediated damage well-beyond the
thermal damage limit for either laser system.
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scans per cell at a scan rate of 20 s/frame, or a 200 s scan, with a corresponding
maximum pulse energy of 0.08 nJ. For our scan rates discussed previously, and
a 7 min. (420 s) continuous scan (to match Ridsdale et al. [37]) at the same
repetition rate (80 MHz), we calculated the pulse energy required to produce a
similar number of damaged molecules, and found this equivalent pulse energy
to be
Eequiv ≈ 14 nJ (3.65)
For an 80 MHz laser source, this corresponds to an average power of 1000 mW,
well above average power damage, and consistent with the lack of damage
observed by Ridsdale. A similar comparison with the data of Hopt et al. [32],
for whom a single scan took 100 ms, an equivalent pulse energy at our scan
rates was calculated to be:
Eequiv ≈ 2 nJ (3.66)
or an average power of approximately 200 mW, again well above damage
thresholds. At 1 MHz, the equivalent pulse energies are 1.200 µJ and 53 nJ,
respectively, well above ablative thresholds.
In light of the excessive pulse bombardment in previous studies, we find
it difficult to draw meaningful conclusions on cell viability as it applies to our
present analysis. In our own laboratory setting, longitudinal animal studies
have been performed using 20 mW or more at the sample surface from a 1
MHz source without observed pathology. Thus, based on our observations
from longitudinal imaging and the absence of meaningful evidence to the
contrary, we are justified in assuming that the damage thresholds we have
determined from our analysis (or very near to them) are the most relevant to
our discussion. Nevertheless, care must be taken in studies requiring extended
periods of imaging, since the results of cumulative damage may not present
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acutely. For example, three-photon absorption of 800-nm excitation wavelength
is equivalent to a single, high-energy, UV photon at 266 nm. Absorption of
this energy could lead to DNA breakage and subsequent apoptosis and/or
deleterious mutations.
3.5.3 Nonlinear Ablation
Finally, nonlinear ablation is a damage mechanism whereby a hot electron
plasma is formed by nonlinear absorption of light in the focal volume of an
objective, vaporizing the surrounding medium and resulting in a subsequent
shockwave [38]. Just as it is possible to excite an electron from the ground
state to an excited state by multi-photon absorption, so it is possible to excite
an electron to the point of ionization or at least to the conduction band
by multi-photon ionization (MPI) (for a review on atomic MPI, see [39]).
However, multi-photon ionization is not the whole picture. A process known
as inverse bremsstrahlung absorption (IBA) [39, 40] results in the free electrons
absorbing photons non-resonantly from the applied laser field. These “hot”
electrons cause impact ionization of the surrounding ions. In turn, these semi-
free electrons absorb photons from the laser field, resulting in more impact
ionization and so on. The result is an electron “avalanche” or cascade, whence
it is sometimes referred to as the “avalanch-breakdown” model [1]. While a
complete review of the topic is not possible, an outline of the theory is given
in [1]. For those interested in a more comprehensive analysis23 with an emphasis
on the use of this form of damage to induce alterations in tissue, the reader is
directed to a review by Vogel and Venugopalan [40]. However, we shall sketch
23Nonlinear ablation is its own field of study
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an overview of these effects here based on [38, 40].
First, we consider that the density of free electrons, ρ, to be given by the rate
equation [38]
dρ
dt
=
(
dρ
dt
)
MPI
(E) + γ(E)ρ− gρ− ηρ2 (3.67)
where the first term corresponds to semi-ionized electrons generated by MPI,
the second to avalanche ionization at rate γ, the third term to electron diffusion
out of the focal volume (and hence no longer subject to the laser field) with
coefficient g, and the last term to recombination of electrons in the conduction
band with holes left in the valence band, at rate η. Note that both of the first
two terms depend on the applied electric field, E, as we have made explicit.
Assuming ρ(t = 0) = 0, the only electrons available to “seed” the process of
avalanche-breakdown are provided by MPI, whereafter the avalanche process
can take place. However, due to recombination and diffusion, this process will
require a critical plasma density ρcr to be reached whereupon (3.67) is positive
and allows for rapid growth. For femtosecond pulses, this corresponded to
ρcr ∼ 1021 cm−3 in water [38]. However, it is critical to note that unlike thermal
damage, (3.67) is predictive of a threshold behavior, below which damage is
minimal to non-existent.
In looking at (3.3), we may raise the legitimate concern that while imaging
may favor a shorter pulse duration, so too would the damage threshold,
suggesting a balance between image contrast and damage mechanisms.
However, Tien et al. [41] have shown while the damage threshold fluence scales
approximately as the square root of the pulse duration above 10 ps, between
10 fs and 1 ps the threshold fluence is nearly constant. This flattening of the
trend can be understood by a consideration of the first two terms in (3.67). MPI
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depends strongly on the peak power
Pp =
E
τ
(3.68)
to promote electrons into the conduction band. In contrast, the cascade of IBA-
associated electrons will depend on how long the pulse continues to accelerate
the electrons, and so will result in an increase of electrons via the avalanche
mechanism. Since most available laser sources operate with pulses in the range
of 50 fs to several hundred fs, it is always advisable to choose the shortest pulse
available, since by (3.3) this will give the strongest signal, but will leave the
damage threshold unchanged [41].
In addition to the damage resulting from the creation of the plasma itself,
the subsequent heating results in the formation of a cavitation bubble. The
time- and length-scale of these structures have been studied extensively in water
[38, 40, 42, 43]. While these results are interesting in their own right, we shall
only mention the occurrence of this effect. This effect is typically how ablative
damage is detected when imaging. In our studies, we have seen damage occur
at 35 nJ (35 mW) for 300 fs pulses (see Fig. 3.4).
Thus far we have considered laser damage as primarily an undesirable
outcome that occurs in the context of trying to achieve higher image
contrast. However, nonlinear ablation is actually a desirable effect for targeted
manipulation of tissue. Since damage is restricted to the focal volume, damage
can be produced below the surface of a structure. For example, Schaffer et
al. [44–47] have demonstrated that it is possible to create subsurface changes in
glass, including the writing of optical waveguides. This finding is particularly
striking since glass is considered transparent at near infrared (NIR) wavelengths
with respect to linear absorption, yet is absorbing via nonlinear processes. In a
biological context, Nishimura et al. [48] have developed the use of fs laser pulses
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for creating targeted models of sub-surface strokes in the brain, which has been
used to subsequently study strokes in penetrating arterioles [49] and ascending
venules [50], as well as the effects of microhemorrhages on cortical structure [51]
and function [52]. We have also used this mechanism for creating minimal
spinal cord injuries [53, 54]. Nguyen et al. [55] have also studied its application
for creating subsurface cuts in the rodent cortex, with a proposed application to
stopping seizure propagation in epilepsy while minimizing collateral damage
caused by traditional blade-based surgeries. It has also been studied extensively
for corneal surgery [56–58], and remains standard procedure for LASIK surgery.
A later chapter in this thesis will examine and review the use of fs laser pulses
for transfecting foreign DNA into living cells.
Thus, unlike the other mechanisms of damage, nonlinear ablation provides
a useful tool with which to study neuropathology, and is used extensively in
three of the following chapters.
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CHAPTER 4
THIRD HARMONIC GENERATION IMAGING OF MYELIN
This chapter contains the manuscript and figures from a study on the use of
third harmonic generation as a technique for imaging myelin in the vertebrate
central nervous system, with minor additions and formatting changes. Myelin
is a critical component of the central nervous system (CNS), and enables long-
distance action potential propagation. Many transgenic animals allow specific
labeling of cell populations–such as subpopulations of neurons– by introducing
a fluorescent reporter gene (such as GFP) with a population-specific promoter.
Thus, every time that promoter is activated in the cell, a simultaneous copy of
reporter protein is also made, which then diffuses about the cytosol. However,
CNS myelin is produced by the multiple windings of the cell membranes of
oligodendrocytes, with no cytosol space in between. Thus, while it is possible to
label the oligodendroctye cell bodies, labeling myelin itself by exogenous means
presents a considerable challenge.
To this end, this work demonstrated that third harmonic generation (THG)
presents a dye-free imaging modality for looking at myelin. This work was
originally published in March 2011 in Biophysical Journal. This paper is
reprinted with permission by Cell Press. The original article may be found
under the following citation:
Matthew J. Farrar, Frank W. Wise, Joseph R. Fetcho, and Chris B. Schaffer. In
Vivo Imaging of Myelin in the Vertebrate Central Nervous System Using Third
Harmonic Generation Microscopy. Biophys. J., 100, 1362-1371, 2011.
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4.1 ABSTRACT
Loss of myelin in the central nervous system (CNS) leads to debilitating
neurological deficits. High-resolution optical imaging of myelin in the CNS of
animal models is limited by a lack of in vivo myelin labeling strategies. We
demonstrated that third harmonic generation (THG) microscopy–a coherent,
nonlinear, dye-free imaging modality–provides micrometer resolution imaging
of myelin in the mouse CNS. In fixed tissue, we found that THG signals
arose from white matter tracts and were colocalized with two-photon excited
fluorescence (2PEF) from a myelin-specific dye. In vivo, we used simultaneous
THG and 2PEF imaging of the mouse spinal cord to resolve myelin sheaths
surrounding individual fluorescently-labeled axons, and followed myelin
disruption after spinal cord injury. Finally, we suggest optical mechanisms that
underlie the myelin specificity of THG. These results establish THG microscopy
as an ideal tool for the study of myelin loss and recovery.
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4.2 INTRODUCTION
Optical imaging provides nondestructive visualization of dynamic processes
in biological systems with subcellular resolution. Conventional, linear optical
imaging, however, is limited in depth penetration and suffers a loss in contrast
when imaging structures in scattering tissue. Various forms of nonlinear
laser scanning microscopy, including two- photon excited fluorescence (2PEF)
imaging [1], circumvent these limitations and have enabled, for example,
fluorescence-based imaging to a depth of 1 mm in the neocortex of a live mouse
with micrometer resolution [2, 3].
The fatty myelin sheaths surrounding a subset of axons in the central
nervous system (CNS) enable fast conduction of action potentials. Diseases
such as multiple sclerosis lead to loss of myelin with consequent deficits in
motor function and sensory perception [4]. Substantial imaging of myelin-
related pathology has been performed in vivo in both human patients and
animal models using magnetic resonance imaging (for reviews, see Le Bihan [5]
and Bakshi et al. [6]) and positron emission tomography [7–9] but at resolutions
of ∼200 µm and ∼1 mm, respectively, these modalities are insufficient to
image the cellular and subcellular structures accessible to optical microscopies.
Although protocols exist for labeling myelin in postmortem tissue sections,
good exogenous dyes for optical in vivo labeling of myelin in animal models
are not available, as existing dyes tend to disrupt the lipid structure of
myelin. Recent work in transgenic zebrafish has enabled myelin visualization
by enhanced green fluorescent protein expression driven by the myelin basic
protein promoter [10]. In addition, coherent anti-Stokes Raman scattering
(CARS) microscopy has enabled imaging of myelinated fibers without labeling
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in live extracted mouse spinal cord [11] and in vivo mouse brain [12]. However,
the technical challenges associated with this modality have limited its broad
adoption as a tool for in vivo studies.
Harmonic generation is attractive for in vivo imaging because it requires no
exogenous dyes or fluorescent proteins. Second-harmonic generation (SHG) has
been used to study collagen [13–15], microtubules [16–18], and cell membranes
[19–21], among other things. However, SHG is produced only from molecules
and structures lacking inversion symmetry and therefore possessing a nonzero
χ(2). This restricts the structures that can be imaged in this modality, providing a
tool that images some macromolecular structures with excellent specificity (e.g.,
collagen), but that cannot image most features of biological interest.
In contrast, third-harmonic generation (THG) is a nonlinear optical process
ubiquitous to all molecules in which three photons at the fundamental
frequency are up- converted to a photon at the third harmonic with an efficiency
proportional to the third-order susceptibility tensor, χ(3)(ω, ω, ω; 3ω), and the
cube of the intensity of the fundamental beam. Unlike 2PEF, THG is a
parametric process that need not have resonances at any of the frequencies
involved. Due to the Gouy phase shift associated with focused Gaussian
beams [22], THG produced in the focal volume but on either side of the focal
plane in the bulk of normally dispersive materials destructively interferes in
the far field, resulting in the absence of signal. The presence of an optical
interface breaks the symmetry across the focal plane and results in a measurable
signal, making THG an interface-sensitive microscopy. THG microscopy has
been used to image neurons and their processes [23, 24], lipid bodies in plant
seeds and Drosophila embryos [25], plant leaf cells [26], Chara rhizoids [27],
zebrafish embryos and larvae [28, 29], cardiomyocytes [30], mouse cartilage
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elastin [31], malaria parasites [32], and human cornea [33]. Owing to phase-
matching conditions, THG is dominantly generated in the forward direction,
making epi-detection possible only after multiple scattering events [34]. Like
2PEF, THG is produced only in the focal volume, making it well suited for
imaging in scattering tissues.
In this article, we studied the utility of epi-detected THG as a tool for imaging
myelin. We first explored the sources of THG signal in fixed mouse CNS tissue
and showed that myelin is the dominant source of image contrast. We then
demonstrated in vivo imaging of healthy and damaged myelin in the mouse
spinal cord using THG. Finally, we explored what optical properties lead to
efficient THG production.
4.3 MATERIALS AND METHODS
4.3.1 Ex vivo tissue preparation and imaging
C57BL/6 mice were deeply anesthetized, and perfused through an intracardiac
catheter with phosphate-buffered solution (PBS) (Sigma-Aldrich, St. Louis, MO)
to clear blood followed by 4% paraformaldehyde (Thermo Fisher Scientific,
Waltham, MA) in PBS as a fixative. Some mice expressed yellow fluorescent
protein (YFP) in a subset of CNS neurons (C57B/6-thy1- YFPH; Jackson Labs,
Bar Harbor, ME). Tissue was then embedded in agarose gel. Mouse brain
sections several millimeters thick were cut using a vibratome (Integraslice
7550 PSDS; Campden Instruments, Lafayette, IN) or brain matrix with low-
profile histology blades. Spinal cord sections were cut while still in the
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vertebral column with a scalpel blade. Tissue was stained in 100:1 dilution of
FluoroMyelin Red (FM Red; Invitrogen, Carls- bad, CA) in PBS for a minimum
of 8 h. Staining was followed by a washout of minimum 10 h in three changes
of PBS. Samples were mounted using 0.5% agarose (Sigma-Aldrich) in PBS for
imaging.
Imaging was performed on a locally designed multiphoton microscope and
images were taken with a high numerical aperture (NA) 20 water immersion
objective lens (NA 14 1.0; Carl Zeiss MicroImaging, Thornwood, NY) or a low
NA 4 objective (NA 14 0.28; Olympus America, Center Valley, PA). A 1043-
nm wavelength, 300-fs pulse duration, 1-MHz repetition rate fiber laser source
(FCPA mJewel D-40; IMRA America, Ann Arbor, MI) was used to generate
THG and 2PEF. Comparison images were taken in some samples with a solid-
state laser source of higher repetition rate (1028-nm wavelength, 300-fs pulse
duration, 10-MHz repetition rate; t-Pulse 500; Amplitude Systemes, Pessac,
France). In tissue stained with FM Red, 2PEF and THG images were taken
sequentially, with FM Red imaged first, so as not to photo- bleach the FM Red
under the higher average powers used for THG imaging. Bandpass filters used
for detection were centered at 350 nm for THG, 645 nm for 2PEF of FM Red and
Texas Red dextran, and 517 nm for 2PEF of YFP.
Spinal cord sections of homozygous shiverer mice (MBP-shi, Jackson Labs,
Bar Harbor, ME)–a strain that is severely myelin-deficient–were compared
against controls. Image stacks were taken with the low NA objective at 5-µm
increments and ∼1-mm maximal depth. Maximum projections were taken to
remove any artifacts from sample tilt that might be introduced by averaging.
To remove the effects of background pixels, images were traced manually and
only pixels interior to the boundary were considered. An image histogram was
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computed, and the THG contrast was defined as the full width at half-maximum
(FWHM) of the intensity histogram.
4.3.2 In vivo mouse preparation and imaging
Wild-type mice (C57BL/6) or transgenic mice expressing YFP in a subset of
pyramidal neurons and dorsal root ganglia (DRG) were used for multimodal
imaging. Mice were anesthetized using inhaled isoflurane (5% to induce
anesthesia and ∼1.5% to maintain anesthesia during surgery and imaging) on
a custom surgery table and a dorsal laminectomy was performed. A rectal
thermometer and feedback-controlled heating blanket were used to maintain
the animal at 37.5◦C. Glycopyrrolate (50 mg/100-g mouse weight) was injected
into the thigh muscle to prevent the buildup of fluid in the lungs. Bupivicane,
a local anesthetic, was injected at the site of surgical incisions (∼0.1 mL of
0.125%). An incision was made in the skin and the muscle was retracted from
the vertebrae spanning T10-T12. The vertebrae were clamped on either side
and held in place using custom holders. The lamina of T11 was removed
with Vannas scissors, and excess bleeding stopped with the use of gelfoam
(Pharmacia & Upjohn, Kalamazoo, MA). Where possible, the dura was left
intact. A #0 coverslip was applied over the cord and the interstitial space filled
with 0.5% agarose in artificial cerebral spinal fluid. Animals were given 5%
(W/V) glucose in saline hourly (1 mL/100-g mouse weight). The blood plasma
was fluorescently labeled by intravenous injection of 50 µL of 2.5% (W/V) Texas
Red dextran (molecular mass = 70,000 kDa; Invitrogen). The mouse was then
transported to the microscopy laboratory and imaging was performed using
the same setup as for ex vivo samples. After the imaging sessions, mice were
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perfused as described above.
4.3.3 In vivo zebrafish preparation and imaging
Six-day-old larval zebrafish were anesthetized in 0.2% tricaine methane-
sulphonate (MS-222; Western Chemical International, Scottsdale, CA), and
the Mauthner cell was electroporated with 70-kDa Texas-Red dextran in 10%
Hanks buffer to fluorescently label the Mauthner axon. Five days later, the
animals were again anesthetized and mounted dorsal side up in low melting
temperature agarose for in vivo imaging on the same setup described above.
4.3.4 Spinal cord microlesioning
Micrometer-scale lesions were produced in the spinal cord by femtosecond
laser ablation using ∼100-nJ pulses from a regenerative amplifier (800-nm
wavelength, 50-fs pulse duration, 1-kHz repetition rate; Legend model,
Coherent Laser, Santa Clara, CA), focused with the 1.0 NA objective into the
spinal cord of live, anesthetized mice. Custom software in MATLAB (The
MathWorks, Natick, MA) allowed the user to draw a trajectory on a projection of
a three-dimensional stack, so as to avoid injuring and rupturing blood vessels,
which would obscure imaging. A shutter was then opened and the translation
stage followed the trajectory moving at 500 mm/s and disrupting tissue in the
focal volume via nonlinear ablation [35], effectively acting as a laser scalpel. The
pattern was continued until the desired depth of the cut was reached. The axial
extent of the disruption produced by a single laser pass was ∼1-2 µm at the
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energies used here and increases with pulse energy. Multiple passes at different
depths were used to make a cut several tens of micrometers in depth. To insure
an adequate lesion, the same pattern was repeated twice for each cut.
4.3.5 Image processing
Image stacks were median-filtered and the average z-projection computed to
show relevant structures. Images taken with the high NA objective were
oversampled in z (0.2-µm increments). Frames containing severe motion artifact
(largely due to breathing) from in vivo imaging sessions were removed and
interpolated between.
For tiled images using the low NA objective, a water/air interface was
present that was absent when using the high NA water immersion objective.
This interface, combined with the field curvature, resulted in images with an
inhomogeneous intensity distribution across the field of view. To correct for this
effect, images were normalized by the intensity distribution from the surface of
the surrounding agarose alone.
4.3.6 Monte Carlo simulation
The method described by Prahl et al. [36] was followed closely. Photon
packets were randomly assigned an initial position within the beam waist and
corresponding azimuthal angle. Polar angles were assigned randomly for 2PEF
simulations, or in a forward propagating arrangement for THG, as described
in Appendix B. Detection was achieved for photons that were incident on an
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aperture within a fixed acceptance angle, with amplitude dependent on the ratio
of path length and absorption length.
All animal procedures were performed with the approval of the Cornell
Institutional Animal Care and Use Committee (IACUC) and under the guid-
ance of the Cornell Center for Animal Resources and Education.
4.4 RESULTS
4.4.1 THG image contrast in mouse spinal cord was dominated
by myelinated axon tracts
Coronal slices of fixed mouse spinal cord were stained with FluoroMyelin Red
(FM Red), a myelin-specific two-photon- excitable dye, and imaged in an epi-
detection arrangement. Imaging with a low NA objective showed bright THG
from white-matter tracts with only a dim signal from the butterfly-shaped
gray matter (Fig. 4.1 a, left), which corresponded well to the pattern of FM
Red-stained myelin seen with 2PEF (Fig. 4.1 a, right). High-resolution (high
NA) THG imaging showed large signal in regions of dense myelination in the
dorsolateral (Fig. 4.1 b, left) and dorsal (Fig. 4.1 c, left) corticospinal tracts. Fine
features resolved in the THG images (Fig. 4.1, b and c, left) were similar to
those apparent in high-resolution 2PEF images of FM Red-labeled myelin (Fig.
4.1, b and c, right). The dark round holes shown in relief against the strong
THG signal (Fig. 4.1, b and c, left) were confirmed to be axons by coregistering
THG images with 2PEF images in spinal cord sections from transgenic mice
that expressed YFP in a subset of the corticospinal tract axons (see Fig. 4.7 and
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Figure 4.1: Myelinated tracts in mouse spinal cord provided a strong source of THG
imaging contrast.
Thick coronal sections of thoracic spinal cord from C57BL/6 mice stained with FM Red
dye and imaged using 2PEF and THG. Imaging with a low NA objective showed the
gross structure of white-matter tracts (a). Individual axons, seen as holes against a
myelin backdrop (arrows), were visible in the dorsal (b) and dorsolateral corticospinal
(c) tracts when imaged with a high NA objective. A least-squares power law fit, S ∼ P b,
of the THG signal, S, from myelinated tissue as a function of average excitation power,
P , gave b = 3.3 ± 0.3 and did not saturate like the 2PEF signal (d). THG imaging with
a 1-MHz repetition rate source produced significantly more signal intensity than a 10-
MHz source with similar wavelength and pulse duration at the same average power
(e).
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additional text in the Supporting Material). To rule out signal arising from
resonant enhancement from either YFP or FM Red, fixed sections of wild-type
C57B6/J mice were imaged and showed no difference in THG contrast (data not
shown).
The average signal at 350 nm from fixed spinal cord scaled as the
cube of the incident laser power (Fig. 4.1 d), with no sign of saturation even
above the threshold for sample damage (∼25–30 mW), consistent with THG.
In contrast, the 2PEF signal of FM Red scaled as the square of the average
power and saturated at high power (Fig. 4.1 d). Using a 10-MHz laser with
similar wavelength and pulse duration, we observed much lower THG signal
as compared to the 1-MHz laser, for the same average power (Fig. 4.1 e). We
were unable to form high-contrast THG images at 10 MHz, whereas this was
routinely achieved at 1 MHz. This observation fits with the expected scaling of
THG signal (see Discussion).
4.4.2 THG imaging enabled in vivo visualization of myelin in
mouse and larval zebrafish spinal cord and was combined
with 2PEF microscopy for visualization of multiple tissue
constituents
The value of THG as an in vivo myelin imaging strategy was evaluated in the
mouse dorsal thoracic spinal cord. The dorsal lamina of one vertebral body was
removed and covered by glass in anesthetized mice that expressed YFP in a
subset of dorsal root ganglia (DRG) neurons and had blood vessels labeled with
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Figure 4.2: In vivo THG and 2PEF imaging allowed identification of individual axons
and their myelin sheaths in mice and zebrafish.
2PEF imaging of YFP labeled axons (green) and blood vessels labeled by
intravascular injection of Texas Red dextran (red), together with THG signal
(white) in the dorsal thoracic spinal cord of a live, anesthetized mouse (a). Small
(∼5 µm) z projections allowed for the identification of individual axons (b and c)
and their respective myelin sheaths (blue arrows). Slicing in the xz plane showed
rings of myelin surrounding individual axons (d, inset). A Texas Red labeled
Mauthner cell axon (e) seen in the dorsal view of 10-day old zebrafish larva
showed similar imaging contrast. Myelination on the contralateral Mauthner
cell axon was also visible (yellow arrow), with the Mauthner axons separated by
the notocord.
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intravenously injected Texas Red dextran (see Materials and Methods). Blood
vessels, notably the large dorsal spine vein at the center of the cord and the
branching venules that drain into it, as well as a subset of DRG axons that merge
with the dorsal column were visible by 2PEF (Fig. 4.2 a). THG imaging revealed
the striated appearance of large numbers of myelinated axons including and
running parallel to axons visible from 2PEF of YFP (Fig. 4.2 a). Individual
YFP-labeled axons show strong THG from a ∼1-µm-thick band immediately
adjacent to the 3-µm-diameter axon lumen, in good agreement with published
measurements of the g-ratio [37], the ratio of the inner axon diameter to the
outer diameter of a myelinated axon, including its myelin sheath (Fig. 4.2, b and
c). THG imaging of the most superficial myelinated tracts show distinct circular
voids, suggesting axonal lumens, the cylindrical cavities of axons (Fig. 4.2 d,
inset). To assess the effectiveness of THG imaging in another common animal
model, we electroporated one Mauthner cell in zebrafish larvae with Texas Red
dextran and imaged live, immobilized animals. THG imaging showed a myelin
sheath encircling the fluorescently labeled axon lumen (Fig. 4.2 e).
4.4.3 In fixed mouse brain, THG contrast was dominated by
myelin and was significantly reduced in myelin-deficient
shiverer mice compared to wild-type animals
To verify that high-contrast THG signal from myelin was not limited to the
spinal cord, we repeated THG imaging and 2PEF microscopy of FM Red in
fixed mouse brain tissue (Fig. 4.3). Low NA imaging of both tangential (Fig.
4.3 a) and sagittal (Fig. 4.3 b) sections showed strong correspondence between
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Figure 4.4: Myelin-deficient shiverer mice showed significantly less THG contrast
than controls.
Thick coronal sections of thoracic spinal cord from a control mouse (a) and shiverer
mouse (b) imaged using a low power objective. The intensity histogram (c) was
computed for each section within the traced regions. Contrast was defined as FWHM
(arrows) of the intensity histogram for control (blue) and myelin-deficient (green) mice.
Control mice (8 sections) showed a higher image contrast as compared to shiverer mice
(12 sections, p ≤ 0.05 ANOVA) (d).
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THG and FM Red. High-resolution THG images of densely myelinated regions
showed individual myelinated mossy fibers in the cerebellar lobes (Fig. 4.3
c) as well as white matter tracts–dense bundles of myelinated axons–in the
corpus callosum and hindbrain (Fig. 4.3, d and e, respectively). As a
further verification of myelin as the source of THG contrast, we compared
thick tissue sections of spinal cord from control mice (C57B/6-thy1-YFPH, n = 8
sections) to myelin-deficient shiverer mice (MBP-shi, n = 12 sections), which are
homozygous for a mutation of the myelin basic protein gene. This mutation
leads to severe hypomyelination in the central nervous system, resulting in
tremors and seizure-like behavior [38]. We characterized THG contrast–defined
as the FWHM of the intensity histogram–for both strains by comparing low
NA images (Fig. 4.4 c). Edges of the sections were omitted by manual tracing
(Fig. 4.4, a and b) to remove any artifacts of tissue sectioning. Shiverer mice
showed less THG image contrast than controls (Fig. 4.4 d). The THG that was
produced in the sections from shiverer mice was largely due to the signal from
the tissue/air interface at the top of the sample. Sections from shiverer mice
labeled with FM Red (not shown) showed a lack of staining, consistent with
this observation. In vivo imaging of the shiverer mice (data not shown) did
not show the characteristic striations visible in the wild-type animals (e.g. Fig.
Fig. 4.2), individual axons could not be resolved, and THG signal was absent
beyond the tissue interface at the dorsal surface of the spinal cord.
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Figure 4.5: Spinal cord microlesions resulted in coordinated myelin and axon
degeneration.
A laser lesion produced with femtosecond laser pulses lead to disruption of myelin
(white) as seen in THG imaging (a). Simultaneous 2PEF imaging of severed axons (green)
showed spatially and tempo- rally overlapped degeneration of axons and myelin after
injury (b). Blood vessels were intentionally spared in creation of these lesions.
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4.4.4 Changes in myelin structure after spinal cord injury
occurred in regions where axons degenerated
We performed in vivo imaging in mice that express YFP in DRG axons before
and after spinal cord injury. Spinal cord lesions were created using nonlinear
absorption of tightly- focused femtosecond laser pulses from a regenerative
amplifier (see Methods). After the microlesion, we performed time-lapsed
imaging of THG and 2PEF of YFP-labeled axons up to 1 h after the injury (Fig.
4.5, a–c). Clear alterations in the myelin structure were evident after the lesion
and the altered region grew in size over time. We assessed the presence and
morphology of YFP-labeled axons within the region of disrupted myelin and
found no undamaged axons and few intact proximal or distal axon tips within
the region of myelin disruption (five lesions across two animals).
4.4.5 The myelin specificity of THG could be accounted for by
the thickness and scattering properties of myelin
One of the distinguishing features of myelin compared to other lipid-water
interfaces is that the multimembrane windings of myelin give an overall lipid
thickness ranging from hundreds of nanometers to micrometers [37], compared
to a typical somatic membrane thickness of only tens of nanometers. We
considered THG in the forward generated direction from a biological interface
modeled as a slab of dielectric of thickness L surrounded by water. The slab
was symmetrically situated about the laser focus at z = 0 (Fig. 6 a). Following
the analysis of De´barre and Beaurepaire [39], but working in our experimental
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limit where, because of tight focusing, the confocal parameter, b, and sample
thickness is short compared to the coherence length (L, b << 2pi∆k−1, where ∆k
is the wave vector mismatch), we arrive at (see Appendix A):
P3ω = αP
3
0
L2
(1 + (L/b)2)2
∣∣∣∣∣ χ(3)sn3ω,s − χ
(3)
2
n3ω,w
∣∣∣∣∣
2
(4.1)
Here, α is a constant dependent on excitation geometry, and n3ω is the index of
refraction at the third harmonic with the subscripts w and s denoting water
and slab, respectively. P3ω and P0 are the intensities of the third harmonic
and fundamental fields, respectively. Equation 1 predicted an approximately
quadratic dependence of THG intensity on sample thickness for L b (Fig. 6 b).
This result suggests that lipid slabs with the thickness of a cell membrane result
in signals up to three-orders-of-magnitude smaller than that of myelin, well
below the noise floor of our THG imaging system. This finding is consistent
with our observation that the lumen of axons appeared as dark holes against
the bright signal from myelin, even though many individual membranes are
present in the axon.
Because THG is generated predominantly in the forward direction, epi-
detection is possible only after multiple scattering events [34]. In contrast,
2PEF leads to isotropic emission, making epi-detection possible even in the
absence of scattering. We used a Monte Carlo simulation to determine collection
efficiency of backscattered THG and 2PEF emission as a function of scattering
length. We modeled our tissue sample as a semi-infinite slab having uniform
scattering and a fixed absorption length of 1 cm. Light was epi-detected after
multiple scattering events provided that the light enters the collection aperture
of the objective within a fixed acceptance angle (Fig. 6 c, see Appendix B). THG
epi-detection efficiency was a decreasing function of scattering length, with
detected THG going to zero as scattering length goes to infinity (Fig. 6 d). In
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Figure 4.6: The strong THG signal from myelin was due to both the thickness and
scattering properties of myelin.
Schematic for analytic calculations, in which a dielectric slab with thickness, L,
much smaller than the coherence length, ∆k−1, was centered on the laser focus (a).
Calculations showed a near-quadratic dependence of THG signal on slab thickness for
sample thicknesses < 1µm (b). Third harmonic is generated in the forward direction
and epi-detected only after backscattering (c). The fate of THG photons in a semi-
infinite sample were to be absorbed (yellow), escape but not enter the objective (mauve),
escape and hit the lens at an angle above the NA (cyan), or enter the objective with the
acceptance angle and be detected (green). Monte Carlo simulations (d) for forward-
generated THG and isotropically emitted fluorescence (i.e., 2PEF) originating from
the focal volume gave the epi-detected fraction of light as a function of scattering
length. (Dashed line) Asymptotic value of the 2PEF collection efficiency for infinite
scattering length (ballistic photons only), while the efficiency tended to zero for THG.
The maximum depth, zmax, at which high signal/noise THG imaging can be performed
using a 1-W laser source to maintain the necessary 25 mW at the focus decreased
linearly with scattering length (e).
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contrast, the 2PEF signal tended to the ballistic photon limit with increased
scattering length (marked by the dashed line in Fig. 6 d). Both THG and
2PEF showed little dependence of collection efficiency on how deep within the
sample the light is generated, assuming constant excitation.
From in vivo 2PEF image stacks of YFP-labeled axons in the white-matter
tracts, we measured the 2PEF signal attenuation length at 1043-nm wavelength,
which has been shown to be dominated by scattering [3]. We fitted the
exponential decay of signal as a function of depth (using constant power
excitation and assuming a constant fluorophore density) and found that the
white matter of the mouse spinal cord has a 2PEF signal attenuation length of
∼20–30 µm at 1043 nm.
We did not consider resonance effects in our analysis of the myelin signal.
4.5 DISCUSSION
4.5.1 THG enables visualization of CNS myelin in vivo and
in fixed tissue and can be implemented on existing
multiphoton microscopes
We demonstrated the ability to image CNS myelin in mice both in vivo (Fig. 4.2)
and ex vivo (Figs. 1 and 3) using THG microscopy. This technique is well suited
for the study of mouse models of demyelination, due to multiple sclerosis or
after spinal injury (Fig. 4.5), because it opens the door to longitudinal imaging
without the complication or artifacts of repeated labeling. Our demonstration
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of THG imaging of myelinated axons in zebrafish (Fig. 4.2 e) suggests this
technique could be combined with high-throughput drug testing in simple
animal models [40]. CARS microscopy has also been shown to be an effective
probe of myelination in vivo [11, 12]. However, this technique requires spatial
and temporal overlap of 2-ps laser pulses at different wavelengths [41], a
technical challenge that limits the widespread use of this modality compared
to 2PEF and harmonic generation imaging.
In CARS microscopy, the myelin specificity is due to the chemical properties
of myelin, namely the high density of carbon-hydrogen bonds. In contrast,
our analysis suggests that the myelin specificity of THG arises predominantly
from the geometrical properties of myelin. One potential advantage of
THG for myelin imaging is that this method can be readily performed on
existing multiphoton microscopes with the simple addition of a suitable–albeit
nonstandard–femtosecond laser source and the correct detection filters, making
broad adoption of this technique straightforward. Also, the laser parameters
appropriate for THG are well suited for 2PEF and SHG imaging (e.g., Fig. 4.2),
enabling straightforward multimodal microscopy, where the different contrast
mechanisms provide complementary information [42]. For example, 2PEF,
SHG, and THG multimodal microscopy has been used to monitor subcellular
details in the cell division cycles during zebrafish embryogenesis [43].
4.5.2 THG is a broadly applicable, dye-free imaging modality
THG is ubiquitous to all molecules, but the efficiency of THG production is both
geometry- and molecule-specific, as shown in Eq. 4.1. Our analysis suggests
that the presence of a significant optical interface–both in geometric extent
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and in optical properties–is both necessary and sufficient for efficient THG.
Consistent with this understanding, our work has shown that myelin in the CNS
can be imaged with THG, while previous researchers have shown that lipid
droplets of several hundred nanometers to several micrometers [39], malaria
hemazoin pigments between 0.2 and 10 µm [32], and red blood cells [44, 45],
can all be imaged using THG. Additionally, we anticipate that THG may be
an effective tool for visualizing myelinated nerves in the peripheral nervous
system, such as the cavernous nerves running along the prostate.
4.5.3 Available excitation power and sample damage thresholds
limit THG signal, suggesting that optimized laser
parameters are essential
One drawback for THG imaging is that although collection efficiency is
improved by short scattering length samples, the maximum depth at which
measurable excitation can be achieved is severely limited. Assuming a 1-W laser
source and the experimentally observed ∼15–20 mW required for 300-fs pulses
at 1 MHz pulse repetition rate to generate reasonable THG signal/noise (still
weak compared to 2PEF of fluorescently-labeled blood vessels and axons), the
maximum depth that can be imaged falls off quickly with increasing scattering
length (Fig. 6 e) due to the attenuation of excitation light by scattering. For
the ∼ 20-µm scattering length of the spinal cord white matter, we predict a
maximal imaging depth of 70 µ m (Fig. 6 e), and we experimentally achieved
∼ 50 µm. The maximum laser energy and power that can be used is set by
sample damage. With the 1 MHz repetition rate laser, we observed immediate
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sample damage at average power of ∼25–30 mW (25–30 nJ per pulse), likely
due to nonlinear ablative processes. By way of comparison, we took images in
the same sample using a 300-fs, 1028-nm source with a 10-MHz pulse train. For
the 10-MHz laser system, we observed immediate sample damage at average
powers of ∼50–55 mW (5–5.5 nJ per pulse), likely due to thermal effects.
In either regime, photochemical-mediated damage may also contribute. One
means of extending the depth limitations and/or improving the signal/noise of
THG imaging, while remaining below damage thresholds, is to optimize laser
parameters. THG signal depends on the inverse squares of both the repetition
rate, R, and pulse duration, τ , and the cube of the average power, < P >:
THG ∼ 〈P 〉3/(Rτ)2 (4.2)
The observed disparity in THG signal (Fig. 4.1 e) between images obtained with
10-MHz and 1-MHz repetition rate laser sources is consistent with this scaling.
Because ablative damage threshold varies little with pulse duration below 10
ps [46], it is always desirable to have the shortest pulse possible, with a pulse
duration of 15 fs at the focus of a large NA objective possible when dispersion
is carefully managed and a broad bandwidth source is used [47]. In addition,
because the THG signal does not saturate, the maximum signal that can be
obtained comes at the intersection of the ablative and average power damage
thresholds. Thus, for a maximum pulse energy of 20 nJ (below ablative damage
threshold) and a maximum average power of 50 mW (below thermal damage
threshold), the optimum pulse repetition rate is 2.5 MHz. Our laser source
operates at 1 MHz and emits 300-fs pulses, suggesting a signal improvement
of ∼1000 is possible with an optimal laser source. In previous studies [24–33]
in which THG imaging was performed in high-collection-efficiency forward
detection systems, the use of suboptimal sources was not the limiting factor on
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image contrast. However, as we have demonstrated by in vivo imaging of CNS
myelin, the reduced collection efficiency inherent in epi-detected THG strongly
suggests that the use of lower repetition rate sources (e.g., Fig. 4.1 e) may lead
to significant contrast improvement, consistent with Eq. 4.2. In contrast, 2PEF
microscopy–where the signal scales as the square of the average power and only
inversely with the repetition rate– may benefit from the higher scan speeds
possible when higher repetition rates and bright fluorophores are used [48].
However, the optimum laser repetition rate will depend on the balance between
efficient signal production and dye saturation determined by the two-photon
cross-section of all the labels present. It is therefore imperative to select laser
sources that optimize signal from the nonlinear process of interest.
4.5.4 THG microscopy provides the capability for in vivo
studies of demyelinating diseases
We imaged acute changes in myelin structure after spinal cord injury (Fig.
4.5). Our observation of axon degeneration involving a brief period of
inaction followed by rapid fragmentation is consistent with the acute axonal
degeneration observed in previous studies [49]. Our comparison of THG images
of myelin and 2PEF images of axons after laser-based spinal cord transections
suggests that acute myelin degeneration spatially and temporally overlaps with
acute axonal degeneration.
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4.6 CONCLUSIONS
We have demonstrated that THG provides a dye-free optical imaging modality
for visualizing CNS myelin in two animal models. We have also seen that
this source of contrast was significantly improved by the use of a high peak-
power, low repetition-rate laser source, suggesting that these laser parameters
may be more suitable for imaging weak nonlinear signals. We anticipate that
these findings will be of use to both the neuroscience community and present
what we believe to be new guidance for the development of laser sources for
nonlinear microscopy.
4.7 APPENDIX A: CALCULATION OF THG SIGNAL FROM
A DIELECTRIC SLAB
We begin with the expression for the THG from a dielectric slab of thickness L,
centered at the laser focus (z 14 0), immersed in water (Fig. 6) given by De´barre
and Beaurepaire [39],
E3ω =iC(~R)E
3
0
{
χ
(3)
s
n3ω,s
(t3ωswt
ω
ws)
∫ L/2
−L/2
dz
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+
χ
(3)
w
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(t3ωswt
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+
(tωswt
ω
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3
∫ +∞
L/2
dz
exp(i∆kw(z − L/2))
(1 + i2z/b)2
]}
(4.3)
where χ(3) is the third-order nonlinear susceptibility tensor, n3ω is the index
of refraction at the third harmonic, ∆k is the wavevector mismatch, b is the
confocal parameter, tω is the transmission coefficient at frequency ω, and C(~R)
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is a factor that depends only on the radial geometry of the beam. Subscripts
w and s denote water and slab, respectively. The difference in the arguments
of the exponential in each integral arises due to requirements of the continuity
of the electric field at a boundary. We neglect transmission coefficients, which
are almost one in most cases of interest. This yields the expression for the third
harmonic field
E3ω = iC(~R)E
3
0
{
χ
(3)
w
n3ω,w
∫ −L/2
−∞
dz
exp(i∆kw(z + L/2))
(1 + i2z/b)2
+
χ
(3)
s
n3ω,s
∫ L/2
−L/2
dz
exp(i∆ks(z + L/2))
(1 + i2z/b)2
+
χ
(3)
w
n3ω,w
exp(i∆ksL)
∫ +∞
+L/2
dz
exp(i∆kw(z − L/2))
(1 + i2z/b)2
}
(4.4)
For the tight focusing geometry used for high-resolution imaging here, the
coherence length, 2pi∆k−1, is much greater than both the confocal parameter,
b, and the sample size, L. If we consider that the Lorentzian term is significant
only when z  b, then we may ignore the exponential phases. Each integral
reduces to the form∫ β
α
dz
(1 + i2z/b)2
=
β − α
(1 + i2β/b)(1 + i2α/b)
(4.5)
which when inserted into Eq. 4.4 gives
E3ω = iC(~R)E
3
0
L
(1 + (L/b)2)2
[
χ
(3)
s
n3ω,s
− χ
(3)
w
n3ω,w
]
(4.6)
Finally, squaring this and integrating over all radial coordinates yields the final
expression
P3ω = αP
3
0
L2
(1 + (L/b)2)2
∣∣∣∣∣ χ(3)sn3ω,s − χ
(3)
w
n3ω,w
∣∣∣∣∣
2
(4.7)
where α represents the integration over radial coordinates, and P3ω and P0 are
the intensities of the third harmonic and fundamental fields, respectively.
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4.8 APPENDIX B: DESCRIPTION OF THE MONTE CARLO
SIMULATION
We determined the fraction of THG or 2PEF light that is detected by an epi-
oriented microscope objective using Monte Carlo simulation. We modeled our
collection optics as corresponding to a 3-mm aperture with an acceptance angle
of 49◦. We modeled our excitation optics as corresponding to an objective with
NA = 1.0 and working distance of 1.8 mm. Each photon had one of four fates:
1. It is absorbed in the sample (yellow in Fig. 6 c), or
2. It misses the aperture entirely (mauve in Fig. 6 c), or
3. It arrives at the aperture with an angle larger than the acceptance angle (cyan
in Fig. 6 c), or
4. It arrives within the aperture below the acceptance angle and is detected
(green in Fig. 6 c) with an intensity dependent on its path length in comparison
to the sample absorption length.
We set the absorption length in our simulation to be 1 cm, in between the
absorption of the hemoglobin in the blood and water. An anisotropy factor of
g = 0.96 was used. For each set of conditions (depth and scattering length), the
fate of 106 photons was determined.
The simulated THG was a forward propagating beam matching the prop-
erties of fundamental focused through a 1.0 NA objective but having a beam
waist of 1/
√
3 the size of the fundamental and correspondingly narrower
distribution of polar angles. Azimuthal angles were chosen at random from
a uniform distribution. For 2PEF simulations, both azimuthal angles and polar
angles were chosen at random from a uniform distribution.
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4.10 Supplementary Text
The appearance of holes in THG images of white matter tracts in the spinal cord
was due to the presence of axons. Transgenic mice expressing YFP in a subset of
pyramidal neurons and DRGs were perfused and the spinal cord was sectioned.
THG and 2PEF imaging were performed simultaneously. Some of the holes in
the THG image of myelin are seen to correspond to fluorescently labeled axon
tips (Fig. 4.7), suggesting that the holes in the myelin seen in Fig. 4.1b and 1c are
axons viewed on axis.
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Figure 4.7: Apparent holes in THG images of the dorsal corticospinal tract were axons
seen on-axis.
Fixed sections of spinal cord from mice expressing YFP in a subset of pyramidal neurons
and DRG neurons were imaged using 2PEF and THG simultaneously. The axons (a)
were seen on-axis perpendicular to the cut, and appear as dark holes (black arrows) in
the THG image (b). Overlaying the images revealed some axons (red arrows) in the
myelin relief (c), indicating that the holes were axons or axon bundles. Because this is a
2D-projection, not all axons have a corresponding visible hole.
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CHAPTER 5
A CHRONIC SPINAL CHAMBER FOR LONGITUDINAL OPTICAL
STUDIES OF THE MOUSE SPINAL CORD
In this chapter, we address one of the needs cited in Chapter 3, namely, the need
for repeated, time-lapsed in vivo microscopy in the spinal cord, analogous to
studies in the brain. Prior to our work, time-lapsed optical imaging in the spinal
cord was limited to protocols requiring invasive surgery prior to every imaging
session, placing limits on the number (and thus frequency) of measurements
that can be made, as well as risking complications with each opening. We
addressed this need and these limitations by engineering a spinal cord chamber
that allows for a nearly arbitrary number of imaging sessions1 without the need
for repeated surgeries.
Specifically, the device had to surmount 3 challenges. First, the vertebral
column undergoes routine motion and has important structural properties, and
so the device must add stability to the area surrounding exposed vertebrae
to compensate for any loss of mechanical integrity due to removal of the
dorsal laminae. Second, the vertebral column is surrounded by and attached
to soft tissue, which makes gluing to the bone or surrounding tissue all but
impossible2. Thus, our chamber had to be secured to the vertebral column
without its primary mode of attachment using glues. Lastly, the chamber had
to be able to be stabilized externally during imaging for the removal of motion
artifact.
Having met these requirements, we have demonstrated the usefulness of this
technique for longitudinal in vivo imaging in both healthy and injured mouse
1The limits being the ability of the animal to withstand repeated bouts of anesthesia, and, of
course, the inherent limitations of the experimenter himself/herself.
2Unlike the cranium, where gluing is routine.
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spinal cords. We are hopeful that this protocol will prove a useful platform
for unambiguously evaluating therapeutic strategies, thereby expediting the
discovery of efficacious treatments. This work was originally published as an
online advanced publication in January 2012 in Nature Methods, with the print
version being released in March 2012. This article is here reprinted with minor
modifications with the permission of Nature Publishing Group. The original
article may be found under the following citation: Matthew J. Farrar, Ida M.
Bernstein, Donald H. Schlafer, Thomas A. Cleland, Joseph R. Fetcho, and Chris
B. Schaffer. Chronic in vivo imaging in the mouse spinal cord using an implanted
chamber. Nature Methods, 3, 297-302, 2012.
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5.1 ABSTRACT
Understanding and treatment of spinal cord pathology is limited in part by a
lack of time-lapse in vivo imaging strategies at the cellular level. We developed a
chronically implanted spinal chamber and surgical procedure suitable for time-
lapse in vivo multiphoton microscopy of mouse spinal cord without the need for
repeat surgical procedures. We routinely imaged mice repeatedly for more than
5 weeks postoperatively with up to ten separate imaging sessions and observed
neither motor-function deficit nor neuropathology in the spinal cord as a result
of chamber implantation. Using this chamber we quantified microglia and
afferent axon dynamics after a laser-induced spinal cord lesion and observed
massive microglia infiltration within 1 d along with a heterogeneous dieback
of axon stumps. By enabling chronic imaging studies over timescales ranging
from minutes to months, our method offers an ideal platform for understanding
cellular dynamics in response to injury and therapeutic interventions.
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5.2 INTRODUCTION
In vivo optical imaging in the live mouse cortex has been achieved at depths of
more than 1 mm with sub-micrometer resolution using nonlinear microscopy
coupled with cranial window preparations [1]. This imaging approach has
particular value for the study of neuropathology. For example, longitudinal
studies (time-lapse imaging of the same region in the same animal over multiple
days) in mouse models have relied on two-photon excited fluorescence (2PEF)
microscopy to study the appearance and evolution of amyloid-β plaques in
Alzheimers disease [2–4], the rate and extent of amyloid-β clearance in response
to antibody therapy [5], the diapedesis of circulating cancer cells and formation
of metastatic tumors [6] as well as the long-term effects of occlusion and
reperfusion of cerebral blood vessels [7]. In all cases, a surgical protocol
enabling repeated optical access to the relevant tissue is a prerequisite to
longitudinal studies. Existing protocols include an open-skull protocol [8] for
a cranial window in which a small portion of the mouse skull is replaced with
glass, thinned-skull preparations [9] and a recently described glass-reinforced,
thinned-skull preparation [10].
Chronic optical imaging could offer comparable experimental advantages to
the study of the spinal cord, including studies of spinal cord injury (SCI), spinal
tumors, syringeomyelia, myelitis and spinal cord ischemia. For example, time-
lapse in vivo studies of axon trajectories after SCI would enable unambiguous
identification of spared, injured and regenerating axons and provide an ideal
platform for evaluating therapies aimed at spurring axon growth. This
approach has been demonstrated in vivo in zebrafish [11], where injured axons
as well as axons that regenerated in response to therapy have been imaged
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over several days after SCI. Others have performed time-lapse fluorescence
imaging in the spinal cord of mice expressing enhanced GFP (EGFP) in a subset
of dorsal root ganglia (DRG) neurons for up to 72 h after SCI [12]. However,
this imaging requires artificial ventilation and the suppression of breathing
during image acquisition, limiting the timescale of cellular dynamics accessible.
Similarly, 2PEF imaging in the spinal cord of mice expressing GFP in microglia
has been demonstrated [13] with up to two imaging sessions in the same
mouse separated by several days. Heavy sedation, whole- body suspension
and local clamping are used to reduce remaining motion artifacts resulting
from breathing and heartbeat. Similar techniques have been used to study
microglia dynamics after a laser-induced microinjury [14], calcium signaling of
dorsal horn neurons [15], the effects of peripheral nerve lesioning on sprouting
of severed DRG axons [16] and experimental autoimmune encephalomyelitis
[17]. Finally, imaging at as long as 4 months after SCI with as many as six
imaging sessions in one subject has been achieved without interfering with
animal breathing during imaging [18].
In all of these studies, obtaining images on days after the initial surgery is
possible only by repeated surgical opening of the animal for each imaging
session. Repeat surgeries increase the risk of infection, add a potentially
confounding source of inflammation, cause tissue damage, cause additional
pain and distress to the animal and severely limit the number of imaging time
points possible. However, unlike the cranium, the relevant portions of the
spine routinely flex and are close to the heart and lungs, requiring any chronic
preparation to maintain the mechanical stability of the spine and minimize
motion artifacts during imaging.
To provide a surgical preparation that enables repeated optical imaging of
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the mouse spinal cord without requiring repeated surgeries, we developed
an implantable spinal chamber that provides continuous optical access to
the mouse spinal cord. Using this chamber, we performed 2PEF imaging
in transgenic mice expressing fluorescent proteins in microglia and afferent
axons, and found axon morphology to be stable over 8 weeks of imaging.
Standard tests of locomotor function did not show deficits in mice with the
implant as compared to control mice. Postmortem histology did not show
evidence of damage to the spinal cord from the surgery but revealed increases
in microglia numbers in the dorsal portion of the spinal cord, consistent with
mild inflammation. Finally, we imaged blood vessels, afferent axons and
microglia after laser-induced microlesioning of the spinal cord using 2PEF
microscopy and quantified microglial infiltration and axon dieback dynamics
on time scales spanning four orders of magnitude. We found that the increase
in microglial density at the lesion site was fastest within the first 24 h after
injury. Axon dieback rates were highly heterogeneous among axons, were
fastest immediately after injury and slowed over 5 weeks after SCI.
5.3 RESULTS
5.3.1 The imaging chamber
The chamber consisted of two metal bars that attach to the spine together with
a top plate that attaches to the bars and holds a glass window (Fig. 5.1a).
The implantation procedure entailed retracting muscles and scraping clean the
dorsal laminae over the imaging site, then fusing three vertebrae by clamping
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Figure 5.1: An imaging chamber for longitudinal optical access to mouse spinal cord
without the need for repeated surgeries.
(a) Photograph of the imaging chamber. (b) Schema showing the implantation of the
imaging chamber in mice at the T11–T12 vertebra, just below the dorsal fat pad (taupe).
(c) Photograph showing the spinal cord imaged through the implanted chamber 144 d
after the surgery. (d) Photograph of a mouse with an implanted chamber (same mouse
as in c).
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them on either side with small metal bars (Fig. 5.1b) held magnetically on fixed
posts and finally performing a dorsal laminectomy with vanna scissors. We
trimmed the lateral edges of the bone as close to the metal bars as possible
and sealed the bone using a combination of cyanoacrylate and dental acrylic.
We maintained clamping pressure as the chamber assembly was completed
by bolting a top plate onto the metal bars, applying a silicone elastomer over
the spinal cord, sealing the chamber with a glass coverslip on top and with
additional glue around the edges, and finally gluing the skin to the base of
the top plate (Supplementary Fig. 5.6, Supplementary Protocol and Online
Methods). During 2PEF imaging, we reduced motion artifacts by securing
the mouse to tapped holding posts twisted onto the set screws in the exposed
wings of the top plate, thereby stabilizing the spine and elevating the mouse
off of the surgical table (Supplementary Fig. 5.7) to permit free expansion of
the chest cavity during inspiration. Mechanical drawings for custom parts
are available in Supplementary Notes 1–6. The chamber enabled continuous
optical access to the spinal cord (Fig. 5.1c) without repeat surgeries. Mice
behaved normally over the weeks after surgery, with no signs of lordosis or
kyphosis (Fig. 5.1d). Micro-computed tomography imaging of a mouse 6 d
after implantation confirmed alignment of the spine and revealed no signs of
vertebral damage (Supplementary Video 13).
5.3.2 Long-term imaging of spinal cord axons and blood vessels
We implanted our chamber in transgenic mice expressing enhanced YFP (EYFP)
in afferent axons from a subset of DRG neurons. We imaged mice at up to eight
3All supplementary videos are available online through www.nature.com/nmeth/
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Figure 5.2: Longitudinal 2PEF imaging of axons and blood vessels over many weeks
after surgery.
(a) Projections of 2PEF image stacks of afferent axons expressing EYFP (teal) and blood
vessels labeled with intravenously injected Texas Red dextran (red) taken over 9 weeks
after chamber implantation. Asterisks indicate the location of red autofluorescence
from invading, likely inflammatory, cells located above the spinal cord at later time
points. Arrows denote landmark features of the axons that were visible at all time
points. (b) High-resolution 2PEF imaging of EYFP-expressing axons from the same
region as in a. (c) Profile and fit (Methods, Equation (5.3)) across maximum intensity
projections of selected axon segments shown in the boxed region in b and in the inset;
scale bar, 30 µm). A.u., arbitrary units. (d,e) Image contrast (d) and lateral spatial
resolution (e) as functions of time after surgery from the fits for all axon segments for
two mice (separate curves for each mouse, 10 axons measured at each time point for
each mouse). Error bars, s.d.
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separate times as long as 67 d postoperatively, revealing that axon morphologies
and numbers of axons were stable (Fig. 5.2a). We used blood vessels labeled
with Texas Red dextran and obvious features of the axons to navigate to the
same region of interest across different imaging sessions. At some time points,
blood vessels had increased or decreased diameter compared to baseline but
with stable morphology. Image contrast visibly diminished over time, which
we quantified by fitting projections of axon segments to a simple model (Fig.
5.2b,c and Online Methods). We found a decrease in image contrast and a loss
of lateral resolution over time (Fig. 5.2d,e), with the greatest change occurring
over the first 14 d owing to the formation of a fibrous growth over the surface
of the spinal cord. The duration over which we could resolve individual axons
expressing fluorescent proteins using 2PEF imaging varied between as few as
5 d and as many as 140 d (Supplementary Fig. 5.8). We found that in mice
that had only minimal fibrosis 1–2 weeks after surgery, axons could routinely
be resolved up to more than 5 weeks. We could image for more than 5 weeks
in ∼ 50% of the mice with implants. At all time points, in mice in which
fibrous tissue growth was minimal, imaging depth was limited to 30–50 µm by
the short scattering length of myelin [19]. In cases in which fibrous growth was
dense, we could not resolve axons at any depth. In some mice, we observed a
myelin-poor region between adjacent dorsal roots that enabled imaging up to
depths of 300 µm, well into the dorsal horn (Supplementary Fig. 5.9).
5.3.3 Locomotor function was preserved after implantation
We used two behavioral assays to assess the impact of the implant on motor
function. We first tested mice for gait abnormalities during normal movement
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[20]. Mice with inked paws ran the length of a narrow enclosure, after which
we analyzed the patterns of their footprints to measure base of support (lateral
distance between hindlimb placement), stride length and running speed for
mice with spinal chamber implants as well as sham controls (shaved and
anesthetized but not receiving surgery; three mice per group). We found no
remarkable differences in gait attributable to the implant at any time point
(Supplementary Fig. 5.5). In the second assay, we assessed spontaneous activity,
rearing behaviors and movement speed by video-monitored open-field testing.
We determined the cumulative time spent immobile, grooming, rearing and
speed distributions from post hoc video analysis. Grooming time in mice with
implants was significantly higher on days 1–3 after surgery than in sham
controls, but this difference did not persist over time (P = 0.0069; n = 3
mice per group). We observed no differences in immobility or rearing times.
We derived nominal top speeds from speed distributions as the average speed
above the 75th percentile. Although we observed a slight reduction in top
ambulatory speed in mice with implants, as compared to sham controls, it
was not statistically significant (Supplementary Fig. 5.5). Finally, mice with
implants did not exhibit any difficulty in grooming hindquarters or climbing
(Supplementary Video 2).
5.3.4 Inflammation but no focal trauma to the spinal cord
We performed histological analysis using mice expressing EGFP in microglia
(CX3CR1-GFP) or in astrocytes (GFAP-GFP) or via standard hematoxylin and
eosin staining (Fig. 5.3a–c).
We implanted the spinal chamber in the transgenic mice and perfused them
134
control  
dorsal
ventral
sur
g.
cau
d.ros
t.
cnt
rl
1 d  
7 d  
a
200 µm
3 mm
H&E
c
d
b
100 µm
1 d  
7 d  
e
m
icr
og
lia
 d
en
sit
y 
(m
m
   
 )
microglia
control  
astrocytes
-2
as
tro
cy
te
 d
en
sit
y 
(m
m
   
 )-2
dorsal ventral
1 d
sur
g.
cau
d.ros
t.
7 d
sur
g.
cau
d.ros
t.
cnt
rl
1 d
sur
g.
cau
d.ros
t.
7 d
80
0
20
40
60
150
0
30
60
90
120
***
# #
#***
Figure 5.3: Histological analysis of reactive microglia and astrocytes, and tissue
morphology after chamber implantation.
(a,b) Wide-field fluorescence images of 30-µm-thick coronal tissue sections from the
laminectomy site 1 d and 1 week after implantation and in non-surgical controls for
mice expressing EGFP in microglia (a) or astrocytes (b). (c) Hematoxylin and eosin–
stained tissue section taken 7 d after implantation. Magnifications of the left and right
boxed regions show the fibrous connective tissue that covered the dorsal aspect of the
spinal cord under the implant and the neural tissue, respectively. (d,e) Microglia (d) and
astrocyte (e) densites in spinal cord sections 1 and 7 d after implantation for sections one
vertebra rostral to the surgical site (rost.), at the surgical site (surg.) and one vertebra
caudal to the surgical site (caud.) and in controls (∗P = 0.012; ∗ ∗ P = 0.0010; ∗ ∗ ∗P =
0.0098; #P < 0.0001;n ≥ 15 measurements per segment per time point; 3 mice per time
point). Error bars, s.e.m.
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for histology analysis 1 d and 1 week after surgery. We used mice that did
not undergo surgery as controls (three mice per group). In mice that received
implants, we analyzed sections from the site of laminectomy as well as the
immediately rostral and caudal vertebrae. Both 1 d and 1 week after surgery,
microglia in sections under the surgical site showed a more condensed structure
with fewer processes compared to controls, but we observed no ameboid
structures indicative of phagocytic microglia [21] (Fig. 5.3a). Microglia densities
(Fig. 5.3d) in the dorsal aspect of the rostral segment of the spinal cord 1 d
after surgery and in the dorsal aspect of all segments 1 week after surgery
were elevated compared to controls. Astrocytes showed no obvious changes
in morphology or cell density (Fig. 5.3b,e) across all groups.
For standard histopathology studies, we killed and perfused mice 1 d, 1
week and 1 month postoperatively (two mice per group). In all cases, control
regions showed normal tissue in nerves, bone, muscle and spinal cord. Mild
dermatitis was present at the skin-implant junction in all mice. Focal meningitis
at the caudal edge of the window occurred in one mouse in the 1-week group.
We observed no signs of meningitis or disruption of neural tissue in the other
mice (Fig. 5.3c) or in other regions of the mouse exhibiting focal meningitis.
Neutrophils were absent in spinal cord tissue of all mice at all time points.
The fibrous tissue (Fig. 5.3c) over the dorsal surface of the cord progressively
thickened over time and was the limiting factor to the duration of imaging.
We observed indications of muscle injury including myositis, myodegeneration
and myoregeneration along with epidural neutrophilic fascitis at the site of
implantation at the 1-d and 1-week time points. Reactive bone growth and
fibroplasia occurred at the lateral edges of the window at the 1-month time
point. The silicone elastomer showed no signs of cellular infiltration.
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Figure 5.4: Imaging and quantification of microglial scar formation at the site of a
laser-induced SCI.
(a,b) Projections of 2PEF image stacks of EYFP-labeled axons (teal) and EGFP- labeled
microglia (mauve) before (a), 1 d (b) and 1 week (c) after producing a 200-µm-long
laser-induced microlesion in the spinal cord. (d,e) Boxplots of the number of microglia
(d) and the microglial scar size (e) in the 300-µm field of view over time (four lesions
in two mice). Horizontal red lines denote the median, blue boxes bound the 25th and
75th percentiles of the data, and the whiskers denote non- outlier extrema (defined as
outside the box by less than 1.5 times the interquartile range).
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5.3.5 Numbers of microglia increased over 7 d after SCI.
We used double-transgenic mice expressing EYFP in a subset of DRG axons
and EGFP in microglia to evaluate the dynamics of microglial scar formation
after a∼ 200 µm-long, 35-µm-deep laser-induced transection injury to the dorsal
column produced using tightly focused femtosecond laser pulses (Fig. 5.4a–c;
four lesions in two mice). We intentionally spared blood vessels in the creation
of the lesion. Microglial cell counts increased dramatically during the first day
and continued to increase more slowly over the following 6 d (Fig. 5.4d). The
spatial extent of the densely packed microglial scar increased steadily over 7 d
(Fig. 5.4e).
5.3.6 2PEF imaging of axon dieback after SCI.
We evaluated axonal response to injury in nine laser lesions in five mice
expressing EYFP in DRG afferent axons (Fig. 5.5a). We imaged two mice for
5 weeks after injury (four lesions). We collected several image stacks at the
lesion site at different times after SCI (Supplementary Video 3). We used
characteristic features of spared axons to define a common point of origin across
different imaging sessions (Fig. 5.5b). We used manual tracking both from
three-dimensional (3D) stacks and 2D projections to determine the distance of
individual axon tips from the lesion along the rostral-caudal direction (Fig.
5.5b,c). Owing to axon density and insufficient spatial extent of the image
stacks, we could not distinguish ascending axons from descending branches
of the DRG neurons. Owing to a loss of image contrast immediately after injury,
tracing was possible for most but not all axons (95 of 107 axons traced) on acute
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timescales (0–2 h). The average response of axons was to die back from the
lesion site, but the extent and rate of axon dieback was highly heterogeneous
(Fig. 5.5b,c). Some axons exhibited the rapid acute axonal degeneration that has
been previously described [12]. Other axons persisted near the lesion site for
several days or even weeks, with some mounting an abortive growth response
(Fig. 5.5b,c). Axon tip morphology (Fig. 5.5b) also varied from day to day. The
average dieback speed of the axons (defined as the change in an axon tips axial
position between successive imaging sessions divided by the elapsed time, with
growth phases excluded) declined by nearly three orders of magnitude over the
5 weeks after injury (Fig. 5.5d).
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Figure 5.5: 2PEF imaging and quantification of axon dieback after a laser-
induced SCI. (a) Projection of a 2PEF image stack from mice expressing EYFP (teal) in
a subset of DRG neurons with the vasculature labeled with Texas Red dextran (red). (b)
Projections of 2PEF image stacks of EYFP-expressing axons shown in the boxed region
in (a) before and at indicated times after a lesion produced by translating high-energy,
tightly focused femtosecond laser pulses through the cord. Mauve circles indicate
easily recognizable patterns in spared axons that were identified at all time points
and provide a point of origin. Yellow arrows, axon that exhibited rapid degeneration;
blue arrows, axon that died back more slowly; red arrows, axon that persisted near
the lesion site and made an ultimately aborted growth response (the morphology of
this axon’s tip is shown in the insets; scale bar in inset, 10 µm); and *, location of
early sprouting responses that did not persist over time. (c) Position of axon endings
over time after the lesion, with positive and negative values corresponding to positions
rostral and caudal to the lesion site, respectively (see schematic in inset) (107 individual
axon trajectories over nine lesions in five mice). Axon trajectories in color correspond
to the locations marked by respectively colored arrows in b. (d) Speed of axon-tip
dieback for axons remaining in the field of view over time after the lesion. Black circles
denote measurements of dieback speed from individual axon tips, horizontal red lines
represent the median, the blue boxes bound the 25th to 75th percentage of the data, and
the whiskers extend 1.5 times the interquartile range beyond the boxes. Points outside
the whiskers were considered outliers and have a red cross through them. Because
axons died back beyond the imaging field over time, the dieback speed at early times
includes data from 100 axons, and the last time point includes data for only 16 axons.
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5.4 DISCUSSION
Our study of microglial invasion after laser-induced SCI revealed that although the
number and spatial extent of microglia continued to increase over time, the largest
fractional change occurred within the first 24 h after injury, consistent with previous
studies [14]. Microglia are known to phagocytose growth-inhibitory axon debris [22] in
white-matter tracts [23], suggesting that the chronic, gradual recruitment of microglia
may be related to the progressive degeneration of the axons involved. Thus, imaging
of microglia infiltration and the clearance of axon debris will be critical for developing
optimal therapeutic strategies to manipulate the microglial response.
One of the key challenges in studies of regenerative strategies for SCI is the
establishment of an optimal therapeutic time window [24–26]. Although the delay
of treatment has been discussed at length with respect to the glial scar [25], our
observation of heterogeneity in axon dieback, instances of early but transient sprouting
and decrease in dieback rate at longer timescales may suggest an optimal therapeutic
window based on axon dynamics. Our axon-by-axon characterization of axon dieback
rates agreed with previous studies of acute [12] and longer-term [27, 28] measurements
but revealed details of this transition and allowed classification of subpopulations of
axons by response: ∼ 15% were stable (remained within 400 µm of the lesion for at least
4 weeks), ∼ 15% rapidly disintegrated (died back beyond the field of view within the
first day) and ∼ 70% progressively degenerated over the first month. Such dynamic
data are inaccessible to postmortem histology or analysis of gross lesion size. In future
studies we will attempt to correlate these classes of heterogeneity in axon dieback with
heterogeneity in regenerative responses to therapy.
Previous studies [12, 13, 16, 18] have demonstrated time-lapse imaging of the spinal
cord via repeated surgical opening of the skin above the spinal cord. Because of
the inherent stresses and risks of repeated surgeries or restrictions placed by the
Institutional Animal Care and Use Committee, the number of times these procedures
may be performed places severe limitations on longitudinal studies. For example, in
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one long-term longitudinal study, only six imaging sessions were possible in 4 months
[18]. To effectively study disease dynamics and especially response to therapeutic
agents, imaging must span a sufficiently long period of time to establish therapeutic
limits with an imaging frequency that enables capture of transient responses. The
chamber we developed requires only a single surgery and grants continuous optical
access, with the frequency of imaging being limited only by the ability of the mouse to
endure multiple rounds of anesthesia. We imaged immediately after SCI up to 2 h after
injury, then every 12 h for 1 d, then daily for 3 d and finally weekly for 5 weeks, for a
total of 13 imaging time points after SCI.
We observed microglia at the surgical site to have higher densities and fewer
processes 1 week after surgery compared to control mice, suggesting an activated but
not phagocytic phenotype [21]. This result is consistent with an analogous study that
considered [29] inflammatory responses under cranial windows , and care will need
to be taken when using our spinal cord window in studies sensitive to even mild
inflammatory responses. However, we observed that even a minimal laser injury
to the spinal cord results in an order of magnitude increase in microglia density
near the injury, including microglia showing phagocytic ameboid morphologies. This
increase far exceeds the less than twofold increase in microglia density owing to the
surgery, suggesting that our chamber does not substantially confound studies in which
microglial responses are more drastic.
When combined with 2PEF imaging of transgenic mice expressing fluorescent
proteins in axons, microglia, astrocytes, oligodendrocytes, endothelial cells and
immune cells and with nonlinear microscopy techniques to visualize myelin (such as
third harmonic generation [19]), the spinal chamber described here is an ideal tool for
longitudinal studies of healthy and diseased-state spinal cord, including pathologies
such as multiple sclerosis, implanted spinal cord tumors or the establishment of
meningitis after bacterial challenge. As our chamber does not lead to motor deficits,
functional loss or recovery may be straightforwardly correlated with cellular images.
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5.5 METHODS
5.5.1 Surgical procedure
We anesthetized mice under 5% isoflurane on a custom-built surgery table
(Supplementary Fig. 5.7) and then maintained on∼ 1.5% isoflurane in 100% oxygen. We
injected 0.05 mg of glycopyrrolate (an anticholinergic) per 100-g mouse intramuscularly.
We also injected 1 mL per 100-g mouse of 5% (w/v) glucose in normal saline
subcutaneously hourly. We used a rectal thermometer and feedback-controlled heating
blanket to maintain body temperature at 37.5◦C. We shaved the dorsal surface above
the thoracic spine and applied three alternating washes each of 70% (v/v) ethanol and
iodine to the skin to reduce the likelihood of infection. We gave a subcutaneous injection
of 0.1 mL of 0.125% (v/v) bupivicaine at the site of skin incision.
We made a small incision in the skin at the T11–T13 level of the mouses spine and
held back the skin with retractors. We made an incision three vertebrae long on either
side of T12 and scraped the bone clean on the top and the sides. We severed tendons
attached to the three vertebrae using surgical scissors. We trimmed all incongruous
tissue to reduce necrosis. We used sterile cotton applicators to control bleeding. We
clamped the three vertebrae by magnetic stainless steel bars with a notched groove
and held under pressure on 30-mm stainless steel posts with a three-pronged plug,
consisting of two pins to prevent rotation and a central magnet to hold the bar. We
removed the dorsal lamina of T12 using vanna scissors, and used sterile gel foam
(Pharmacia & Upjohn Co.) or cotton applicators along with sterile saline to control
bleeding and keep blood off the surface of the cord. We trimmed the lateral edges of
the bone back as close as possible to the edges of the bars and the surface of the bone
sealed with dental acrylic and cyanoacrylate. Where possible, we left the dura intact.
Keeping the cord irrigated with normal saline, we positioned a top plate and screws
inserted into the metal bars. We injected Kwik-Sil silicone elastomer (World Precision
144
Instruments) into the space between the cord and the top plate and sealed the chamber
with a 5-mm diameter coverslip. We used cyanoacrylate glue and dental acrylic to
seal the chamber at the rostral and caudal vertebrae. With pressure maintained by
the screws, we removed the three-pronged steel posts. We pulled the skin to the
edge of the implant and secured it with cyanoacrylate glue and dental acrylic. We
inserted set screws into the wings of the top plate. An illustration of the procedure with
accompanying photographs is available in Supplementary Figure 1. We again injected
bupivicaine (0.1 mL, 0.125%) around the edge of the implant. During recovery, we
placed the mouse on a heated surface and administered ketoprofen (5 mg kg-1d-1) and
dexamethasone (0.2 mg kg-1 d-1) every 24 h for 72 h. A step-by-step description of how
to perform the procedure, with suggested solutions to common problems, is available
in the Supplementary Protocol. We performed all surgery under a stereomicroscope
(Leica MZ12.5).
All animal procedures performed were approved by the Cornell Institutional
Animal Care and Use Committee and were performed under the guidance of the
Cornell Center for Animal Resources and Education.
5.5.2 Mice
For imaging, we used mice of the YFP-H line (Jackson Labs), which express EYFP in a
subset of pyramidal neurons and dorsal root ganglia. In addition we used CX3CR1-GFP
mice (Jackson Labs), which express EGFP in microglia. We also used crosses between
the YFP-H and CX3CR1-GFP lines. For histopathological analysis, we used mice of the
YFP-H line and mice of the Emx-1-cre (Jackson Labs) lines. We used CX3CR1-GFP mice
and GFAP-GFP (Jackson labs), which express GFP in astrocytes, to study reactive gliosis
in microglia and astrocytes, respectively.
In all cases, mice were of both sexes and 3–12 months in age when the device
was implanted, and they were heterozygous for each transgene. Mice were group-
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housed before chamber implantation and were singly housed in rat-size cages after
implantation to minimize the risk of the mouse bumping the implanted chamber
against the cage lid.
5.5.3 Histology
We deeply anesthetized mice and perfused them transcardially with phosphate
buffered saline (PBS; pH 7.4) (SigmaAldrich) to clear the blood, followed by fixation
with 4% (w/v) paraformaldehyde (PFA) (ThermoFisher Scientific) in PBS.For gliosis
studies in GFAP-GFP and CX3CR1-GFP mice, we immersed whole spines in PFA for
1 d after perfusion followed by removal of the spinal cord from the vertebral canal by
microsurgical dissection. We immersed dissected spinal cords in 30% (w/v) sucrose
in PBS until saturated. We froze spinal cords in optimal cutting temperature (OCT)
compound (Tissue-Tek) and cut sections at a nominal thickness of 30 µm on a Microm
HM550 cryotome (ThermoFisher Scientific). We took sections at the rostral and caudal
edges of the implant, under the glass and control regions located one vertebrae in the
rostral and caudal direction from the edges of the implant. We examined tissues under
an Olympus BX41 wide-field fluorescence microscope.
For hematoxylin and eosin staining–based histopathology studies, we examined
whole fixed mice for gross pathology, and gently freed and removed the skin
surrounding the chambers. We separated the chambers from their attachment to the
subjacent vertebral bodies starting at one end by gentle dorsal traction. Once freed
from the vertebral bodies, we carefully separated the chambers from subjacent soft
tissues (epaxial muscle and connective tissues). We removed any material (mostly
injected silicone) that had adhered to the ventral surface of the glass windows using
a scalpel and reserved it for staining. After removing ribs and organs from the
vertebral column, we collected 3-mm crosssections of the vertebral column, including
surrounding muscle, from 1 cm rostral, 1 cm caudal and directly below the center
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of the window by making cuts perpendicular to the vertebral column using a broad
tissue blade. We inserted tissues into cassettes and immersed them again in PFA. We
decalcified tissues by rinsing tissue cassettes under running water for 15 min, followed
by placement in a vacuum jar containing equal volumes of 20% (w/v) sodium citrate
dihydrate and 50% (v/v) formic acid. Tissues were held under vacuum at room
temperature (20–25◦C) with constant stirring using a magnet for ∼24 h. After this
procedure, we rinsed tissues under running water for 10 min and put in a solution of
70% (v/v) ethyl alcohol. We then embedded tissues in paraffin wax using an automated
tissue processor (Tissue-Tek VIP), sectioned (4-µm thick sections) them and stained
them with hematoxylin and eosin using an automated stainer (Shandon Varistain 24-
4; Thermo Scientific). We sealed slides with a coverslip and examined them using an
Olympus BX40 microscope.
5.5.4 2PEF microscopy
To image (or reimage) the spinal cord, we anesthetized mice with isoflurane and placed
them on the custom surgery table described previously for the laminectomy procedure.
Mice also received glycopyrrolate and glucose as described above. We used tapped 30-
mm posts secured in an optical post holder to screw finger-tight onto the set screws of
the wings of the top plate of the implant to locally immobilize the spine (Supplementary
Fig. 5.6g). We elevated mice slightly by the implant to allow room for chest expansion
and contraction during breathing. After imaging, we twisted off the posts and the
mouse was allowed to recover on a heated surface.
We performed imaging using a custom-designed multiphoton microscope with
a 20X water-immersion objective lens (numerical aperture (NA) = 1.0; Carl Zeiss
MicroImaging), a 40X water-immersion objective (NA = 0.8; Olympus) or a 4X objective
(NA = 0.28; Olympus). We performed 2PEF imaging using 1,043-nm wavelength, 1-
MHz, 300-fs pulses from a fiber laser (FCPA µJewel D-400; IMRA) and/or 920-nm, 87-
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MHz, 100-fs pulses from a Ti:sapphire laser oscillator (MIRA HP; Coherent). We used
emission filters at 645/65 nm (center wavelength/bandwidth), 550/50 nm and 517/65
nm (Chroma Technology) to isolate fluorescence from Texas Red dextran, YFP and GFP,
respectively (see Supplementary Note 7 for individual image details).
5.5.5 Spinal cord lesioning
We made lesions measuring 100–300 µm long, 5–10 µm wide and 30–40 µm deep
in the dorsal spinal cord by femtosecond laser ablation using ∼100-nJ pulses from a
regenerative amplifier (800-nm wavelength, 50-fs pulse duration, 1-kHz repetition rate;
Legend, Coherent). We used custom software in Matlab (MathWorks) to define a 2D
trajectory by tracing a pattern on a z-dimension projection of a 3D image stack. To
minimize the loss of image contrast caused by excessive bleeding, we intentionally
avoided cutting blood vessels where possible. To execute the pattern, the mouse was
translated at 500 µm s-1 along the traced trajectory in the x-y plane while a shutter
controlling the femtosecond pulses was opened, producing a cut ∼2–3 µm deep. The
mouse was then translated by 1 µm in the z direction, and the cut pattern was repeated.
This procedure was iterated until a cut depth of 30–40 µm was achieved. The shutter
was closed during translation in the z dimension. When deemed necessary, we repeated
the cut to ensure complete transection of axons. Because the damage was mediated by
an electron-ion plasma formed by nonlinear optical absorption and there was very little
thermal energy deposited, the damage was largely confined to the focal volume.
5.5.6 Image processing
We computed image projections by taking the standard deviation (s.d.) along the z
axis of three-dimensional image stacks. For contrast and resolution measurements,
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we used maximum pixel intensity projections of isolated axon segments. As we
oversampled image stacks, we manually removed frames with large motion artifacts
resulting from breathing without loss of information. Owing to the high density of
microglia observed after SCI, there was ambiguity in distinguishing cell bodies from
densely packed processes. We manually identified microglia cell bodies as fluorescent
ameboid structures with visible boundaries, traced them and counted them in 2D
projections using custom Matlab software. We defined microglia scar size as the mean
square radius in manual traces of the boundary of the largest contiguous aggregate
of microglia. For axon tracing, we Fourier filtered high-resolution (0.59 µm pixel-1.)
3D image stacks, took the s.d. projection and stitched the images together using
PanaVue stitching software. We used spared axons that were stable over the duration
of the experiments to define a common point of origin among imaging sessions. We
marked axon endings and tracked them using custom software in Matlab. We resolved
ambiguities by examining trajectories in the 3D stacks.
In double-transgenic mice expressing YFP in axons and GFP in microglia, we used
emission filters with 517/65 nm and 550/50 nm (center wavelength/bandwidth) with
920-nm excitation for 2PEF imaging. We linearly unmixed images in custom software
written in Matlab. Briefly, we manually selected image features corresponding to axons
(YFP) or microglia (GFP) in both imaging channels and generated a mixing matrix.
We then solved for the inverse matrix and calculated the resultant unmixed images
containing separate fluorescent species.
5.5.7 Contrast and resolution fitting
. To characterize the contrast and resolution, we first used ImageJ to isolate axon
segments of ∼40–50 µm in length from image stacks of the same region across multiple
days. We performed subsequent analysis in Matlab. We computed the maximum
projection along the z axis and median-filtered the resulting image with a 1-pixel filter
149
radius. To orient the segment so that the axis ran parallel to the y axis, we used a radon
transform to find the angle of orientation and rotated the image accordingly.
As we considered the maximum intensity projection across the axon volume, the
intensity profile is equal to the value of the intensity profile taken immediately through
the center of the axon, where, to good approximation, the excited fluorescence in the
axon is approximately constant in the x direction. For an axon of radius R, and
displaced from the origin by an amount δ, the fluorophore concentration profile, C,
in a single scan at the center is
C(x) = C0 (θ(x+R+ δ)− θ(x−R+ δ)) (5.1)
where C0 is the axonal fluorophore concentration and θ(x) is the Heaviside step
function. For a Gaussian beam with intensity profile
I(x) = I0 exp
(
− x
2
2a2
)
(5.2)
where I0 is tthe peak laser intensity and a is a measure of the beam waist, the image
intensity, F(x), is given by the convolution of equations (5.1) and (5.2) with the addition
of a background noise floor, B
F (x) = A
(
erf
(
x+R+ δ√
2a
)
− erf
(
x−R+ δ√
2a
))
+B (5.3)
where
A =
√
pi
2
aI0C0 (5.4)
We fit equations (5.3) to each line of the axon profile (Fig. 5.2c) and averaged the results.
Failure to converge by nonlinear least-squares fitting or an R2 value less than 0.85 was
used to exclude data points. We defined contrast as
F (−δ)−B
F (−δ) +B (5.5)
which ranges between 0 (no contrast) and 1 (noiseless contrast), where F (−δ) is the
intensity peak in the axon. We took resolution as the parameter a.
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5.5.8 Behavioral assays
We subjected mice to open-field and runway assays. We first made measurements 1 d
before implantation of an imaging window, followed by measurements each day for the
first 7 d and a final time point at 14 d after implantation. We made all measurements
at the same time of day to avoid circadian variability. We tested mice that were shaved
and anesthetized, but not operated on, simultaneously as sham controls.
We constructed analysis of footprints from the runway assay in which mice with
inked paws traversed the length of a Plexiglass enclosure (76 cm long× 8 cm wide× 20
cm high) to enter a dark goal box at the end of the runway. We placed mice on an inked
pad in a 15-cm-long staging area separated from the main runway by a sliding insert.
We placed paper tape on the floor of the runway to collect ink pawprints. Removal of
the insert marked the beginning of the trial. All trials were video-recorded from above.
We performed three trials at each time point, and took footprint measurements from
5 consecutive steps in each trial. We then returned mice to their home cage between
trials to minimize the effects of fatigue. Mice received 10–14 d of behavioral training
before surgery. During training, we encouraged mice to traverse the length of the
runway without pausing, receiving prompting from the experimenter where necessary.
We deemed training complete when mice traversed the length of the runway without
pausing or prompting. We assessed hindlimb base of support as the lateral distance
between hindlimbs and stride length as the distance between the central pads of two
consecutive hindlimb prints on the left or right. We determined average speed by
dividing the runway length by the total time of the trial, as determined by the video
clock.
We assessed rearing, grooming, mobility and top ambulatory speeds in open-field
measurements. We placed mice in the center of a Plexiglass enclosure (46 cm long ×
46 cm wide × 47 cm high) with black sides and a white base. We recorded mice from
above for 5 min under red-light illumination. Video tracking analysis was performed
based on the videos using ANY-maze software (Stoelting Company) and Matlab. We
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defined rearing as any period during which the mouse lifted both of its forelimbs off the
ground simultaneously. We defined grooming as any period during which the animal
licked its fur or moved its forelimbs over the head. Top speeds were determined as the
mean of the speeds greater than the 75th percentile.
5.5.9 Statistical analysis
We compared grooming time, time spent immobile, rearing time, base of support, stride
length and average speed using the analysis of variance (ANOVA) test. Where the
null hypothesis was rejected, we performed post hoc analyses using Tukeys honestly
significant difference for pairwise comparisons. We compared top speeds of mice
receiving surgery and sham treatments each day using a Mann-Whitney U test.
We compared microglia and astrocyte densities using ANOVA. Where the null
hypothesis was rejected, we performed post hoc analyses using Tukeys honestly
significant difference on mean to compare groups.
We performed statistical tests in Kaelidograph (Synergy) and Matlab. We set the
criterion for significance in all cases to be α = 0.05
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5.7 SUPPLEMENTARY MATERIALS
a
c
e
hg
f
d
b
2 mm
14 d post-op
Figure 5.6: A metallic spinal chamber implant was mounted via a custom delivery
system onto the vertebral column and provided long-term optical access to the spinal
cord.
The exposed vertebrae (T10–T12) were clamped by notched metal bars attached to
holder posts (a,b) after soft muscle had been retracted. Vanna scissors were used to
complete a dorsal laminectomy (c,d) on the central vertebra (T11). A top plate was
secured using four screws, maintaining the clamping pressure (e). Silicone elastomer
was placed over the cord and the chamber was sealed with glass, while set screws were
inserted into the wings of the top plate (e,f). Holder posts were removed (e) and the skin
was sealed using a combination of cyanoacrylate adhesive and dental acrylic cement (f).
To image, mice were anesthetized and the spine was locally immobilized by securing
the implant to holder posts via the set screws (g). Optical access was possible for several
weeks or more (h).
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MS12B
MSH2
MS2R
MSH075
MSAP90
ER90B
table front
table back
table 
center
Figure 5.7: A custom surgery table allows for both surgery and imaging procedures.
A procedure table –composed of rotary wings and a center part–designed for surgery
and imaging is readily built with relatively inexpensive optics parts. Parts as labeled
are available from Thor Labs under the following part numbers: φ6 mm posts (MS2R)
and post- holders (MSH2), right-angle post adapters (ER90B), post-holder for nose-cone
(MSH075), angle bracket (MSAP90), φ1/2” post (TR2) and post-holder (PH1.5) (below
the surgery table), and breadboard (MS12B). The posts that screw to the set screws in the
top plate of the imaging chamber, as illustrated in Fig. 5.1g, mount to the ER90B right-
angle adaptors. Shown mounted here is a vertebral clamp for acute imaging where a
chronic chamber is not required. Optionally, posts can be added to the table front to
prevent sliding during surgery.
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Supplementary Figure 3
*
100 µm
140 d33 d
200 µm
a
1 db
Supplementary Figure 3: Imaging with individual axonal resolution is possible out to as 
many as 140 days post-surgery.  In one animal considered, multiple imaging sessions were 
possible out to as long as 140 days.  An injury induced during surgery was evident one day after 
the surgery (a, mauve asterisk) and a region rostral to the injury (a, yellow box) remained 
sufficiently clear so as to image individual axons.  Axonal degeneration progressed rostrally over 
time (b), with little change on one day post-surgery, severe degeneration in the selected region by 
day 33, and only spared axons present at day 140. 
Figure 5.8: Imaging with individual axonal resolution is possible out to as many as
140 days post-surgery.
In one animal considered, multiple imaging sessions were possible out to as long as 140
days. An injury induced during surgery was evident one day after the surgery (a, mauve
asterisk) and a region rostral to the injury (a, yellow box) remained sufficiently clear so
as to image individual axons. Axonal degeneration progressed rostrally over time (b),
with little change on one day post-surgery, severe degeneration in the selected region
by day 33, and only spared axons present at day 140.
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Supplementary Figure 4
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Supplementary Figure 4: Anatomically myelin-poor regions of the spinal cord enable deep-
tissue imaging.  Regions of the dorsolateral spinal cord between dorsal roots (a, yellow box) 
exhibit regions deficient of densely myelinated axons (YFP, teal).  In these regions, imaging of 
neuron cell bodies (yellow arrows), dendrites (orange arrows), axons (mauve arrows), and 
vasculature (Texas Red dextran, red) in the dorsal horn is possible up to several hundred 
micrometers below the surface (b-e).  Image projections are taken at and over the depths given 
by the illustrations (right).   The dotted line marks the stark change in contrast between areas 
underlying myelinated superficial axons and regions of sparse axon density.  
Figure 5.9: Anatomically myelin-poor regions of the spinal cord enable deep- tissue
imaging.
Regions of the dorsolateral spinal cord between dorsal roots (a, yellow box) exhibit
regions deficient of densely myelinated axons (YFP, teal). In these regions, imaging
of neuron cell bodies (yellow arrows), dendrites (orange arrows), axons (mauve arrows),
and vasculature (Texas Red dextran, red) in the dorsal horn is possible up to several
hundred micrometers below the surface (b-e). Image projections are taken at and over
the depths given by the illustrations (right). The dotted line marks the stark change in
contrast between areas underlying myelinated superficial axons and regions of sparse
axon density.
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Supplementary Protocol
1.  A mouse is anesthetized on 5 % isoflurane mixed with 100 % oxygen in an induction 
chamber.
2.  Once initial anesthesia has been achieved, the isoflurane is reduced to ~1.5-2 % for the 
duration of the procedure.
3.  The mouse receives glycopyrrolate (0.05 mg per 100-g mouse), an anticholinergic, via 
intramuscular injection into the hindlimbs.
4.  The mouse is transferred to a shaving/washing station away from the sterile surgery field 
where the relevant portions are shaved and receive three alternating washes of iodine and 70 
% ethanol applied by cotton applicator. 
5. The mouse receives 0.1 mL of 0.125 % bupivicaine, a local anesthetic, subcutaneously near 
the peak of the thoracic curvature.  Between the ears or anywhere distal to the surgery site, 1 
mL per 100-g mouse of 5 % glucose in saline, 0.25 mL per 100-g mouse of 0.5 mg/mL 
ketoprofen, and 0.2 mL per 100-g mouse of 0.1 mg/mL dexamethasone are administered by 
subcutaneous injection.
6. The mouse is transferred to custom spinal surgery table (Supplementary Fig. 3) with a 
feedback-controlled heating blanket overlaid with sterile drapes.  All surgical tools should be 
sterilized by autoclaving or other suitable sterilization technique.  
7. A small (~1 cm incision) is made with a #10 scalpel in the skin near the thoracic arch, and 
fascia connecting the skin to the underlying muscle is gentle pulled away using forceps.
8. Retractors are use to hold back the skin, creating an approimately ~1” x 1.5” exposed field.
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9. After finding T11, T10 is firmly grasped through the muscle using forceps, and a scalpel is 
used in combination with a bone scraper to remove the muscle overlying T10-T12.  Sterile 
cotton applicators are used to control bleeding as well as to gently remove tissue adhered to 
the bone.
10. Using curved scissors and forceps, tendons are severed from the transverse processes of 
vertebrae T10-T12.  
11. Tissue lateral to the vertebral column is severed and retracted from the bone deep and wide 
enough to allow insertion of the side bars, but taking care not to injure the dorsal roots.  
Bleeding is controlled with sterile cotton applicators.  Critical Step: To avoid necrosis, tissue 
must be trimmed smooth, especially along the transverse process of the vertebrae. 
12. Side bars are delivered on custom 3-pronged post-holders (bar holder) and fuse the 3 
vertebrae by clamping.  The compression is held by tightening set screws on the right-angle 
post adapter.  
13. Critical Step: It is essential that all soft tissue be effectively removed from T11.  This can be 
achieved by drying the bone with cotton applicators and/or by applying a modest amount of 
cyanoacrylate glue and removing it after hardening, effectively providing a means of tissue 
debridement.
14. Vanna scissors are inserted just into the epidural space on either lateral aspect of the dorsal 
lamina of T11.  If the bone is sufficiently dry, the initial cut should cause the bone to crack 
along its length.
15. The process is repeated for the contralateral side, and any rostral or caudal soft tissue is 
gently cut away while pulling the dorsal lamina away from the spinal cord with forceps.  
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Bleeding is controlled at the edges of the laminectomy using sterile cotton applicators.  Blood 
is cleared from the spinal cord by flushing the exposed cord with artificial cerebrospinal fluid 
(ACSF).  Critical Step: During the removal of the bone, part of the periosteum may detach and 
cover the spinal cord.  This tissue should be delicately removed with a dural hook or small 
needle.  Care should be taken to distinguish the periosteum from the dura mater.  
16. Once the initial lamina is removed, carefully trim back the bone on the transverse processes 
to more fully expose the spinal cord.  The surface of the bone may be sealed by carefully 
applying dental cement to both the bone surface and the side bars.  
17.Once bleeding has been controlled and the spinal cord cleanly exposed, the top plate is 
positioned on top of the side bars and centered over the laminectomy.
18. Four #000-120 screws can then be partially inserted, starting with diagonally opposite slots.  
Once the final position is satisfactorily achieved, these screws may be tightened.
19. Kwik Sil elastomer is injected into the laminectomy site, taking care to avoid air bubbles.  
20. Immediately after injection, a #0  cover slip is inserted to seal the laminectomy, gently 
applying pressure to squeeze the silicone into the rest of the chamber.
21. Approximately 10-20 minutes should be given to allow the silicone to set.  
22. The silicone and chamber are sealed at the rostral and caudal edges by applying small 
amounts of dental acrylic and/or superglue to the chamber, silicone, and the exposed bone of 
T10 and T12.  
23. The set screws on the right-angle adapters are loosened and the custom-delivery system is 
gently removed from the side bars.
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24. Retractors are removed, and the skin is pulled up around the edges of the implant and secured 
with cyanoacrylate glue.
25. #0-80 set screws are inserted into the wings of the top plate.
26. Dental acrylic is applied on top of the skin at the edges of the implant and used to fill the 
slots in the top plate, providing a good seal on the chamber.
27. A second injection of 0.1 mL of 0.125 % bupivicaine is administered around the implant and 
the animal is transferred to a clean cage on a heat pad to recover.
Step-by-Step Imaging Procedure
1.  The mouse is anesthetized on 5 % isoflurane mixed with 100 % oxygen in an induction 
chamber.
2. Once anesthesia has been achieved, the isoflurane is be reduced to ~1.5-2 % for the duration 
of imaging.
3.  The mouse receives glycopyrrolate (0.05 mg per 100-g mouse), an anticholinergic, via 
intramuscular injection into the hindlimbs.
4. The mouse is transferred to the custom surgery table (Supplementary Figure 3) with a 
feedback-controlled heating pad.
5. Tapped posts (chamber holders) are inserted into the right-angle adapter and twisted onto the 
set screws on the wings of the chamber.
6. Set screws on the right-angle adapter are tightened to prevent the chamber from moving 
during imaging.
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7. The posts are raised in the post-holders to elevate the thorax from the surgery table, thereby 
allowing for free expansion of the chest upon inspiration without introducing motion artifact.  
Set screws on the post-holders prevent up-down motion of the posts.
8. Vasculature is labeled by intravascular injection of a fluorescent dextran by retro-orbital 
injection.  Briefly, a syringe is inserted under the eyeball with the bevel towards the nasal 
septum while dye is slowly ejected.
9. Multiphoton microscopy is performed for up to several hours.
10. The tapped posts (chamber holders) are unscrewed and the mouse is allowed to recover.
Trouble Shooting
Problem Possible  Reason Solution
1. Chamber detaches 
from spinal cord post-
surgically
• insufficient clamping pressure
• insufficient gluing
• ensure appropriate pressure applied and 
that set screws in right-angle adapters are 
tight
• apply glues more liberally at the rostral 
and caudal edges of the implant
2. Profuse bleeding in 
peripheral tissue during 
surgery.
• severing of major artery • cauterize bleed with electro- or thermal 
cautery
• apply pressure to bleed until stopped with 
cotton applicator
3. Air bubbles in 
silicone under window.
• air in mixer tip
• air entering through edges of 
chamber
• ensure that air has been evacuated from the 
mixer tip prior to filling chamber
• apply glues more liberally at the edge of 
the chamber to prevent silicone from pulling 
away from tissue
• ensure that silicone has opportunity to set 
prior to disturbing the chamber
4. Blood in window 
post-surgery.
• bleeding in peripheral tissue 
entering under silicone
• bleeding from vertebral body
• bleeding from the spinal cord 
itself
• determine the source of bleeding by 
removing the silicone, and if necessary, 
replace it. 
• apply glues more liberally at the rostral 
and caudal edges of the implant to seal out 
any peripheral fluid from entering
• ensure that the bone has stopped bleeding 
before applying silicone
• carefully applying a thin layer of superglue 
to the bone can help reduce bone bleeds
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Problem Possible  Reason Solution
5. Rapid (few days) loss 
of image contrast
• fibrous tissue growth • trim back more of transverse processes and 
seal with dental acrylic
• reduce space for fibrous tissue to grow by 
minimizing the space between the glass and 
spinal cord by appropriate leveling of the 
implant
6.  Motion artifact 
complicates imaging.
• chamber is loose
• chamber is not securely held
• mouse is insufficiently 
elevated
• spinal cord moving within 
vertebral column
• ensure appropriate pressure is applied and 
that set screws in right-angle adapters are 
tight
• apply glues more liberally at the rostral 
and caudal edges of the implant
• ensure all set screws are tightly fastened
• elevate mouse so that chest can expand 
freely upon inspiration
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CHAPTER 6
THE MOUSE POSTERIOR SPINAL VENOUS SYSTEM AND CHANGES IN
FLOW AFTER POSTERIOR SPINAL VEIN OCCLUSION
In this section, we describe a work in progress on the mouse spinal vasculature. This
project was worked on with two students under my supervision, Jonathan Rubin and
Darcy Diago, whose hard work and insights have led to the development of this project.
Jonathan Rubin adopted a ferric (III) chloride technique for inducing vascular clots, and
applied this method to the posterior spinal vein (PSV) of the mouse spinal cord. This
technique allowed us to create a point occlusion in the PSV without causing collateral
damage to surrounding vessels or tissue. In effect, we were able to study the changes in
blood flow resulting purely from disruption in flow and in the absence of larger-scale
trauma.
Darcy Diago adopted a tissue clearing technique, allowing us to characterize the
posterior spinal vasculature up to a depth of approximately 700 µm from the posterior
surface, including the PSV and posterior spinal arteries. Given that the short scattering
length of myelin limits in vivo imaging or imaging without clearing to less than 100
µm, this technique presents a considerable advantage to mapping the spinal cord
microvasculature. Darcy has also mapped the spinal vasculature by manual tracing
and classification. My contributions to this work include project definition and scope,
mentorship and experimental oversight, the performance of in vivo measurements
(along with Jonathan Rubin), the development of our simple model, and manuscript
preparation. While this chapter is written in the style of a paper, its results and
conclusions should nevertheless be considered tentative, especially with respect to our
observation of hemorrhaging. We aim to publish this work in the near future under
the title (or similar):
Farrar, MJ, Diago, DM, Rubin, JD and Schaffer, CB. The Mouse Posterior Spinal Venous
System and Changes in Flow After Posterior Spinal Vein Occlusion.
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6.1 ABSTRACT
The availability of transgenic mouse models has made the mouse an increasingly
popular model for studying spinal cord injury (SCI). Essential to understanding the
injury and post-injury environment of SCI is a knowledge of the vascular architecture
of the spinal cord. Unlike larger animals, fewer studies of the spinal cord vasculature
have been performed in mice, with most of these studies focusing on the arterial supply
of the spinal cord. We have mapped the mouse posterior spinal cord vasculature in the
lower thoracic (T9-T13), with an emphasis on the veinous drainage. We have examined
this vasculature at the large scale of the posterior spinal vein (PSV) down to the capillary
and arteriole levels up to 700 µm below the posterior surface of the mouse spinal cord.
Among our findings, we discovered that the PSV contains large branches exiting the
spinal cord, shunting blood back to the heart. In addition, we have developed a model
of atraumatic occlusion of the PSV and measured flow into the PSV at baseline and
following PSV occlusion. We observed that the change in flow was highly dependent
on the location of the clot with respect to the large branches. In some cases, changes in
pressure were severe enough to result in the formation of a distal hemorrhage. We have
developed a simple model to explain our results.
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6.2 INTRODUCTION
Spinal cord injury (SCI) remains one of the most debilitating neurological diseases,
affecting an estimated 265,000 persons in the U.S.A. alone [1]. In addition to the
immediate tissue disruption caused by trauma, considerable secondary injury results
from vascular disruptions, including hemorrhage, ischemia and edema [2–4]. Besides
traumatic SCI, spontaneous SC infarct [5–11] is a clinically observed ischemic condition
leading to paralysis, and is particularly difficult to diagnose [12,13]. While the majority
of these cases are on the arterial side, venous infarcts have also been observed [14, 15].
A complete understanding of the ischemic susceptibility of the SC to SCI and infarct,
requires a detailed understanding of the SC microvascular architecture.
To this end, previous studies have used the corrosion cast technique to study
the anatomy of the spinal cord vasculature in humans [16, 17], rabbits [18], cats
[19], pigs [20, 21], and rats [22–24]. However, the growing availability of transgenic
mouse strains makes the mouse spinal vasculature of particular interest, yet vascular
architecture of the mouse remains much less explored. While magnetic resonance
imaging (MRI) techniques have been used for comparative angiography between mice
and rats, anatomical focus has largely been at the level of arterial supply [25]. Moreover,
although these studies have brought anatomical understanding to the SC in different
species, they did not attempt a graph-theoretic analysis of the microvascular network.
In addition to vascular architecture, spinal cord blood flow (SCBF) has been
measured [26–33] in healthy and diseased states. In all but one case [33], these studies
determined blood flow as an average over some region and did not consider flow at
the level of individual vessels. Miyazaki et al. [33], have measured blood flow and
diameters of individual capillaries in the anterior horn of the lumbar spinal cord in
wild type mouse and a transgenic mouse model of familial amyotrophic lateral sclerosis
(fALS). Nevertheless, SCBF at the level of individual pre-capillary arterioles and post-
capillary venules remains largely unexplored.
In contrast to the spinal cord, detailed 2-D surface maps [34] and 3-D volume maps
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[35, 36] of microvascular in the rodent neocortex have been made and the connection
of topology to transport made by targeted vessel occlusion. In addition, detailed blood
flow studies of the rodent cortex have examined changes in flow as a result of neural
activation [37–39], and after clot formation in penetrating arterioles [40] and ascending
venules [41] as models of ischemic small stroke [42].
We have adopted a method of tissue clearing [43] combined with a fluorescent
intraluminal vessel fill to study the mouse SC microvasculature, with a focus on
the posterior vasculature in the lower thoracic spinal cord. Using 2-photon excited
fluorescence (2PEF) microscopy, we performed ex vivo imaging of these tissues and
created 3-dimensional images of the vascular architecture. By tracing these images, we
created a topological map of the SC vasculature and measured key network properties
of the posterior SC. At the large scale, we identified large branches in the PSV which
exit the spinal cord, “shunting” blood back to the heart.
In addition to vascular mapping, we have developed a model of atraumatic
occlusion of the posterior spinal vein (PSV) using a ferric (III) chloride thrombosis
model [44]. Using this technique along with 2PEF in vivo imaging of the posterior
mouse SC, we measured diameter and flow velocity in pre-PSV feeder venules before
and after PSV occlusion. We observed resultant changes in flow, with increased,
decreased and unchanged flows after occlusion. Comparison with our vascular maps
revealed that feeder venule flow disruption by occlusion of the PSV varied strongly
with proximity to the large shunts, with the most pronounced effects occurring for
clots close to these shunts. In some cases, this pressure redistribution resulted in
hemorrhaging distal to the site of occlusion. We developed a simple resistance-flow
model in conjunction with our vascular maps to address these observations.
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6.3 Methods
6.3.1 Mouse Surgery and Clot Formation
We performed surgery on mice of a C57B6/J background using the setup and methods
described previously [45]. In a few cases, mice heterozygous for EmxCre were used.
Briefly, mice were anesthetized using a 5 % isofluorane/oxygen mixture, which was
reduced to 1-2 % after induction of anesthesia. Mice received 50 µg glycopyrrolate
per 100-g mouse intramuscularly and 0.1 mL 5% W/V glucose hourly throughout
both surgery and imaging. Surgery was performed on a custom table, and a rectal
thermometer monitored temperature on a feedback-controlled heating pad set to
37.5 ◦C. Skin and muscles were retracted and a double posterior laminectomy was
performed at T11-T12 using spring scissors. Warm 1% agarose (Sigma-Aldrich) solution
was applied to the spinal cord and a #0 coverslip (Electron Microscopy Sciences) laid on
top. After the gel set, the coverslip was removed and the agarose near the cut site was
carefully cut away. A small patch of dura over the PSV was removed, and the coverslip
reapplied. Gel foam (Pharmacia & Upjohn) and 0.9% W/V saline were applied over the
exposed spinal cord.
To initiate a clot, we adopted a ferric(III) chloride (FeCl3) technique [44]. Briefly,
the coverslip was removed and dry gel foam and cotton swabs were used to reduce
fluid over the PSV locally. A glass micropipette filled with 5% W/V FeCl3 was gently
touched to the exposed PSV, depositing a small droplet by capillary action. A clot was
seen to form within 10-20 minutes of exposure by cessation at the point of application
(i.e. a “white clot”). The area was subsequently flooded with saline to remove the FeCl3
and excess fluid was removed.
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6.3.2 Ex Vivo Tissue Preparation
Mice were deeply anesthetized using sodium pentobarbital. After the absence of reflex
in response to foot or tail pinch stimulus, animals were perfused transcardially with
1x phosphate-buffered solution (PBS; pH = 7.4; Sigma-Aldrich) prior to perfusion with
4% W/V paraformaldehyde (Thermo-Fischer Scientific) in PBS. In mice where ex vivo
fluorescence imaging of blood vessels was performed, these solutions were warmed to
at least 37.5 ◦C prior to perfusion and followed by perfusion with 1% low-melting-point
agarose (Sigma-Aldrich) mixed with 5% W/V lysine fixable Texas Red dextran (MW =
70 000; Invitrogen) [35]. Mice were then rapidly cooled using crushed ice until agarose
had set.
To determine gross PSV architecture, we injected 2 mL India ink following
perfusion.
6.3.3 Gross Angiography and Tissue Staining
To determine the region of the clot with respect to large veinous drains, whole
spines were removed from the lower lumbar to lower cervical regions, and successive
posterior laminectomies were performed. Wide-field fluorescent images were taken in
situ on a fluorescent microscope (Examiner D1; Carl Zeiss), and the location of the clot
and shunts was carefully marked.
For ink fills, a similar procedure was followed, except that the posterior processes
were removed from the foramen magnum to the caudal equina. Bright-field
illumination was used in place of fluorescence microscopy.
To determine the location of any hemorrhages relative to the clot location, an
approximately 1-cm segment of the spinal cord centered on the clot site was excised
from the vertebral canal. This segment was then cut in half at the clot site, yielding
a rostral segment 0.5 cm above the clot and a caudal segment 0.5 cm below the clot.
181
Segments were marked for correct orientation by injecting a small amount of Evans blue
to the segment side opposite the clot. Segments were stained with diaminobenzidine
(DAB) Peroxidase Substrate Kit (Vector Labs) for 15 minutes. Segments were then
transferred to 60% sucrose for at least 24 hours prior to sectioning. Each segment
was cut into 40 µm sections on a cryotome (Microm HM550; Thermo-Fisher Scientific)
after embedding in optimal cutting temperature (OCT; Tissue-Tek) compound. If a
hemorrhage was visible to the unaided eye during the sectioning process, sections were
saved and the axial distance was determined by the number of slices taken from the clot
site.
6.3.4 Tissue Clearing
We followed the clearing procedure described by Dodt et al. [43] closely. All spinal
cords perfused with lysine-fixable-Texas-Red-dextran-labeled agarose were extracted
on ice and immediately placed in 4% paraformaldehyde fixative for one day at 4C.
We then removed the spinal cords from vertebrae T9 through T13 and placed them in
fixative again for one hour at room temperature (20-25C). We rinsed all tissues 2 times
in 1x PBS, and stored them in PBS for one day at 4C. Spinal cords were dehydrated
by successive incubation in ethanol (30%, 50%, 70%, 80%, 96%, and twice in 100% for
one day each) at room temperature. The tissues were then rinsed and left in 95% hexane
(Sigma-Aldrich) for one hour. Tissues were finally transferred to a solution of 1:2 benzyl
alcohol/benzlbenzoate, which was the final clearing solution in which the tissue was
stored and imaged. Since dye diffuses out of the gel and leaves the vessels over time,
a balance between duration of tissue clearing and fluorophore concentration must be
optimized. We found that after four days we could achieve imaging depths over 500
µm with robust vessel labeling.
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6.3.5 2PEF Imaging and Blood Vessel Measurements
Following surgery, mice were transported to the microscopy laboratory where we
performed 2PEF imaging on a custom microscope. Mice were injected retroorbitally
with 2.5 % W/V Texas Red dextran (MW = 70,000 kDa; Invitrogen) A low numerical
aperture (NA) objective (NA = 0.28; Olympus America) was used to take a large (∼ 3
mm) field of view image of the vasculature.
To measure blood vessel diameters and flow speeds, we used a large NA objective
(NA = 1.0; Carl Zeiss). After focusing on the vessel of interest in the xy plane, the animal
was translated axially in z in increments of 1 − 2 µm while simultaneously recording
images. Average vessel diameter was determined using custom Matlab software, in
which vessel boundaries were manually traced from the maximum intensity projection
of the image sequences.
To measure flow speeds, we used the 2PEF line-scan method described previously
[37]. The center of the vessel was estimated by eye, and after centering the vessel in
the xy plane and rotating the scan pattern such that the vessel was oriented along the
x axis, a single line was repeatedly raster-scanned over time. Since red blood cells
(RBCs) exclude the fluorescently labeled plasma, they appear as dark regions against a
bright background on the scan. Scans are repeated at constant intervals, generating a
2-D image with time as the y axis. The slope of these lines was then calculated using
a radon-transform algorithm [46], giving the average speed in the vessel center. The
volumetric flow, Q, was determined according to
Q =
1
2
pir2vmax (6.1)
where r is the vessel radius and vmax is the RBC speed at the center of the vessel (see
Section 6.7.1).
Ex vivo imaging was performed using the same objectives. We found that we
could obtain imaging depths between 550-750 µm from the posterior surface of the
intact spinal cord using the clearing procedure described. During imaging, samples
were housed in an imaging chamber filled with 1:2 benzylalcohol/benzybenzoate
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clearing solution. Since the clearing solution dissolved polystyrene petri dishes, we
constructed a custom imaging chamber. The imaging chamber consisted of a glass-
bottom petri dish edged with Kwik-Sil Elastomer (World Precision Instruments) and
topped with a cover slide. This construction also prevented the spinal cord from
moving during imaging.
6.3.6 Determination of Pressure Changes After an Occlusion
To determine the pressure drop across the measured feeder venules, we fit the function:
Q(a, b; r) =
a
1 + br4
(6.2)
to the measured values of flow and vessel radii before and after occlusion. Here, the
parameter a ∝ ∆P , for pressure drop ∆P (see Section 6.7.1). The parameter b is a
constant depending only on resistances upstream of the feeder venules.
To allow for greater stability when fitting, we first fit (6.2) to the baseline data and
determined the most likely value of b by nonlinear least squares fitting. Baseline data
was then re-fit with b fixed at this value, making a the only free parameter. Post-
occlusion data were also fit with b fixed at this value.
6.3.7 Vessel Tracing and Classification
We obtained 3D reconstructions of the spinal cord tissues from z-stacks 550-750 µm
in depth with overlapping regions of interest. A custom image stitching software was
used to create a 3D composite stack of the microvasculature environment in each tissue.
We used custom tracing software to manually delineate and label each vessel. Principal
arteries and veins were classified using: stereotypical location (e.g. posterior arteries),
orientation, branching pattern, and vessel width; capillaries were identified by having
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the smallest diameter and the highest branching number. Lines and nodes denoted
vessels and branching points, respectively.
Networks were analyzed as an adjacency matrix. Degree was determined as the
mean of non-zero rows larger than unity. Geodesics were determined using Dijkstra’s
algorithm implemented in Matlab.
6.4 RESULTS
6.4.1 Multiple imaging modalities reveal posterior spinal cord
vasculature
To study the gross anatomy of the PSV, we injected 2 mL India ink to the mouse
vasculature following perfusion with paraformaldehyde (Fig. 6.1a). We then exposed
the posterior aspect of the spinal cord from the base of the medulla oblongata to the
cauda equina. We observed (n = 3 mice) that the large posterior spinal vein traverses
the entire length of the spinal cord and branched and exited the spinal cord at four
locations. These “shunts” were seen at distances of 5.1 ± 2 mm (cervical), 22.3 ± 7
mm (mid to lower thoracic), 34.5± 10 mm (lower thoracic upper lumbar), and 47.4± 4
mm (lumbar), relative to the bifurcation point at the medulla oblongata, with the two
caudal-most shunts being the most pronounced.
Since we were most interested in the thoracic region, we considered the middle
thoracic shunts both in vivo and using ex vivo fluorescently-labeled agarose vessel fills
(Fig. 6.1b), as in [35]. From ex vivo sections (including ink fills), we measured the
distance between shunts to be 10.3 ± 9 mm (n = 11 mice), containing N = 115 ± 30
feeder venules (n = 4 mice), or a density of 11.6 ± 2 vessels•mm-1 (n = 4 mice).
From in vivo measurements, we observed a mean feeder venule-diameter 24.8± 9
µm (n = 187 vessels in 9 mice; error is± S.D.) and a mean PSV diameter of 146± 40 µm
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Figure 6.1: Mapping of the dorsal spinal vasculature.
Ink perfused vasculature in the exposed whole spine (a) reveals that the PSV extends the
full length of the SC and is relieved by large shunts (arrows) along its length. We focused
on the mid-thoracic to upper-lumbar region of the SC (teal box). In other mice, agarose
mixed with lysine-fixable Texas Red was perfused into mice to fluorescently label
vessel lumens (b), allowing for quantitative measurements of PSV (navy) length and the
number of feeder venules (cyan) between shunts (arrows). Quantitative vessel mapping
from 3-D image stacks (c-e) was used to trace vascular path and map connectivity.
Vessels were classified as posterior spinal arteries (PA; red), penetrating arterioles (PA;
red), feeder venules (FV; blue), PSV (green), or capillaries (yellow). Nodes were marked
by green circles. Images (c-e) are representative slices of different depths from the dorsal
surface of the SC.
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reduce the degree3.
6.4.2 A Clot in the PSV Results in Diverse Upstream Flow
Changes
Optical access for in vivo optical imaging of the mouse SC was obtained by performing
a double posterior laminectomy at T11-T12 (Fig. 6.2a). We measured vessel diameter
and vmax in approximately 20 vessels caudal to the clot both at baseline and following
an induced clot. Vessel diameter was determined by taking small (∼ 10 − 50µm) 2PEF
image z-stacks encompassing the diameter of the vessel. The maximum projection (Fig.
6.2b) was computed and the average vessel diameter determined by manual tracing.
A line scan (see Methods) was taken at the center of the vessel (Fig. 6.2b, red line),
creating a 2-D image of that line vs. time (Fig. 6.2c). This approach allowed for a
straightforward measurement of maximum RBC flow speed, vmax. Volumetric blood
flow was computed according to (6.1). In one mouse, we measured line scans of
the PSV on either side of the rostral shunt and saw that blood flowed into the shunt
from both sides, corresponding to flow in opposite directions (see Section 6.8, Fig.6.7).
After baseline flows were measured, a point occlusion in the PSV was generated by
application of FeCl3 to the exposed PSV (Fig. 6.2d). The PSV was observed under
a stereomicroscope until clot formation was observed. After clot formation, flows
were remeasured. Approximately 30 min. elapsed between the end of baseline
measurements and the beginning of post-clot measurements. Control experiments
received saline rather than FeCl3, and 30 min. was allowed to elapse before vessels
were remeasured. Tracings of the venules feeding into the PSV (6.2e,f) were used to
map vessel flow speeds at baseline (Fig. 6.2e) and after occlusion ((Fig. 6.2f).
We induced clots at a variety of locations with respect to adjacent pairs of
3For example, a hexagonal lattice (honeycomb) network has a degree of 3 at all interior nodes,
but a degree of only 2 for some of the nodes on the boundary of the network.
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Figure 6.2: In vivo 2PEF imaging allowed for blood flow measurements in the
primary feeder venules of the PSV.
A posterior laminectomy allowed for optical access to the spinal cord, which was
subsequently imaged by 2PEF microscopy (a). Small image stacks centered on feeder
venule segments were taken and maximum intensity projections of image stacks were
used to measure diameters (b). Repeated raster scanning of a line in the center of the
vessel (b; red line) was used to generate a flow profile (c), the slope of which gives the
speed. FeCl3 was used to create a clot in the PSV (d). To visualize flow changes, we
created flow maps before (e) and after (f) clot formation. Vessels experiencing a more
than 2-fold decrease in flow are highlighted in red. An “X” marks the clot location.
Units of flow are µm3/ms.
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Figure 6.3: Clot location determines changes in upstream flow.
We measured blood flow speeds and diameters in the first 20 feeder venules (a-c) caudal
to the clot site at baseline (blue triangles) and after a clot (red squares). The parameter
a (proportional to the pressure drop across the feeder venules) was determined by
fitting (6.2) to baseline (solid blue line) and post-clot (dashed red line) measurements.
Representative data and fits are shown for a clot near the rostral shunt (a), medial to
the shunts (∼4 mm from the rostral branch) (b), and sham clot samples (c). Images
show the clot location in the PSV (arrows).
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PSV shunts, and measured resulting changes in flow in 20 upstream feeder venules.
To determine the pressure drop across feeder venules, we computed the volumetric
flow Q, and plotted this as a function of vessel diameter, 2r (Fig. 6.3a-c). The pressure
drop was determined by fitting (6.2) to the data. If shunt location was not visible
within the laminectomy site, the animal was perfused with lysine-fixable Texas Red-
labeled agarose and the distance of the clot from the shunts was determined by ex vivo
imaging (data not shown). For a clot formed just below the rostral shunt, we found
a severe decrease in the flow in upstream feeder venules (Fig. 6.3a). In contrast, very
little change was seen for a clot produced towards the middle of the shunts (Fig. 6.3b;
∼ 4mm from the rostral shunt). A sham control measurement showed no changes
in flow (Fig. 6.3c). Combining results across mice, we considered the pressure drop
across feeder venules before and after clot as a function of clot location with respect
to the location of the shunts (Fig. 6.4a). We normalized the clot location by the total
distance between adjacent shunts, choosing our convention such that the caudal shunt
corresponded to 0 and the rostral shunt to correspond to 1. The largest differences were
observed for clots nearest the shunts. Sham control experiments showed no change
(∆Pclot/∆Pbaseline = 0.95± 0.04; n = 3 mice; error is ± S.D.).
6.4.3 A Simple Flow-Resistance Model Predicts A Variety of
Upstream Flow Changes
To understand why change in flow depended on clot location, we developed a network
flow model (see Section 6.7.2) to simulate baseline and post-clot flows and pressure
drops as a function of clot location, using the length convention described above. We
considered a model of 100 feeder venules between PSV shunts, with branch number
“0” corresponding to the branch nearest the caudal shunt and branch number “100”
corresponding to the branch closest to the rostral shunt. In our model, baseline
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Figure 6.4: A simple model predicted that changes in flow depend strongly on clot
location.
We observed that the largest changes in pressure drop across feeder venules occurred
for clots nearest the PSV shunts (a). Error bars are from 95% confidence intervals
in fit parameters. Clot location was specified as fractional distance between adjacent
shunts, with 0 corresponding to the caudal shunt and 1 to the rostral shunt. To compare
with measured values, we simulated the average pressure drop ratio, ∆Pclot/∆Pbaseline,
across the first 20 caudal (solid line) and rostral (dashed line) feeder venules as a function
of clot location (b). Flow in individual feeder venules (c) before (black line) and after clot
(colored circles were also considered for a variety of clot locations.
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conditions resulted in flow bifurcation in the PSV at the mid-point between the two
shunts, with flow converging towards the shunts in either direction (data not shown).
Baseline flow in the feeder venules followed a parabolic trend (Fig. 6.4b; solid line).
We calculated the change in flow as a function of length along the PSV (i.e. in each
feeder venule) for several clot locations (Fig. 6.4c). Clots were simulated by setting
the resistance for that segment of the PSV equal to infinity. Simulations showed that
clots formed in the center of the PSV had no effect on feeder venule flow, as that is a
predicted point of bifurcation in the direction of PSV blood flow. In contrast, simulated
clots towards the rostral (caudal) shunt resulted in a decrease (increase) in feeder venule
flow caudal to the occlusion site. The reverse trend was observed in flow rostral to the
occlusion site.
Our model contained only unitless flows and constant resistances, making the
pressure drop across vessels the only point of comparison between theory and
experiment. The pressure drop, ∆P , was determined experimentally by fitting
volumetric flow as a function of diameter (Fig. 6.3). The fit parameter, a, is directly
proportional to ∆P , such that aclot/abaseline = ∆Pclot/∆Pbaseline. Using the simulated
data, we calculated the average pressure drop ratio directly in the first 20 vessels
caudal to the clot (Fig. 6.4b). We similarly calculated the same measure for the first
20 vessels rostral to the clot for reference. The resultant changes in pressure caudal to
the clot followed the opposite trend of flow changes rostral to the clot, and vice versa.
Comparison of experimental data (Fig. 6.4a) with simulated data (Fig. 6.4b; solid line)
showed agreement for clots near the rostral shunt and midpoint, but the simulated data
did not agree with the decrease in pressure drop seen for a more caudally located clot.
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Figure 6.5: Occlusion of the PSV can lead to a hemorrhage distal to the clot site.
We observed hemorrhages distal to the clot at the boundary of the gray and white
matter (a). These clots were typically several hundred micrometers (linear dimension)
in size (b). We used our flow model to simulate the difference between the baseline and
post-occlusion pressures in the PSV along the PSV length (c). We considered a variety
of clot locations (colored circles). Pressures were normalized by the pressure difference
between the distant pressure source and the shunt pressure, ∆P = P − Pground (see
Section 6.7.2).
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6.4.4 Occlusion of the PSV Can Lead to Distal Upstream
Hemorrhaging
To study the acute effects of PSV occlusion, we examined the mouse SC for blood
products near the clot site histologically. Following clot formation and/or 2PEF
imaging, mice were euthanized and perfused intracardially with paraformadelhyde.
Tissue was stained for red blood cells using a DAB staining protocol. Strikingly, we
observed hemorrhages within the SC but distal in approximately 1/3 of mice (11 out
of n=30 mice; 1 of n = 6 control mice). Sections which showed a hemorrhage (Fig.
6.5a,b) were identified during the sectioning process. Hemorrhages were observed
at the boundaries of the gray/white matter. From our vessel tracing, this location
corresponded to either at pre-capillary arterioles or post-capillary venules.
In some mice (3 of n = 30 mice in clot experiments; 1 of n = 6 in control mice), we
observed hemorrhages that were atypical in both location, size (an order of magnitude
larger in area compared to the majority of hemorrhages), or both. These data were
excluded in a blinded study of histological slices and were believed to be artifacts of
the surgical procedure.
To understand this result, we considered the difference between the baseline and
post-occlusion pressures along the PSV for a variety of clot locations (Fig. 6.5c). We
normalized this change in pressure by the network pressure drop between distant
arterioles and PSV shunts, ∆P = P − Pground (see Section 6.7.2). Analogous to our
predictions for flow, we found that a large pressure change in the PSV occurred for clots
close to the large shunts, while a mid-point clot resulted in no pressure re-distribution.
As for flow, the largest changes in PSV pressure were seen at feeder venule nodes closest
to the clot.
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6.5 DISCUSSION
6.5.1 The mouse PSV has stereotyped topology but highly
variable geometry
We observed the mouse spinal cord to be supplied by three arteries and drained
by two veins, with the ASA and PSV being the largest of the arteries and veins,
respectively. This architecture is analogous to the human SC [17], further supporting
mice as a valuable model for studies of SC pathology. However, while we consistently
observed large shunts along the length of the PSV, the location of these shunts varied
considerably, occurring in different segments across animals. This observation is
consistent with the high degree of variability in spinal vasculature more generally. In a
survey of the literature [48], the number of anterior and posterior radicular arteries in
humans was reported as varying between 2-17 and 11-25, respectively. The largest and
most stereotyped of these anterior radicular arteries is the artery of Adamkiewicz, the
location of which varied as much as by 11 segments, between T6 and L4 [48]. The high
degree of variability has caused some [49] to question the very existence of this artery
in rats. In humans, the variability of the veinous system is reportedly higher than the
arterial side [50]. Thus, the variability we observe in shunt location and the inadequacy
of our model to account for all of the observed behavior in changes in flow direction
after occlusion are in agreement with current knowledge of SC vascular anatomy.
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6.5.2 The mouse SC is susceptible to Ischemic Injury of
Veinous Origin
Our present study showed that occlusion of the PSV near large shunts can result in
more than a 70% change in pressure across upstream feeder venules, suggestive of
significant flow impediment and upstream ischemia on acute timescales. In addition,
the potential for hemorrhage that we have observed may suggest further pathology,
such as those arising from neurotoxic blood products [51]. In contrast to the middle
cerebral artery network in the brain which has a mean vessel/node ratio of 1.5 [36], the
mouse SC capillary network has a ratio of approximately unity, meaning that alternate
routes of perfusion following occlusion of an upstream (or downstream) vessel are
extremely limited. This limitation may make the mouse SC more susceptible to ischemic
injury. In line with this observation, longitudinal studies [52, 53] of PSV occlusion
in rats have shown atrophy of the posterior columns, reactive gliosis, macrophage
infiltration, and onset of paraplegia. Interestingly, in a study examining the results of
PSV ligation [53], variability in pathological SC “softening” was attributed to unknown
veinous anastomoses. This attribution fits well with our model and measurements
which described the relationship between these anastomoses and flow redistribution
within the SC following PSV occlusion.
In contrast, a study in rhesus monkeys [54] demonstrated that large-scale occlusion
(as many as 9 vertebral segments) of the PSV did not result in clinical pathology,
although demyelination was observed in posterior columns. Dilation of the ASV was
seen to compensate for PSV occlusion. Care must therefore be taken when applying
murine models of veinous SC ischemic injury to humans or other animal models,
despite anatomical similarities.
In addition, the use of vascular endothelial growth factor (VEGF) has had a
controversial role in pre-clinical animal studies of SCI, with a robust finding that
exogenous injection of VEGF [55], viral induction of VEGF expression [56], or
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transplantation of VEGF-expressing neural stem cells (NSCs) [57] led to increased
number of vessels within 7-10 days post-SCI, increased gliogenesis, increased spared
tissue, less axon disintegration, and improved behavioral outcomes. While the
majority of these VEGF-mediated effects–with the exception of increased vascularity–
are believed to be the result of VEGF on neural and glial targets directly [58, 59],
a systematic graph theoretical study of capillary connectivity analogous to the one
we have performed is pertinent to understanding therapeutic mechanism. Similar
connectivity studies would be of value in age-related studies of vascularity, as a
decrease in capillary and central artery density with age has been observed in rats [22].
6.5.3 The PSV serves as a potentially bi-direction drain for the
mouse spinal cord
Our toy model and observation of the variability of blood flow rearrangement with
respect to clot location after PSV occlusion suggest that the PSV has or has the potential
for bidirectional flow between adjacent shunts. At a minimum, our observation of
bidirectional flow at the rostral shunt confirms that flow within the PSV as a whole is not
unidirectional. This observation is consistent with the partial flow theory of SCBF [2],
which accounts for bidirectional flow and even flow reversals in the spinal cord under
physiological conditions. In the brain, basal and stimulus-induced fluctuations in blood
flow have been observed [37–39], owing to neurovascular coupling. Like the brain,
the SC is auto-regulatory in blood pressure [27], and functional MRI studies of the
SC [60–62] have revealed similar changes in activity-dependent perfusion.With respect
to network topology, recent modeling [63] has revealed that the optimal structure of
a transport network depends not only on steady-state flow, but also on fluctuating
sources. These findings suggest that the bidirectional nature of PSV blood flow is part
of a larger optimization strategy for fluctuating arteriole pressures.
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6.5.4 Future studies
Our present findings on flow disruption are encouraging, but lack statistical power.
The same can be said of the observation of post-occlusion hemorrhaging, especially
since we have not yet been able to rule out the possibility of hemorrhaging induced
by the invasive surgery procedure required for access to the dorsal SC. Additional
experiments along the same lines will help improve the strength of these conclusions.
In addition, it is our intention to explore nano computer tomography (nanoCT) studies
of hemorrhaging. By injecting iodine intravascularly immediately prior to clotting, we
will be able to deduce the origins and 3-dimensional size of hemorrhage more precisely
than using present post-mortem histological techniques.
Similarly, our 3-dimensional tracing/mapping of the dorsal SC vasculature is
incomplete, spanning only a few feeder venules on one side of the spinal cord. A more
complete mapping will allow for greater network characterization, especially at the
level of larger vessels.
Finally, our minimalist mathematical description of the PSV allowed for an
understanding of the observed variety in upstream feeder venule flow to PSV occlusion.
While satisfying Occam’s razor, the ability of our model to capture the true nature
of flow in the PSV could be improved upon by allowing for physiologically relevant
fluctuations in pressure and the replacement of fixed feeder venule resistances with a
distribution of resistances provided by in vivo imaging data.
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6.7 APPENDIX A: THEORY
6.7.1 Vessel speeds fitting function
Experimentally, we were able to measure only the flows in the primary feeder branches
of the PSV (cyan branches in Fig. 6.6b,c). Flows at the center of the PSV were too fast for
2PEF line-scan measurements, and the physiological burden of anesthesia places time
constraints on further upstream measurements. We thus measured the blood velocity
in the center of the primary feeder venules and their diameters close to the PSV.
For Poiseuille flow [64] in a tube, we have the relation:
Q = −pir
4
8ηl
∆P (6.3)
where r is the radius of the vessel under consideration, η is the fluid viscosity, l is the
tube length, and ∆P is the pressure drop across the tube. From the form of (6.3), we
can identify resistance as:
R ≡ 8ηl
pir4
(6.4)
whereupon we have a simple resistance-flow relation:
Q = −∆P
R
(6.5)
We also have that the flow profile takes the form [64]:
v(ρ) = −∆P
4ηl
(r2 − ρ2) (6.6)
for radial coordinate ρ. Comparing this expression to (6.3), we have
Q =
pir2
2
vmax (6.7)
where vmax ≡ v(ρ = 0) is the velocity at the center of the vein.
Since we know from our vascular maps that the veins are isolated from each other
by a large resistance, we treat them as causally isolated. Moreover, we know that
both the posterior spinal artery and the posterior lateral arteries supply the mouse
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spinal cord, with the ascending venules providing a common drain. Therefore, we
considered the feeder venules to be attached to a common pressure source dropped
across a resistive load,R∞, of capillaries, arterioles and feeder venules prior to reaching
the feeder venules as has been done in similar modeling in the brain [65]. Each feeder
venule was then assumed to have a composite resistance (Fig. 6.6a) given by:
R = R(r) +R∞ (6.8)
whereR(r) has the form of (6.4) and all venules were taken to have approximately equal
length l. Inserting (6.8) into our basic flow relation given by (6.5) and substituting (6.4)
for R(r) we have
Q =
∆P
8ηl
pir4
+R∞
(6.9)
We therefore have a fitting function to the experimental data of the form
Q(a, b; r) =
a
1 + br4
(6.10)
where we have the interpretation
a =
∆P
R∞
(6.11)
b =
8ηl
R∞pi
(6.12)
6.7.2 Flow Network
Network Model
We considered a segment of the PSV containing N feeder venules flowing into the PSV.
We devised a numbering scheme such that the nodes corresponding to the pressure
sources of the feeder venules are denoted by even indices, P2j , for j = 1, . . . , N .
The beginning source node for the PSV is denoted as P0 and the final sink as P2N+1.
The nodes which link feeder venules to the PSV were thus at pressures P2j−1 for
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Figure 6.6: Flow in the mouse PSV was modeled by a simple resistance-flow network.
To fit the experimental data, we considered the feeder venules to derive their pressure
from a common distant artery source, dropped across a radially-dependent resistance
in the feeder venule and an upstream average (constant) resistance, R∞ (a). To
characterize the venous system (b), we considered the PSV (b;blue) to be fed by feeder
venules (b; cyan), which in turn are fed by upstream venules, capillaries, arterioles and
arteries (b; black). Periodic “shunts” were observed leaving the spinal cord (a;arrows, b
(top,bottom). We modeled the system as consisting of N feeder venules feeding into the
PSV with shunts at either end (c).
201
j = 1, . . . , N (see Fig. 6.6c).
By our convention, we took the the volumetric flow rates, Qj , to be towards the PSV
in the feeder venules and considered this direction to be positive (i.e. Q2j > 0 when
flows were directed towards the PSV). Similarly, we took the flows between adjacent
segments of the PSV to be positive when flowing caudal to rostral (i.e. Q2j−1 > 0 when
flows were from bottom to top in Fig. 6.6c). We modeled our system by specifying the
end-point pressures, P0, PN+1, P2j and resistances, and solved for the resultant flow. To
simulate an occlusion, we set the target edge of the network to have infinite resistance,
but assumed that end-point pressures remain fixed. At each point, we assumed the
relation
Pn − Pm = QnmRnm (6.13)
for nodes n,m with resistance Rnm between them and resultant flow, Qnm. To simplify
notation, we denoted all flows in the feeder venules by the feeder venule node (i.e. Q2j
corresponds to the flow out of node P2j to the PSV). We followed a similar convention
for PSV nodes (see Fig. 6.6c).
Conservation of flow at each junction gave
Q2j +Q2j−1 = Q2j+1, j = 1, .., N (6.14)
Summing (6.14) over all values of j gave the conservation for the network:
N∑
j=1
Q2j = Q2N+1 −Q1 (6.15)
Similarly, computing pressure drops between any feeder venule and node 0 gave
P2j −Q2jR2j +
j∑
n=1
Q2n−1R2n−1 = P0 (6.16)
At this point, the system was completely determined up to the specification of model
parameters and/or the addition of some assumptions about our system.
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Initial Parameters and Assumptions
From (6.4), we see that R ∝ r−4. From a larger scale anatomical perspective, we
know that the region where we image is bounded by large branches leaving the PSV,
effectively shunting blood flow from the PSV back to the heart. We considered these
“shunts” to be the analog of electrical grounding wires, and so we set P0 = P2N+1 =
Pground
4. Also, based on ex vivo experimental data (see Section 6.4.1), we considered
N = 100 feeder venules in between these large shunts.
To simplify analysis, we considered the feeder venules to have equal resistance (i.e.
R2j ≡ Rfv, j = 1, 2, . . . , N ). We use (6.4) to obtain the relative resistances of the feeder
branches to the PSV resistance:
R2j−1 ≡ RPSV =
(
rfv
rPSV
)4
Rfv ≈ 10−3Rfv, j = 1, 2, . . . , N + 1 (6.17)
where we have used experimental measurements (see Section 6.4.1) for the respective
radii.
Finally, we considered the feeder venules to be attached to a distant source of
arteriole pressure (i.e. the lateral spinal arteries and/or the posterior spinal artery)
which is reduced after passing through a resistive network of branching arterioles,
capillaries, and upstream venules with magnitude R∞ [65](Fig. 6.6a), arriving at the
feeder venules with an approximately uniform pressure, P .
Using our assumptions above, we rewrite (6.16) as:
RfvQ2j −
j∑
n=1
R2n−1Q2n−1 = P − Pground = ∆P, j = 1, 2, . . . , N (6.18)
where
∆P ≡ P − Pground. (6.19)
and recall thatR2n−1 = RPSV = 10−3R2j , n = 1, 2, . . . , N+1 prior to the clot formation.
Combining (6.18) with (6.14), we have 2N equations for 2N + 1 unknown flows. Taking
4Recall that we could at least one pressure in our circuit to an arbitrary value, since only
pressure differences will matter.
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one final loop at the rostral end gave the final needed equation.
RfvQ2N +R2N+1Q2N+1 = ∆P (6.20)
Since we only compared relative changes in flow experimentally, we simplified our
model by turning our equations into dimensionless flows. Takinge our unit of flow
such that
∆P
Rfv
≡ 1 (6.21)
then dividing (6.18) and (6.20) by Rfv and (6.14) by ∆P/Rfv gave:
Q2j − 10−3
j∑
n=1
Q2n−1 = 1, j = 1, 2, ..N (6.22a)
Q2N + 10−3Q2N+1 = 1 (6.22b)
Q2j +Q2j−1 −Q2j+1 = 0, j = 1, .., N (6.22c)
where we have invoked (6.17) as well.
The only free parameter left in our model was the clot location, which we denoted
by X and could occur along any of the edges in the PSV. The sparse flow matrix given
by (6.22) was easily solved by reduction to row-reduced echelon form, giving the flow
solution. To simulate the results of the clot, we set RX →∞ and Q2N+1 = 0 and solved
for the flows once again, assuming that the end-point pressures (i.e. ∆P ) remain fixed.
Since the pressure drop between the feeder venules and the PSV are linearly related to
the flows with unit proportionality in our model, we reported the relative changes in
pressure drops.
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6.8 APPENDIX B: SUPPLEMENTARY FIGURE
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Figure 6.7: Flow into PSV shunts is bidirectional.
A segment of the PSV (a) containing a large veinous shunt (a top; b) was seen to have
bidirectional flow into the shunt. The shunt was partially obscured by surrounding
bone. Blood flow in the PSV rostral and caudal to the shunt (b) was too fast to measure
quantitatively, so line scans caudal (green line) and rostral (red line) of the PSV was taken
at the luminal wall of the PSV where the flow is slower to measure direction only. Line
scans on either segment were performed in the same direction, caudal to rostral.The
slope of the line scan in the rostral segment (c) was seen to flow in a rostral-caudal
direction (negative slope), while the slope of the line can in the caudal segment (d) was
seen to flow in the caudal-rostral direction (positive slope).
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6.9 APPENDIX C: SIMULATION CODE
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6/21/12 12:24 PM /Users/MJF/Documents/Dorsal .../clot_simulation.m 1 of 2
function [Q DP] = clot_simulation(varargin)
%%This code simulates the dorsal spinal vein (DSV) occlusion in a mouse.
%%The model assumes 100 side−branches, with equal side branch pressure
%%sources and large pressure sinks spanning the DSV.  Theory for this model
%%is found in the Theory section of the manuscript.
 
 
%Initialization of Model Parameters
N=100; %number of nodes
P0 = 0; %end pressure
PF = P0; %final endpoint pressure
P = 1; %sidebranch pressures
RDSV = 1e−3; %DSV segmental resistance
R = 1; %side branch resistance
target = []; %vessel to clot ("X" in the theory)
 
if nargin %If a target is specified as an argument, use it
    target = cell2mat(varargin(1));
end
 
%Initialize Resistances
R(2:2:2*N) = R;
R(1:2:2*N+1) = RDSV;
 
 
%Solve for Resultant Flow
 
for clot = 0:1 %Before and After clot
    
    %Pre−allocate memory for flow matrix
    FlowMat(1:2*N+1, 1:2*N+2)=0;
 
    %Conservation of Flow Block: Q(2j) +Q(2j−1) − Q(2j+1) = 0 
    for j=1:N
        FlowMat(j,2*j)=1;
        FlowMat(j,2*j−1)=1;
        FlowMat(j,2*j+1)=−1;
    end
 
    %Pressure Drop Loop: R(2j)Q(2j) − sum R(2j−1) Q(2j−1) = P−P0
    for j=1:N
        for n=1:j
        FlowMat(j+N,2*n−1) = −R(2*n−1);
        end
        FlowMat(j+N,2*j) = R(2*j);
        FlowMat(j+N,2*N+2)= P−P0;
    end
    
    %Pressure Drop Loop: R(2N)Q(2N)+R(2N+1)Q(2N+1) = P−PF
    FlowMat(2*N+1,2*N)= R(2*N);
    FlowMat(2*N+1,2*N+1)=R(2*N+1);
    FlowMat(2*N+1,2*N+2) = P−PF;
    
    
    %Solve for the flows by reducing to row−reduced echelon form
    temp = rref(FlowMat);
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    %store results as a column (1 = before clot, 2 = after clot)
    Q(clot+1,:) = temp(:,2*N+2);
    
    %Cause clot in target vessel
    if ~clot
        if isempty(target) %if no target specified as input
        target = str2num(cell2mat(inputdlg(’Which Vessel Number do you wish 
to clot?’))); %target DSV edge to clot
        R(target) = 1e4; %Set value to very large number (effective 
infinity)
        end
    end
end
 
%Calculates the pressure drops across the side branches
DP(:,1) = Q(1,2:2:2*N).*R(2:2:2*N); 
DP(:,2) = Q(2,2:2:2*N).*R(2:2:2*N);
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CHAPTER 7
NONLINEAR OPTICAL REFLECTION MICROSCOPY (NORM) AS A
TECHNIQUE FOR VISUALIZING OPTICAL INTERFACES
In this section, we present preliminary data and the underlying theory of a microscopy
technique that was developed as part of my admission to candidacy exam. In essence,
this technique changes the amount of reflected light at an interface by modulating
the intensity-dependent indices of refraction in both media. At the time of writing,
experiments have been limited to proof-of-principle experiments, and we have not
yet developed NORM into a true microscopy. Our largest challenge at present is the
elimination of off-interface signal, which we hope to eliminate by tighter focusing of
both the pump and pulse beams. Provided that this endeavor is successful, evaluation
for imaging biological specimens will be determined in fixed tissue. Extending these
studies to in vivo imaging and upgrading to a mirror-scanning microscopy will be
essential later developments for multi-modal imaging with established techniques of
2-photon excited fluorescence and harmonic generation.
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7.1 ABSTRACT
Multi-photon microscopy has made possible the imaging of in vivo dynamics at the
micrometer scale deep inside scattering tissue. However, contrast generated by the
creation of new wavelengths results in spectral overlap between different species of
interest, limiting the number of tissue constituents that can be imaged simultaneously.
We present both theory and data on nonlinear optical reflection microscopy (NORM),
a technique that allows for non-specific mapping optical interfaces. This modality can
provide contextual information to labeled structures without adding multiple imaging
channels or contrast agents. The technique uses lock-in amplification to measure small
changes in the reflectance of a probe beam induced by modulation of the intensity-
dependent index of refraction, n2, from a strong pump beam. Current experiments
consist of axial scans of polymeric materials, which are expected to have large values of
n2. Present challenges and future experiments are discussed.
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7.2 INTRODUCTION
The advent of nonlinear laser scanning microscopy (NLSM) by Denk et al. [1] made
sub-micrometer optical image generation possible even deep in scattering tissue.
Mechanisms of contrast for NLSM in biological tissue include 2-photon excited
fluorescence (2PEF) [1] [2], second harmonic generation (SHG) [3–6], third harmonic
generation (THG) [7–10], and coherent anti-Stokes Raman spectroscopy (CARS) [11].
All have been employed for biological imaging by generating new wavelengths via
nonlinear processes which take place only at high intensities. These high intensities
are achieved by ultrashort pulses and tight focusing, with the signal being generated
appreciably only at the focus of the objective. Since the origin of the novel wavelength is
known a priori, light simply has to be collected as opposed to imaged, which eliminates
image blurring by scattering. By raster scanning the focus, an image can be effectively
built up in point-by-point fashion.
In addition to techniques that generate new wavelengths, it is also possible to
measure intensity changes relative to some baseline. For example, envelope modulation
and the quadratic dependence of two-photon absorption (TPA) on laser intensity has
been exploited to harmonically deplete the incident laser pulse train [12]. A similar
technique [13] was used in a two color TPA modulation approach. This technique has
been used to distinguish melanomas from benign nevi [14] and to image changes in
blood oxygenation [15]. Photo-thermal lensing has also been used as a pump-probe
technique to visualize optical chromophores, such as red blood cells [16].
Moreover, the nonlinearity (and thus, optical sectioning) does not have to arise
from higher-order susceptibility tensors as in the techniques above, but can arise from
a product of linear effects, as in pump-probe spectroscopy. Excited state absorption
[13] uses linear absorption of a pump beam to excite chromophores into a higher
energy level. Chromophores in this excited state–but not the in the ground state–
absorb probe light, resulting in a depletion of probe light. Conversely, stimulated
emission microscopy [17] [18]uses a pump beam to achieve population inversion in
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chromophores, which then return to the ground state when stimulated by a probe
beam. In all cases the change in transmitted probe intensity was determined by lock-in
amplification.
Pump-probe spectroscopies based on self-phase modulation (SPM) have been
exploited in spectroscopy measurements by transmission modulation [19–21].
However, it should be noted that these measurements are not based on interface
dynamics, but from phase modulations in the bulk. SPM has also been used as a
source of contrast by the filling of a spectral hole in a shaped pulse [22, 23]. Nonlinear
reflection modification has been studied theoretically [24]and experimentally [25–28]
as an optical switching technique by modulating the index of refraction at the angle
giving rise to (linear) total internal reflection. Hysteresis effects in the intensity were
also predicted/observed [24–28].
In spite of these advances, no nonlinear analog of differential interference contrast
(DIC) imaging has yet been developed to visualize the big picture context surrounding
structures of interest labeled fluorescently or imaged using other means of nonlinear
contrast. This deficit potentially results in the omission of important aspects of the
tissue environment. We have developed a pump-probe microscopy technique that uses
the intensity-dependent index of refraction to modulate the total indices of refraction–
and thus the coefficient of reflection–at an optical interface. We have called this
imaging modality Nonlinear Optical Reflection Microscopy (NORM). We here present
an experimental schematic, theoretical background, and supporting data. Also, we
have demonstrated proof of principle based on expected dependences on pump power,
polarization angle, temporal delay.
Our discussion includes key challenges at present and a discussion and strategies
to overcome these drawbacks.
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7.3 THEORY
7.3.1 Cross-phase modulation and the intensity-dependent
index of refraction
We consider our analysis in the plane wave limit of the nonlinear wave equation, which
is sufficient to describe our system. In this limit, the wave equation reduces to:
dAj(z)
dz
= i
ω2j
2kjc2
Pj(z)/0 (7.1)
where subscript j indexes the frequency and we have the forms
Ej = Aj(z) exp[i(kjz − ωjt)] + c.c. (7.2)
PNL,j = Pj(z) exp[i(kjz − ωjt)] + c.c. (7.3)
for the electric field and nonlinear polarization, respectively. The abbreviation “c.c.”
denotes “complex conjugate”. Here, ω denotes angular frequency, k is the wave vector,
c is the speed of light, and 0 is permittivity of free space. We have already assumed
that the electric field envelope, Aj(z), is a slowly varying function of z compared to the
phase in (7.2). Since we will consider two frequencies in a pump-probe experiment, we
will index the pump with j = 1 and the probe with j = 2. The polarization is related to
the electric field by
PNL = 0
∑
m≥2
χ(m) : Em (7.4)
where χ(m) is the mth-order electric susceptibility tensor and colon denotes tensorial
product. While the tensor product is the most general form, we shall assume we are
working in a principle direction for an isotropic material, and treat χ(m) as a scalar.
We work in the Rayleigh-Debye [29] limit of (7.1) and (7.4), where we consider
the mixing of fields at all frequencies algebraically and use these values in the right
hand side of (7.1). For centrosymmetric molecules (which comprise the majority
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of molecules) χ(2) vanishes, making χ(3) terms the lowest-order nonlinear effect to
consider. For dual input beams of ω1 and ω2, we have:
P1 =0χ(3)
[
6|A2|2 + 3|A1|2
]
A1 (7.5)
P2 =0χ(3)
[
6|A1|2 + 3|A2|2
]
A2 (7.6)
We neglect all other four-wave mixing terms due to phase mismatch. In the limit of a
strong pump and a weak probe (i.e. |A1|  |A2|), we are left with
P1 =30χ(3)|A1|2A1 (7.7)
P2 =60χ(3)|A1|2A2 (7.8)
These terms correspond to self-phase modulation (7.7) and cross-phase modulation
(7.8). Since we are interested in the effect on the probe beam, we will concentrate on
(7.8).
If we insert (7.8) back into (7.1), we have the differential equation
dA2(z)
dz
= i
3ω22
k2c2
χ(3)|A1|2A2 (7.9)
In the limit of a strong pump, |A1|2 ≈ constant, and (7.9) integrates directly to give:
A2(z) = A2(0) exp(i3
ω2
nω2c
χ(3)|A1|2z) (7.10)
where we have used that k2 = nω2ω2/c for index of refraction, nω2 . We have assumed
bounds of (0, z) on our integral, though in principle these depend on boundary
conditions specified by the geometry of interest. We convert between field amplitude
and intensity using I = 2nω0c|A|2, leaving us with:
A2(z) = A2(0) exp
(
i
ω2
c
[
3χ(3)
2nω1nω20c
]
I1z
)
(7.11)
The form of (7.11) gives rise to the definition:
n2 ≡ 3χ
(3)
2nω1nω20c
(7.12)
such that the oscillating electric field has the structure given by (7.11) and (7.2):
E2 = A2(0) exp
{
i
[
(nω2 + n2I1)ω2
c
z − ω2t
]}
(7.13)
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Thus, the effect of cross-phase modulation is an intensity dependent index of refraction
n2I1.
7.3.2 Reflection from a dielectric interface
Consider a dielectric slab with combined index N2 existing on 0 < z < L and
surrounded by a medium of index N1, as shown in Fig. 7.1b. We denote the reflection
and transmission coefficients from medium 1 to medium 2 by r12 and t12, respectively.
If we denote the signal (reflected) field as ES then by considering the diagram in Figure
7.1b we arrive at:
ES = E2{r12(θ) + t12(θ)t21(φ)r21(φ)
∞∑
m=0
[r221(φ) cos(Φ(L, φ))]
m} (7.14)
where the first term represents the initial reflection and the summation accounts for
internal reflections. The angles θ and φ are an incidence/refraction angle pair related
by Snell’s Law:
N1 sin θ = N2 sinφ (7.15)
and
Φ(L, φ) =
2ω2
c
∫ L
0
N2(z)dz
cosφ
(7.16)
is the phase acquired by internal reflections. As before, we take the probe beam to be
much weaker than the pump beam, such that:
N2(z) = n0,2 + n2,2I1 (7.17)
N1 is defined analogously.
The sum in (7.14) is a geometric series and is easily evaluated:
∞∑
m=0
[r221(φ) cos(Φ(L, φ))]
m =
1
1− r221(φ) cos(Φ(L, φ))
(7.18)
which in turn gives our governing equation:
ES = E2{r12(θ) + t12(θ)t21(φ)r21(φ)1− r221(φ) cos(Φ(L, φ))
} (7.19)
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The Fresnel equations describe the index of refraction of light on a dielectric surface
for both s and p polarizations, and may be found in any standard optics text. Using
these equations we eliminate refraction angle φ in the phase integral to get:
Φ(L, θ) =
2ω2
c
∫ L
0
N (z)N2(z)dz√
N 2(z)− sin2 θ
(7.20)
where
N ≡ N2N1 (7.21)
For most biological interfaces of interest, the interface thickness L  b for
confocal parameter b, and so the intensity and therefore the indices of refraction are
approximately constant over the region of interest. In this case, the integral evaluates
trivially to give:
Φ(L, θ) =
2ω2LNN2
c
√
N 2 − sin2 θ
(7.22)
7.3.3 The semi-infinite slab approximation
For epi-detection microscopy, normal incidence (i.e. θ = 0) is the most relevant
consideration. Moreover, we will consider a semi-infinite slab, such that material 1
exists everywhere for z < 0 and material 2 exists everywhere for z > 0. In this case,
internal reflections in (7.14) do not contribute to the signal, and only the first reflection
matters. For normal incidence, the reflectivity coefficient, r, is given by:
r =
(
1−N
1 +N
)
(7.23)
where we now write N explicitly as:
N = n0,2 + n2,2I1
n0,1 + n2,1I1
(7.24)
where the first subscript denotes the linear (n0) or intensity-dependent (n2) index of
refraction, and the second subscript denotes the medium. We now consider some
pertinent special cases.
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Linear index mismatch
It is convenient to define the variables:
∆n2 ≡ n2,1 − n2,2 (7.25a)
σn2 ≡ n2,1 + n2,2 (7.25b)
∆n0 = n0,1 − n0,2 (7.25c)
σn0 = n0,1 + n0,2 (7.25d)
By the definitions of N1,2, we have:
r =
1−N
1 +N =
∆n0 + ∆n2I1
σn0 + σn2I1
(7.26)
Keeping only terms at most linear in the intensity-dependent indices (since n2I1  n0)
of refraction we have:
ES = E2
{(
∆n0
σn0
)[
1 +
(
∆n2
∆n0
− σn2
σn0
)
I1
]}
(7.27)
Squaring (7.27) to get the intensity and keeping only terms linear in the intensity-
dependent index of refraction as before we arrive at the signal intensity:
IS(I1) =
(
∆n0
σn0
)2 [
1 + 2
(
∆n2
∆n0
− σn2
σn0
)
I1
]
I2 (7.28)
which has a modulation depth:
∆IS
IS(I1 = 0)
≡ ∆R = 2
(
∆n2
∆n0
− σn2
σn0
)
I1 (7.29)
where ∆R is the change in reflectivity. As expected, we have a quadratic nonlinear
signal by virtue of the fact that the (7.28) scales as the product of the pump and probe,
I1I2.
Linear index matching
A second interesting case is for linear index matching (n0,1 = n0,2 ≡ n0) without
intensity-dependent index matching (n1,2 6= n2,2). In this case, similar analysis gives
IS =
(
∆n2
2n0
)2
I21I2 (7.30)
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There are two interesting points about (7.30). First, the signal is in reference to a null-
point: in the absence of the pump, no reflected signal exists (i.e. IS(I1 = 0) = 0), unlike
the linear index-mismatched case, where a strong carrier signal is weakly modulated.
Second, the scaling is now a cubic effect in terms of intensities, receiving two intensity
powers from the pump and one from the probe. However, since the lowest order of this
effect is in (∆n2)2, we anticipate this effect to be very small.
7.3.4 Finite thickness slabs
For biological specimens of interest, we are typically concerned with interfaces similar
in thickness to cell membranes (∼10 nanometers). Still assuming normal incidence, we
return to the full form of (7.14) for normal incidence. In this limit, and for wavelengths
between ∼ 500 nm-1 µm, the signal to lowest order in Φ becomes
IS = I
(0)
S
(1−N )4Φ4
64N 2 (7.31)
where superscript 0 denotes the estimates without accounting for internal reflections
(i.e the semi-infinite slab approximation). Using (7.22) with θ = 0, we have:
Is = I
(0)
S
(1−N )4(k2L)4
4N 2 (7.32)
Cell membranes are on the order of 10 nm, while the probe light has a 520-nm
wavelength, giving k2L ≈ 0.1. For the first medium of water (n0,1 = 1.33) and the
second medium a cell membrane (n0,2 ∼ 1.48 [30]), we haveN ≈ 1.1. This contribution
gives a back-of-the-envelope estimate of
Is ≈ 10−9I(0)S (7.33)
Thus, in samples where internal reflection terms cannot be ignored, we anticipate a
much weaker signal with a strong dependence on sample thickness. Moreover, since
n2 varies widely with dielectric (1.9 × 10−20 m2/W [31]for water; 1.54 × 10−19 m2/W
for fused silica [20]; n2 of −2.42 × l0−12 m2/W for polystyrene (PS) [32]), the extent of
modulation will depend critically on the materials at the interface.
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7.3.5 Polarization dependence
In addition, it should be noted that while signal depends on pump and probe intensity,
we have suppressed the tensorial nature of (7.4). In reality, the index of refraction will
be modulated in the direction(s) determined by the pump polarization and the third-
order electric susceptibility tensor, χ(3). For an isotropic material with no off-diagonal
tensor terms, maximum signal is obtained when the pump and probe polarizations are
aligned and signal is destroyed when they are orthogonal.
7.4 METHODS
Our experimental setup was as shown in Fig. 7.1a. Briefly, a low-repetition rate (1
MHz) 1040-nm laser source with 300-fs pulses (FCPA µJewel; IMRA America) was
split into two arms. The first arm was frequency doubled in a lithium triborate (LBO)
crystal (Newlight Photonics) to 520 nm light, which was used as the probe light. Any
unconverted fundamental was filtered using an interference filter (517-nm bandpass
filter; Chroma Technology). The second (pump) arm passed through a delay arm and
was modulated by an optical chopper at 6.4 kHz. To control power, a half-waveplate
mounted on a rotation mount was used to rotate the polarization of the light prior to
passing through a polarizing beamsplitter. A second half-wave plate was placed in the
pump path to allow for polarization rotation with respect to the probe. Pairs of lenses
were used to form telescopes to resize each beam. The two arms were recombined at a
dichroic mirror and incident on the back aperture of the microscope objective. Beams
were overlapped spatially. Temporal alignment was achieved using the delay line
produced by a pair of mirrors on a translation stage (Fig. 7.1a; MM). Reflected light was
epi-detected by a 50:50 non-polarizing beamsplitter and a photodiode. Pump light was
filtered by a blocking filter (Schott BG39; Thor Labs). Modulation of the reflected probe
beam was measured by lock-in amplification (SRS530; Stanford Research Systems) of
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Figure 7.1: Figure 1: A nonlinear optical reflection microscopy (NORM) setup.
(a) A fiber laser source (1 MHz pulse repetition rate; 300-fs pulses, 1040-nm central
wavelength) is split into two arms by a 50:50 beamsplitter (BS). Lens L1 focuses light
into the frequency doubling crystal (χ(2)) where second harmonic generation (SHG)
results in 520-nm light (green) being produced. L2 is used to collimate the resulting
light. Fundamental wavelength (red) is filtered by blocking filter (BF1). The pump arm
passed through a delay stage with movable mirrors (MM). A chopper (C) modulated
the pump at 6.4 kHz. Half-waveplates (λ/2 WP) and polarizing beamsplitters (PBS)
were used for power control of both the pump and probe arms. Rejected light was
removed by beam blocks (BB). A second half-waveplate was used to rotate the pump
polarization. Telescopes (L3 and L4; L5 and L6) were used to resize the the pump
and probe beams, which were combined at the dichroic mirror (DCM) and focused
onto the sample through a microscope objective (OBJ). The sample was placed on
a computerized three-dimensional translation stage. A non-polarizing beamsplitter
(NPBS) reflected the return light onto a photodiode (PD). Pump light was filtered by
blocking filters (BF2). Off-axis light was blocked by an aperture (A). The photodiode
signal was amplified using a lock-in amplifier (LIA) with the chopping frequency from
the chopper as a reference, and the lock-in output was read using a computer (CPU).
(b) Pump light modulates the indices of refraction at an interface of a dielectric slab of
thickness L and index N2 surrounded by a medium of index N1, leading to a change in
reflectivity at the interface, ∆R, (c), which provides optical contrast.
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the photodiode signal at the chopper frequency and the lock-in output was digitized
using a custom script in Matlab (Mathworks Inc.). The sample was placed on a
three-dimensional translation stage (GTS30V and ILS-100; Newport Corporation) also
controlled by the Matlab script. To date, we have only performed scans in the axial
direction.
The pump changed the indices of refraction at interfaces (Fig. 7.1b) by cross-phase
modulation (i.e. the intensity-dependent index of refraction). A differential change
in the reflectivity of the interface (c) resulted in a modulation of the probe light. The
transmitted light is oppositely modulated, but non-ballistic trajectories from back-
scattered transmission were blocked by an aperture (Fig. 7.1a). Fig. 7.1c shows a
positive modulation for illustrative purposes, but the sign of modulation depends on
the optical properties of the two materials.
We performed axial scans of dielectrics with a lock-in integrating constant of
100 ms and no signal averaging. Stage speed and sampling rate were chosen to
allow approximately 10 points/m. We used a sample of 1-mm thick polyethylene
terephthalate (PETG) with a water-immersion lens (40x, NA = 0.8; Olympus America).
We also performed experiments on 800 µm thick PS (data not shown).
7.5 RESULTS
PETG has an index of refraction of [33] 1.567, but we were unable to find a measured
value of n2 in the literature. PS (data not shown) has an index of refraction of 1.589 [33]
and an estimated value between n2 = −9.3 × 10−13 [34] and n2 of −2.42 × 10−12
m2/W [32]. Water has an index of refraction of 1.33 and 1.9×10−20 m2/W [31]. We thus
anticipated both a strong modulation from the PETG or PS and a strong carrier signal
from linear index mismatch. Axial scans (Fig. 7.2a) showed a sharp peak in the NORM
signal at the interface of water/PETG. We observed a second broad peak inside the
PETG, presumably due to an off-axis nonlinear Kerr effect. We used a weakly-focused
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Figure 7.2: Axial scan measurements showed hallmarks of NORM.
(a) An axial scan showed interface sensitivity. The scan revealed weak-focusing of the
probe beam (blue). A sharp peak (cyan arrow) in the lock-in signal (green) is believed
to have arisen due to NORM while a broader pulse of opposite modulation (red arrow)
is believed to have arisen from out-of-focus Kerr effects. (b) Signal varied sinusoidally
as a function of the polarizer angle. Polarization of the pump with respect to the probe
is twice the polarizer angle. (c) Signal varied linearly with pump power. (d) Signal
strongly depended on temporal overlap, with a full width of approximately 300 fs.
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probe pulse to facilitate ease of axial alignment. That the probe was weakly focused
was readily seen from the raw reflectance (probe) trace for the interface (Fig. 7.2a; blue
trace). Since the objective had NA = 0.8 ,we anticipated resolution on the order of 0.3
µm, whereas the full-width-at-half-maximum of the probe trace was approximately 60
µ. This weak focusing was achieved by the use of a narrow beam, under-filling the back
aperture of the objective and reducing the effective NA.
Axial scans were performed for a variety of polarizer angles of the pump (Fig. 7.2b).
For a perfect polarizer, the polarization of the pump will rotate 90◦ every time the
polarizer rotates 45◦. Since polarization is unique only in the range 0◦ to 90◦, for an
isotropic material the signal is then expected to oscillate with a period of 90◦ in the
polarizer angle. Signal was determined from the axial scan as the peak in the lock-in
signal. After normalizing the data, a cosine was fit to the data with a period of 94±7◦, in
good agreement with the theoretical prediction of 90◦. Incomplete extinction of NORM
signal at 45◦ was likely due to inefficiency in the polarizer and/or local anisotropy in
the material of interest.
Analogously, we measured signal peaks from axial scans as a function of pump
power (Fig. 7.2c). A linear fit was confirmed with R2 = 0.97. Probe power was not
scanned due to the proximity of the minimum probe power required for efficient signal
to the damage threshold for PETG. No signal was observed when either the pump or
probe was blocked.
Finally, signal peaks were determined from axial scans with varying temporal
offsets produced by a delay line (Fig. 7.2d). Temporal increments were measured from
1/4 turns of a 50-µm/turn fine adjustment dial. A full width of approximately 300 fs
was observed, in good agreement with 300-fs pulse duration of the laser.
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7.6 DISCUSSION
Our data showed four hallmarks expected by the theoretical description of NORM:
interface sensitivity, polarization dependence, linear power scaling, and temporal
sensitivity in the 100-fs range.
Since NORM is an interface microscopy, we anticipated significant signal only at
an interface where the change in index of refraction results in a robust reflected carrier
signal. However, this observation alone is not sufficient to rule out other interface-
sensitive processes, such as interference between interface-SHG and the probe.
The linear power scaling of the signal with pump laser intensity ruled out effects
such as interface-SHG or any higher-order effects, since these depend on higher powers
of the pump laser power. However, the interface sensitivity and scaling do not eliminate
thermal effects, such as photothermal lensing [16] which could possess both features.
However, the dependence of the signal on both polarization and its temporal
sensitivity ruled out such a process. First, absorptive processes are largely independent
of polarization, whereas the observed signal was strongly polarization dependent.
Second, absorptive effects last at least as long as electron relaxation times (typically on
the order of nanoseconds [35]), while thermal effects depend on the thermal diffusion
coefficient (typically on the order of microseconds). Thus, the observation of a 300-fs
window during which signal is efficiency generated is exactly what is expected for a
parametric process.
The sum of these four findings is strongly indicative of NORM. However, Fig. 7.2a
contains an unfortunate, broad, off-interface signal. This effect had the same power
scaling and polarization dependence as the narrower peak (data not shown), suggesting
that it is a Kerr effect. Since this microscopy is technically challenging, we used narrow
beams to under-fill the back aperture of the objective, thereby creating weaker focusing
in the sample. This allowed for easier axial and planar alignment of the two beams.
However, as our observation shows, this compromise introduced artifacts which would
complicate any kind of imaging. Future experiments will use tightly focused pump and
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probe beams to eliminate effects away from an interface.
Finally, with this correction made, it will be important to assess the value of
NORM for imaging biological interfaces by using all three dimensions of translation.
Initially, we will evaluate NORM as a stage-scanning microscopy. However, since this
significantly reduces the speed of image acquisition, we will upgrade the system to
a mirror-scanning protocol than can be performed simultaneously with other NLSM
modalities. We are optimistic in our assessment of NORM as an in vivo DIC analog.
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CHAPTER 8
OPTOPORATION AND GENETIC MANIPULATION OF CELLS USING
FEMTOSECOND LASER PULSES
In this chapter, we will report on our work on an optical technique for transfecting cells
in a targeted manner. The introduction of a foreign gene–ranging from simple reporter
genes, such as a fluorescent protein, to gene knockdown by siRNA vectors–is one of
the most powerful tools available to molecular biology. However, chemically-induced
membrane permeability techniques, such as the use of Lipofectamine
TM
, do not allow
for cellular targeting, and so are limited in their use to whole populations of plated
cells. While other techniques, such as single-cell electroporation allow for cellular
targeting, in vivo application of these techniques requires the insertion of probes into the
tissue of interest and requires considerable technical prowess, as cellular targeting may
require the reaching a single neuron with a micropipette tip after penetrating layers of
overlying tissue! This challenge severely limits the number of cells that may be targeted,
since each cell requires a separate insertion.
Optoporation–the process of creating an optically-induced transient pore in the
cell membrane–circumvents both these limitations. Because there are no probes to be
inserted (past the injection of plasmid into the extracellular matrix), cellular targeting
may be performed in a “point-and-shoot” fashion by co-aligning imaging and ablation
lasers. Moreover, because there are no probes to insert, targeting of multiple cells can
easily be achieved on experimental time scales.
The experiments in this chapter were completed by Andrew Davis, a former
undergraduate student in the lab. I assisted in this project by developing a
mathematical model and aiding in quantitative data analysis, as well as providing
guidance with respect to experiments and the scope of the paper. Other experimental
and intellectual contributions were provided by Dr. Nozomi Nishimura, Dr. Moonsoo
Jin, and of course, Dr. Chris Schaffer. The manuscript was jointly written by Andrew
Davis, Chris Schaffer, and myself. We aim to publish a revised version of this
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manuscript in the near future under the title (or similar):
Davis, AD Farrar, MJ, Nishumura, N, Jin, M and Schaffer, CB. Optoporation and genetic
manipulation of cells using femtosecond laser pulses, 2012.
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8.1 ABSTRACT
Femtosecond laser optoporation has emerged as a powerful approach to introduce
membrane-impermeable exogenous molecules into targeted cells, and has been used
extensively to transfect individual cells in culture. Despite this utility, only a narrow
range of potential laser regimes for optoporation have been explored. In addition, the
dynamics of the laser-produced membrane pores and the effect of pore behavior on
cell viability and transfection efficiency remains poorly elucidated. We quantified the
formation and resealing of transient pores in cultured cells after irradiation by tightly-
focused femtosecond laser pulses in two distinct irradiation regimes: millions of low-
energy pulses and two higher energy pulses. Acute pore resealing was found to be
a reliable indicator of long-term cell viability in both regimes. Laser energies where
cells could be reliably permeabilized and survive, and where targeted cells could be
transfected, were determined for both irradiation regimes. We further quantified the
pore radius and pore duration produced as a function of incident laser energy. These
data showed that pore size was the governing factor in cell viability, regardless of which
laser irradiation regime was used to produce the pore. Surprisingly, we found that
for cells that successfully resealed, larger pores tended to reseal more quickly than
smaller pores, essentially ruling out a passive resealing mechanism. These data provide
a quantitative understanding of the formation of membrane pores after femtosecond
irradiation and the dependence of the pore behavior on laser parameters
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8.2 INTRODUCTION
Femtosecond laser optoporation has emerged as a powerful technique for introducing
foreign genetic material into targeted cells and has been applied to a variety of cell
types, in vitro. Previous studies [1–5] have optoporated cells using high-repetition rate
trains (∼80 MHz) of low energy (∼1 nJ) near infrared (800 nm) laser pulses that were
focused at high numerical aperture (∼1.4 NA) onto the membrane of targeted cells for
short durations (∼40 ms). In this regime, nonlinear absorption of laser energy in the
focal volume is thought to lead to the production of a low-density electron plasma that
causes disruption of chemical bonds, release of free electrons, and the production of
thermoelastic stress waves [6]. Over many pulses, these effects cumulatively cause
a transient disruption of the cell membrane that has been used to allow exogenous
dyes [2, 3], macromolecules [7], gold nanoparticles [5], or DNA plasmid [1–4] to enter
the cell. In an appreciable fraction of optoporated cells, the pore in the cell membrane
reseals, leaving the cell intact and healthy [8].
The possibility of translating femtosecond laser optoporation from an in vitro to
an in vivo setting offers great potential as a technique for studying the pathogenesis
of complex diseases in model organisms and for exploring genetic regulation of cell
fate and behavior. Few existing approaches for in vivo transfection offer the possibility
of physically targeting individual cells. For in vivo optoporation deep inside tissue,
the laser energy will have to be increased to make up for scattering losses and deliver
sufficient intensity to the focal volume to drive nonlinear absorption. However, thermal
damage thresholds bound the average laser power that can be used, suggesting that
lower-repetition rate laser sources, or even single pulses, may have an advantage
for in vivo optoporation applications. The mechanism for membrane damage and
pore formation, however, will likely be different when cumulative effects between
successive pulses are no longer a factor [6]. For irradiation with a small number of
pulses at low repetition rate, higher pulse energies will likely be necessary and will
result in the formation of a high-density plasma at the laser focus through multiphoton
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and avalanche ionization, leading to ablative damage and vaporization of material
in the focal volume [9]. Such an ablative mechanism has previously been used to
damage blood vessels in the brain of rodents as a means to model ischemic [10, 11]
and hemorrhagic [11, 12] microstrokes. This ablative mechanism has not, however,
been explored for cell optoporation and transfection, and optimal parameters in this
irradiation regime need to be determined in vitro in order to establish the feasibility for
future in vivo work. In addition, a more quantitative understanding of the membrane
pore size that is produced for different laser parameters and the influence of pore size
and dynamics on subsequent cell viability and transfection efficiency would be of great
benefit to the field. Finally, although expression of exogenous DNA after optoporation
has been extensively studied, the mechanisms for DNA plasmid entry have not been
explicitly considered and may not be as simple as diffusion through the laser-created
pore.
In this article, we explored femtosecond optoporation in cultured cells across two
different laser irradiation regimes: irradiation with millions of low energy pulses, as
has been used extensively in previous work, and irradiation with two higher energy
pulses. By monitoring efflux of a small intracellular dye after optoporation and later
measuring cell viability, we determined acute resealing of membrane pores to be a
reliable indicator of long-term cell viability. We measured pore formation and cell
viability as a function of laser energy for both irradiation regimes and found optimal
parameters for cell-targeted DNA transfection and demonstrated ∼30% transfection
efficiencies for both irradiation regimes. We estimated the size of the laser-produced
pore from our data on dye efflux and found that pore size was the determining factor
in cell viability for both low-energy, high repetition-rate pulse trains and higher-energy,
isolated pulses. Surprisingly, we found that large membrane pores closed faster than
small ones in cells that resealed, suggesting that active cell resealing mechanisms are
likely. Finally, we found that fluorescently-labeled DNA plasmid accumulates over time
on the cell membrane after optoporation with two higher energy pulses, suggesting the
possibility of a novel mechanism beyond diffusion for plasmid entry into the cell. This
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work builds a quantitative understanding of pore creation after optoporation across two
laser irradiation regimes and sets the stage for future in vivo optoporation of targeted
cells using low repetition rate lasers.
8.3 METHODS
8.3.1 Cell culture
Optoporation experiments were performed using adherent chinese hamster ovarian
(CHO) cells that were grown to a sub-confluent monolayer in 35-mm glass-bottomed
culture dishes coated with poly-d-lysine (MatTek Corporation, Ashland, MA) and
placed in a humidified incubator with 5% CO2 / 95% air at 37◦ C. Growth media
solutions were made using advanced Dulbeccos modified eagle medium (D-MEM)
with 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA), 1% GlutaMAX
TM
solution (Invitrogen, Carlsbad, CA), 1% Penicillin-Streptomycin (Invitrogen, Carlsbad,
CA), and 50 µg/mL Gentamicin (Invitrogen, Carlsbad, CA). During optoporation and
imaging experiments, the cells were placed in media consisting of D-MEM, 1% sodium
pyruvate (Invitrogen), 1% GlutaMAX
TM
solution, 1% Penicillin-Streptomycin, and 50
µg/mL Gentamicin. Imaging cells in this solution was necessary to avoid optical
absorption of emitted fluorescence in the normal growth media by the pH indicator.
8.3.2 Two-photon excited fluorescence microscopy
CHO cells were imaged using a custom-built two-photon excited fluorescence (2PEF)
microscope with two simultaneous fluorescent detection channels. Images were
acquired using a Ti:Sapphire laser (MIRA-HP; Coherent, Inc., Santa Clara, CA) with
100-fs pulse duration, a central wavelength at 800-850 nm, and a repetition rate of 76
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MHz. A 20X-magnification, 1.0-numerical aperture (NA) water-immersion microscope
objective (Zeiss, Thornwood, NY) was used for all imaging. Fluorescence emission from
green fluorescent molecules (green fluorescent protein (GFP), calcein-AM, fluorescein)
was collected through a 517-nm bandpass filter with 65-nm bandwidth, while a
645-nm bandpass filter with a 70-nm bandwidth was used for red-emitting dyes
(ethidium bromide, CellTrace
TM
calcein red-orange AM). Image series were acquired
during optoporation and three-dimensional image stacks with 0.5-µm spacing in the
axial direction were attained at baseline and after optoporation. Image processing
and analysis were performed using ImageJ and custom scripts written in MATLAB
(MathWorks: Natick, MA).
8.3.3 Cell membrane disruption using femtosecond laser
systems
Targeted membrane disruption was performed using two laser systems. The first was
a low repetition rate, high pulse energy Ti:Sapphire regenerative amplifier with 100-
fs pulse duration, 1-kHz repetition rate, and 800-nm central wavelength (Legend-USP;
Coherent, Inc., Santa Clara, CA). A polarizing beamsplitter cube was used to introduce
this beam into the 2PEF microscope so that the pulses were focused at the center of
the imaging field and in the 2PEF imaging plane, enabling real-time monitoring of
optoporation dynamics. Laser energy incident on the cells was controlled by neutral
density filters, and a fast mechanical shutter limited the number of pulses incident on
each cell to two pulses. We also optoporated cells using pulses from the 76-MHz laser
used for 2PEF imaging. The laser beam from the Ti:Sapphire oscillator was split so that
one beam could be used for 2PEF imaging, while the second was aligned, as above, to
focus at the center of the imaging field and in the imaging plane. Laser energy was
varied using a half-waveplate/polarizing beamsplitter pair, and exposure time was
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controlled to be 50 ms, corresponding to 3.8× 106 pulses, with a mechanical shutter. In
both cases, a mechanical stage with sub-micrometer motion control in three dimensions
(Newport, Irvine, CA) enabled precise targeting of the laser focus to the edge of the
plasma membrane of the cell.
8.3.4 CHO cell labeling with calcein dyes
We labeled CHO cells for 2PEF imaging using calcein-AM or CellTrace
TM
calcein red-
orange AM (Invitrogen, Carlsbad, CA). Initially, calcein dyes are nonfluorescent due to
an ester-bond attached group that both quenches fluorescence and makes the dye cell
membrane permeable. Once inside functional cells, the intracellular esterases cleave the
quenching group, producing a hydrophilic, membrane-impermeable fluorescent label
in the cytoplasm of the cell. We added 5 µL of a 1 mg/mL Calcein-AM or CellTrace
TM
calcein red-orange AM dissolved in dimethyl sulfoxide (DMSO) to 10 mL of phosphate
buffered saline (PBS). The growth media was siphoned and 2 mL of dye solution was
added to each culture dish and incubated at room temperature for 45 minutes. For each
assay, Calcein-AM or CellTrace
TM
calcein red-orange AM was chosen so this cytoplasm-
labeling dye could be excited simultaneously with and the fluorescence emissions
spectrally separated from other fluorescent species used in the assay (e.g., ethidium
bromide or GFP).
8.3.5 Monitoring efflux of calcein dye after optoporation
The dependence of optoporation efficiency on laser parameters was evaluated by
monitoring efflux of calcein dye from the cell after laser irradiation of the membrane.
For calcein-AM, we used an 850-nm wavelength for 2PEF imaging. Dye efflux was
quantified from images using custom scripts in MATLAB (MathWorks: Natick, MA). To
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determine the fluorescence intensity as a function of time, which is directly proportional
to dye concentration inside the cell, we outlined the targeted cell by hard thresholding
to create a mask and calculated the average fluorescence intensity of the pixels within
this mask over time. The mean background pixel intensity was subtracted off all data
points. The baseline fluorescence was determined from the average across several
frames taken before cell targeting. We established a detection threshold for dye efflux
based on the fluctuations in fluorescence of controls cells (N = 83). Irradiated cells with
a decrease in fluorescence intensity of more than twice the standard deviation of the
fluctuations in control cells were defined as permeabilized.
8.3.6 Assessing cell viability after optoporation
To determine cell viability, cells were restained with 4-µM calcein-AM and 4-µM
ethidium bromide (EtBr) 90 min after optoporation and were reimaged. Cells
that exhibited increased fluorescence after calcein-AM restaining and exluded the
membrane-impermeable, nucleic acid binding EtBr were interpreted to have intact
plasma membranes that had resealed after optoporation and to have active intracellular
enzymes and thus be alive and functional.
8.3.7 Measurement of volume change after optoporation
To assess changes in cell volume after optoporation, CHO cells were transfected with
GFP and 2PEF image stacks were taken before and after optoporaiton. GFP-labeled
cells were used instead of calcein-AM-labeled cells in order to minimize efflux of
cytoplasmic fluorescent molecules after optoporation. Cells were transfected with
pAAVeGFP via Lipofectamine
TM
2000 24 hours prior to optoporation. Approximately
2 µg of DNA plasmid was added to 750 µL OPTI-MEM (Invitrogen, Carlsbad, CA)
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and 5 µL Lipofectamine solution was added to 750 µL OPTI-MEM in a separate tube.
The two tubes were then combined, mixed gently, and incubated at room temperature
for 20 min before the solution was added to the cells. Three-dimensional (3-D) 2PEF
image stacks, with 0.5 µm spacing between sections, were attained at baseline, 30 s,
and 5 min after membrane irradiation. Volume analysis was performed using Volocity
Imaging Software (PerkinElmer, Waltham, MA). The cell of interest was selected by
hard thresholding and the cell volume was reconstructed from the 3-D image stack.
Images of the volume projections were created using OsiriX Imaging Software. Volume
measurements were made in cells where a hole was produced and the membrane
resealed, and volume changes of non-targeted, control cells were assessed at the same
time points.
8.3.8 Movement of labeled DNA plasmid after optoporation
In order to track DNA plasmid behavior after optoporation, we monitored the
movement of fluorescently-labeled DNA plasmids in the extracellular solution after cell
membrane irradiation. We used 20 µg/ml LabelIT R© Plasmid Delivery Control (Mirus
Bio, Madison, WI) labeled with fluorescein (∼1 fluorescein molecule for every 20-60
bp of DNA plasmid). The 2.7-kb plasmid was not capable of protein expression due
to the locations of fluorescein binding. Fluorescein-labeled plasmid was imaged using
800-nm excitation. The cells were labeled with CellTrace
TM
calcein red-orange. The
2PEF imaging laser intensity had to be increased in order to image the labeled plasmid,
causing some photobleaching of the calcein red-orange dye. We quantified the intensity
of labeled plasmid on the targeted patch of the plasma membrane after optoporation
by monitoring the average fluorescence intensity over time. Two control experiments
were performed. In the first control, localized increases in signal after optoporation
due to, for example, autofluorescence were examined at the location of membrane
irradiation in the absence of labeled plasmid. In the second control, labeled plasmid
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accumulation in non-targeted cells was measured to establish a detection threshold for
plasmid accumulation at the membrane of targeted cells.
8.3.9 Transgene expression
In order to transfect single cells using laser-based optoporation, DNA plasmids were
prepared from transfected Escherichia coli cells using a Midiprep DNA Purification
System (Qiagen, Valencia, CA). A 4.7-kb pAAVeGFP plasmid that coded for GFP was
dissolved in clear growth media solution at a concentration of 10 µg/ml and applied
to cell culture plates for the duration of the optoporation session. CellTrace
TM
calcein
red-orange AM was used to label the CHO cells, and 800-nm excitation was used for
2PEF imaging. We used femtosecond laser ablation to place distinguishing marks in the
polystyrene culture dish underneath the targeted cells to facilitate later identification
of specific cells. After each optoporation session, the plasmid solution was siphoned,
normal growth media was applied, and the cells were stored in a humidified incubator
at 37◦ C. Cells were imaged again using either 2PEF or wide-field fluorescence
microscopy 24 and 48 hours after optoporation to monitor expression of GFP. To rule
out double-counting of successfully transfected cells due to cell division, targeted cells
were separated by at least 100 µm. Two cells expressing GFP in close proximity (e.g.,
less than 20 µm apart) 48 hours after irradiation were considered a single transfection
event followed by cell division. To ensure the plasmid was functional, a Lipofectamine
transfection reagent was used as a positive control. Negative controls were performed
by leaving a solution containing plasmid and clear growth media in a cell culture dish
for the length of the optoporation session without targeting the cells.
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8.3.10 Statistics
Statistical comparisons were made using a two-tailed Fishers exact test (Figs. 1h and
5h). Results were considered significant when p < 0.05. All error bars shown in bar
graphs (Figs. 1h, 2a-d, 3d, 5h, and 6f) represent 95% confidence intervals and were
calculated using a binomial distribution. The boxplots (Figs. 1i and j, 3b and c, and
4d) display the 25thto 75th percentile (box), the median (red line), and data within 1.5
times the interquartile range from the 25th and 75th percentile (whiskers). Outliers were
defined as points that fell outside the range denoted by the whiskers and are identified
with a red “+” through the datapoint. Means were calculated without statistical outliers
and are indicated by an orange “x” on the box plots. All means and standard deviations
reported in the paper do not include statistical outliers.
8.4 RESULTS
8.4.1 Imaging dye efflux allowed quantification of pore
creation and cell viability after optoporation
In order to identify optimal laser parameters for membrane pore creation, we tightly
focused femtosecond laser pulses on the membrane of CHO cells labeled with calcein-
AM and monitored the efflux of dye over time using 2PEF (Fig. 8.1a-c). We used
two different exposure conditions: either two pulses from a 1-kHz repetition rate
pulse train with pulse energies between 9 and 26 nJ (amplifier, see Fig. 8.1a-c), or
3.8 × 106 pulses from a 76-MHz pulse train with pulse energies between 0.4 and 1.3
nJ (oscillator). For both exposure conditions, cells that were permeablized exhibited an
exponential decrease in fluorescence intensity immediately after targeting, indicative
of pore creation (Fig. 8.1g). The fluorescence intensity then either stabilized, indicating
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resealing of the pore, or continued to decrease, suggesting the laser-created pore did not
reseal (Fig. 8.1g). Non-targeted cells served as controls and exhibited stable fluorescence
intensity over time.
Ninety minutes after targeting, cells were stained with additional calcein-
AM and with EtBr, then re-imaged and scored for cell viability (Fig. 8.1d). EtBr
uptake and unchanged calcein-AM fluorescence (Fig. 8.1e) indicated cell death, while
EtBr exclusion and increased calcein-AM fluorescence (Fig. 8.1f) suggested both an
intact plasma membrane and functional esterase activity inside the cell, indicating a
viable cell. All cells that were negative for EtBr also exhibited an increase in calcein-
AM fluorescence. For both of the laser exposure conditions, over 90% of cells that
resealed acutely were viable at 90 min (Fig. 8.1h). The total amount of dye efflux
was higher for cells killed by permeabilization as compared to cells that survived for
both amplifier (Fig. 8.1i) and oscillator (Fig. 8.1j) irradiation. However, permeabilized
cells that remained viable after amplifier irradiation showed greater dye efflux, on
average, than permeabilized, viable cells irradiated with the oscillator, and cells killed
by amplifier irradiation showed much more dye efflux than those killed by oscillator
irradiation (Fig. 8.1i and j). Because we found such a strong relationship between acute
membrane resealing and cell viability at 90 min (Fig. 8.1h, p = 1.0× 10−13 for amplifier,
p = 3.2×10−10 for oscillator, Fishers exact test), we considered cells that resealed acutely
as viable in all subsequent analyses.
The threshold for membrane permeabilization with amplifier irradiation was 9.5
nJ and the percentage of permeabilized cells increased to 100% at the highest energies
used, although cell viability decreased sharply for pulse energies higher than 14 nJ (Fig.
8.2a). For the oscillator pulses, our threshold for permeabilization of 0.65 nJ agreed
well with previous reports [2, 3]. The percentage of permeabilized cells increased more
gradually with increasing energy for the oscillator pulses as compared to the amplifier
irradiation, while cell viability decreased significantly only at the highest pulse energies
used (Fig. 8.2b). The fraction of cells that are successfully permeabilized and remain
viable reached a maximum of 45% for 12 nJ pulse energy for the amplifier irradiation
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Figure 8.1: Pore formation and cell viability after femtosecond laser irradiation.
CHO cells were irradiated with femtosecond pulses (2 pulses; 14 nJ) at the plasma
membrane (a, arrow) and calcein fluorescence intensity (green) was monitored over time
(b,c). Multiple spatially separated cells were irradiated (d, arrows). Application of
calcein-AM and EtBr (red) 90 minutes after optoporation produced EtBr-labeled nuclei
in dead cells (e). Live cells showed no EtBr labeling and exhibited an increase in
calcein fluorescence (f). Fluorescence intensity was monitored as a function of time
(g) for cells targeted with either the amplifier (amp; 2 pulses, 1 kHz) or oscillator
(osc; 3.8 × 106 pulses, 1 MHz) sources at various energies. Cells with final intensities
approaching the noise floor had failed to reseal (red), while cells with stabilized,
constant intensity had regained membrane integrity (green). The labeled arrows along
the green trace representing amplifier optoporation correspond to the fluorescence
intensity at timepoints of the images in (a-c). Cell viability at 90 min. for holes that did
and did not reseal acutely, for optoporation with each laser source (h). Fluorescence
intensity after optoporation expressed as a fraction of baseline intensity was compared
against cell permeabilization (permeabilized, P.; not-permeabilized, N.P.) and viability
for cells irradiated with the amplifier (i) the oscillator (j). Cells with an intensity drop
of two standard deviations below baseline intensity were considered permeabilized.
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Figure 8.2: Cell viability and permeabilization probability as a function of
irradiation energy.
The percentage of cells that were permeabilized and the percentage that were viable
after irradiation, considered separately, across a range of energies for pulses from the
amplifier (a) and oscillator (b). The percentage of cells that were both permeabilized and
viable after 90 min. as a function of irradiation energy for amplifier (c) and oscillator
(d) irradiation.
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(Fig. 8.2c) and reached 70% for 1.0 nJ pulse energy for the oscillator irradiation (Fig.
8.2d).
8.4.2 Modeling of dye efflux after optoporation
A simple diffusion-based model was used to estimate laser-produced hole radii in
both laser regimes. Briefly, we considered a laser-produced hole of radius r in the cell
membrane that is much smaller than the cell diameter. We further assumed that the hole
radius was constant in time while the pore was open, then rapidly closed. This model
predicts the initial decrease in dye concentration, φ, inside the cell to be an exponential
decay (see Section 8.6):
φ(t) = φ0 exp(−t/τ) (8.1)
where φ0 is the initial concentration of dye within the cell and τ is the diffusive time
constant for the hole. For viscosity, η0, dye molecule radius of gyration, Rg, membrane
thickness, e, cell volume, Vcell, temperature, T , and Boltzmann constant, kB , τ is given
by (see Section 8.6):
τ =
6η0RgeVcell
kBTr2
(8.2)
We fit the initial decay of fluorescence (linearly proportional to dye concentration) after
optoporation to (8.1) and used (8.2) to determine the initial hole radius (Fig. 8.3a). We
further estimated an effective hole opening time, thole, which was taken as the time it
would take for the concentration to decay to the final value observed after membrane
resealing, φ∞, assuming a constant hole radius, i.e.
thole = τ log
(
φ0
φ∞
)
(8.3)
In both laser regimes, hole radii increased with increasing laser energy, and holes
produced with the 1-kHz laser were larger, on average, than holes produced with
the 76-MHz laser (Fig. 8.3b and c, respectively). In the optimal energy range for the
amplifier pulses where the greatest percentage of targeted cells were permeablized and
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viable (∼12 nJ), the hole radii were 160± 115 nm (mean +/- std. dev.). For the oscillator
pulses at optimal energy (∼1.0 nJ), the holes had radii of 77 ± 55 nm. Hole radius was
a strong predictor of cell viability for both amplifier and oscillator pulses (Fig. 8.3d).
We found phenomenologically that the approximate duration the pore was open,
thole, scaled as a power law with the initial radius (Fig. 8.3e):
thole = arγ (8.4)
where a and γ were determined by a least squares fit. We found a = 4.0± 3× 104 s and
γ = −1.60.2 where r was measured in nm. Surprisingly, larger holes were observed to
reseal more quickly in optoporated cells that remained viable.
8.4.3 Cell volume transiently increased after optoporation
Cells expressing GFP were irradiated using optimal energy ranges and three-
dimensional 2PEF stacks were taken at baseline, 30 s, and 5 min after irradiation to
determine changes in cell volume that resulted from optoporation. Cells exhibited a
protrusion at the target location on the membrane for both the amplifier and oscillator
laser pulses shortly after membrane irradiation, which then retracted back over time
(Fig. 8.4a-c, amplifier example). On average, the protrusion produced by the amplifier
was larger than that produced by the oscillator, resulting in a larger volume increase
after irradiation (Fig. 8.4d).
8.4.4 DNA plasmid accumulated on the plasma membrane of
cells targeted with amplified laser pulses
To understand the movement of DNA plasmids after optoporation, we irradiated
cells in the presence of fluorescently-labeled DNA plasmid. Cells targeted with
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the amplifier exhibited increased fluorescence at the site of membrane irradiation,
suggesting membrane accumulation of DNA at the irradiated location (Fig. 8.5a-c).
In comparison, cells irradiated by amplified pulses in the absence of labeled plasmid
showed negligible increase in fluorescence (Fig. 8.5 e-g). Plasmid accumulation at the
plasma membrane began about 20-60 s after membrane irradiation (Fig. 8.5d). Forty
percent of cells (12 of 30) irradiated in the presence of labeled DNA plasmid exhibited
a localized increase in fluorescence at the irradiated site on the membrane, while only
4% of cells that were not irradiated showed an increase (Fig. 8.5h; p = 0.004, students
t-test) The signal to noise of 2PEF imaging of the labeled plasmid was not sufficient
to resolve plasmid entry into the cell. In control experiments with the oscillator, we
observed a localized increase in autofluorescence at the target location on the plasma
membrane, which precluded similar measurements of DNA plasmid movement after
oscillator-based optoporation.
8.4.5 Single cells were transfected using both laser systems
Single cells were optoporated in the presence of a DNA plasmid that coded for the
production of GFP, and expression was assessed at 24 and 48 hours after optoporation.
Both single cells (Fig. 8.6a, amplifier example) and cells that had divided post
optoporation (Fig. 8.6b and c, oscillator example) were observed after single cell
transfection for each laser system. The transfection efficiency, defined as targeted cells
that both survived and expressed GFP, was approximately 25% (30%) for the amplified
(oscillator) laser pulses when using the optimal energies determined above (Fig. 8.6d).
The spontaneous transfection without laser irradiation was negligibly low (< 1 in 106
cells).
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8.5 DISCUSSION
We investigated pore dynamics and cell viability after femtosecond laser optoporation
with two different laser irradiation regimes: a train of millions of low-energy pulses
at high repetition rate (the dominant approach in previous work) and two higher-
energy, isolated pulses. The mechanisms that lead to pore formation are quite different
in these two regimes, with cumulative damage across many pulses arising from low
density plasma dominating in the former case and ablative damage from a high density
plasma by each pulse governing the latter [6]. We identified optimal laser parameters
for optoporation in both regimes, defined by both successful permeabilization of the
membrane and viability of the cell. We found that cell viability after optoporation,
indicated by both enzymatic function and membrane integrity at 90 min. after
irradiation, was completely dependent on resealing of the laser-produced pore over
10 s after irradiation for both laser irradiation regimes. Using trains of low-energy
pulses, the laser energy we identified for optimal rates of optoporation (∼1 nJ) agrees
well with that found in previous work for similar focusing conditions and exposure
times [3], and successful pore formation was achieved in about 70% of targeted cells1.
The 12-nJ pulse energy found to be optimal for isolated, higher-energy pulses is above
the breakdown threshold for water at the 1.0-NA focusing used here, supporting an
ablative mechanism for pore formation. In this case, a lower fraction of targeted
cell, about 45% were successfully optoporated, and cell viability dropped rapidly with
increases in pulse energy above the optimal range.
By carefully measuring and modeling the efflux of a small dye out of optoporated
cells, we quantified the size and dynamics of the laser-created pore. For both irradiation
regimes, the pore size increased with laser energy. Pore size was, on average, about
twice as large at the energy associated with optimal optoporation for higher-energy,
isolated pulses ( 160-nm radius) as for trains of low-energy pulses ( 80-nm radius).
For the same hole radii, however, the two irradiation regimes resulted in a similar
1Pore formation was assayed by dye leak-out, independent of DNA transfection.
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percentage of cells permeabilized and viable. Collectively, these data suggest that the
total area of the laser-produced pore, independent of the irradiation regime used to
form it, dictated the acute resealing behavior of the pore and therefore the long-term
viability of the cell.
Interestingly, the rate for successful DNA transfection was similar between the two
laser systems, at about 30%. This suggests that a larger fraction of cells successfully
optoporated with trains of low-energy pulses do not take up the DNA plasmid as
compared to cells optoporated using isolated, higher-energy pulses. The DNA plasmid
is much larger than the small molecule dye we used to indicate permeabilization, and
we found that the average pore size created with trains of low-energy pulses is smaller
than that produced with isolated, higher-energy pulses. Taken together, this suggests
that perhaps pore sizes were on the small side for successful entry of enough DNA
plasmid into the cell when optoporated with trains of low-energy pulses. In any case,
the ∼30% transfection rate agrees well with recent experiments that carefully quantify
transfection rates.
Although we ignore any dynamic changes in the pore radius in our model (until
it is assumed to rapidly snap closed), our predictions for initial dye efflux agree well
with experimental data. Our model proposes diffusion as the transport driver, allowing
us to make quantitative predictions about the rates of transport of different solute
molecules. For example, we observed significant efflux of calcein dye molecules, but a
much more limited transport of GFP protein, which has a larger radius of gyration (data
not shown). In fact, the GFP efflux was below the detection threshold for optoporation
with a train of millions of low-energy pulses. In contrast, efflux of GFP was observed
after optoporation with isolated, higher-energy pulses, consistent with the larger pore
radius produced. From the pore size estimates based on calcein efflux, we were able to
predict the amount of GFP efflux experimentally observed (data not shown), confirming
that diffusion is the dominant driver of solute transport through the pore.
As mentioned above, our model is limited compared to previous models by Puc
et al. [13] and Wang et al. [14] because it did not account for hole resealing dynamics.
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Incorporating a robust theory of the pore dynamics is difficult, however, because more
is at play than passive membrane dynamics. Previous research by Brochard-Wyart et
al. [15] and Karatekin et al. (2003) described the dynamic behavior of transient pores
in giant unilamellar vesicles. A complete explanation was achieved by considering
competing effects of surface tension, line tension, and relaxation of the Laplace pressure
by fluid leak out through the transient pore. Importantly, such models predict a pore
lifetime that is an increasing function of initial pore size. In stark contrast, we find that
larger pores actually close faster in cells that successfully resealed after optoporation.
This result strongly suggests that the passive sealing processes used to describe the pore
dynamics in vesicles will be inadequate for cells. Indeed, other researchers have shown
that resealing of transected neurites is a calcium-mediated, active process [16]. We note,
however, that there is some selection bias in our results, as we must only include cells
that did successfully reclose in this analysis and it is possible that for larger diameter
pores, only the ones that reclosed quickly were able to reclose at all.
The mechanism for DNA plasmid entry into optoporated cells has been assumed
to be diffusion. From our measurements, we have excellent estimates of the radius
of the pore and the duration the pore is typically open. We calculated how many
plasmids of 4.7 kb would diffuse into the cell as a function of pore size, assuming
the size-dependent pore duration derived from our data and shown in Fig. 8.3e. We
find that, for the 100 nm pore size associated with optimal optoporation efficiency
that the concentration of DNA plasmids inside the cell will be only about 10−3 of
the extracellular concentration (Fig. 8.7). For typical concentrations of plasmid used
in these experiments, this suggests that just a few copies of the DNA enter the cell.
This should be compared to the hundreds to thousands of copies of DNA plasmid
that are estimated to enter the cell using electroporation or reagents like Lipofectomine.
Because of intracellular barriers that degrade or block cytoplasmic DNA from reaching
the nucleus and expressing, it is unclear that just a few plasmids entering the cell via.
diffusion is sufficient to drive transgene expression.
Under irradiation with higher-energy, isolated pulses we found that DNA plasmid
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accumulates on the plasma membrane at the irradiated site (Fig. 8.5). Several factors
may play a role in this. First, the cell strongly depolarizes after optoporation [3],
lowering the barrier for negatively-charged DNA to adhere to the cell membrane.
Second, the ablated patch of the cell membrane likely requires some time, perhaps
long after the pore has resealed, to fully regain a normal complement of proteins
and to otherwise regain normal structure and function. This, in turn may create a
permissive environment for DNA to adhere at the damaged spot. Over time, the
DNA adhered to the cell membrane would likely be endocytosed, thus providing an
alternative mechanism for DNA plasmid entry after optoporation. Because of signal-
to-noise limitations, we were, unfortunately, unable to follow the DNA that adhered to
the cell membrane over time to see if it was endocytosed. It is possible that a similar
accumulation of DNA at the irradiated site of the membrane occurred when we targeted
cells with a train of millions of low-energy pulses, but we were unable to resolve the
DNA plasmid accumulation at the membrane after irradiation in this regime due to
a localized increase in autofluorescence at the target location on the membrane that
would mask the signal from DNA accumulation. A similar mechanism was observed
for electroporation mediated DNA entry, with DNA plasmid sticking to the plasma
membrane and then being endocytosed into the cell about 30 min. later [17]. The
plasmid accumulation on the membrane only occurred at the electropermeabilized side
of the cell facing the cathode. Our observation of plasmid interaction with the targeted
patch of the plasma membrane may suggest common mechanisms for plasmid entry
in optoporation and electroporation. If delayed endocytosis is, in fact, a mechanism
for DNA entry, this would have implications for the best choice of parameters for laser
transfection. Perhaps many small patches of membrane that are rendered sticky for
DNA by irradiation would provide higher transfection efficiencies.
In conclusion, we have built on a quantitative understanding of pore creation and
resealing after optoporation across two distinct regimes of irradiation with femtosecond
lasers. In addition, we have identified mechanisms for DNA plasmid entry after
optoporation that rely on DNA adherence to patches of cell membrane altered by
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Figure 8.6: Transfection of cells with oscillator and amplifier laser pulses.
Cells were targeted in media containing plasmids coding for eGFP. Cells were targeted
with either two 12-nJ pulses from the amplifier (a) or 3.8 × 106 1.0-nJ pulses from the
oscillator (b,c). All cells were labeled using calcein red-orange (red) with transfected
cells expressing GFP (green). To avoid double counting due to cell division after
transfection (b,c), cells were sparsely targeted (a). Transfection efficiencies were
determined for both laser sources and were not statistically different (d).
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Figure 8.7: Calculated diffusive entry of DNA plasmids through laser-created pores.
On the basis of the experimental fit for the time the pore remains open, thole, as a
function of pore radius, r, and the dependence of the diffusion time, τ , on radius
we estimated the intracellular DNA plasmid concentration in terms of the fraction of
extracellular plasmid concentration (green; right-hand axis) assuming only diffusive
entry. The blue curve depicts the number of plasmids that enter the cell (left-hand axis),
for the extracellular plasmid concentration used in this work (10 µg/ml). Pore radii
associated with optimal transfection efficiency were around 100-200 nm, predicting the
entry of only 2-3 plasmid copies by diffusion.
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irradiation and later endocytosis. Importantly, the demonstration of transfection using
higher-energy, isolated femtosecond laser pulses in cultured cells sets the stage for
future in vivo optoporation studies without the limitations of potential thermal tissue
damage that would be likely when using a train of millions of low-energy pulses.
We anticipate that these findings will be critical for the development of a minimally
invasive, high fidelity transfection technique that can be used in vivo and has the
potential to probe complex diseases through precise genetic manipulation of single cells
in a living organism.
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8.6 APPENDIX: Model of dye efflux from an optoporated cell
To model the efflux of cytoplasmic dye from a cell after optoporation, we used Ficks
first law of diffusion, where the diffusion flux, J, is given by:
J = −D∇φ (8.5)
where D is the diffusion constant. We approximated the gradient as being one-
dimensional across the cell membrane, and we took the concentration of dye, φ, inside
the cell to be uniform at all times and positions within the cell. We further approximated
the derivative as a finite difference over the membrane thickness, e:
dφ
dx
≈ ∆φ
∆x
=
φ
e
(8.6)
The change in the number of dye molecules, N , inside the cell was equal to the flux
through a pore of radius, r:
dN
dt
= Jpir2 (8.7)
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Dividing by the cell volume, Vcell, and using (8.5) and (8.6), we have:
dφ
dt
= −Dpir
2
eVcell
φ (8.8)
Assuming a constant radius for the pore, this equation is integrated to give:
φ(t) = φ0 exp(−t/τ) (8.9)
where φ0 is the initial concentration of dye within the cell and τ is the diffusion time
constant for the pore and is given by, eVcell/Dpir2. From the Stokes-Einstein relation,
D =
kBT
6piη0Rg
(8.10)
where η0, is viscosity, Rg is the radius of gyration of the molecular, T is temperature,
and kB is the Boltzmann constant, we arrive at,
τ =
6η0RgeVcell
kBTr2
(8.11)
We fit the initial decrease in cellular fluorescence (which is proportional to the
concentration) to (8.9). Using Rg = 0.6 nm for calcein dye, η0 = 1 cP (nominal value for
water), e = 10 nm (nominal membrane thickness), kB = 1.38 × 1023 J•K−1, T = 298 K,
and Vcell = 1.2× 103 µm3 (based on volume measurements from image stacks), we use
(8.11) to determine the initial hole radius, r.
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CHAPTER 9
CONCLUDING THOUGHTS AND FUTURE DIRECTIONS
9.1 Summary and Reflection: Are we any further ahead?
At the end of one’s doctoral training, it is instructive to pause and ask what has been
accomplished throughout one’s years of study. And so, the question hangs, “What have
we learned through considerable investment of time and resources?”
First, we have demonstrated label-free third harmonic generation (THG) imaging
of myelin, a key central nervous system (CNS) component that is notoriously difficult
to image using exogenous labeling strategies. The value of this work was impressed
upon me only lately in both email and phone conversations with Dr. Benjamin
Odermann, a recently hired faculty member at the University of Bonn, Germany. He
is a neuroscientist who has seen the value of modern microscopy techniques, and was
particularly interested in using THG imaging of myelin as an assay in his laboratory
for studies in zebrafish models. It is truly exciting to see the development of a
technique start to progress from a technical demonstration to routine experimental
assay. It is my hope that others follow suit in adopting this technique to study myelin-
associated diseases of the central nervous system, including multiple sclerosis (MS) and
demyelination of axons in an injured environment, such as spinal cord injury (SCI).
Whereas our studies of THG imaging of myelin have gained in interest over time,
our studies of longitudinal spinal cord injury have had considerable interest even
prior to publication. Our poster presentation at the 2010 Society for Neuroscience
Annual Meeting engendered considerable interest. Manuscripts and parts drawings
were provided wherever requested, and studies using our chamber and procedure
are already well under way. For example, Daniel Coˆte´ at Laval University, Que´bec,
Canada has adopted our technique for CARS studies of experimental autoimmune
encephalomyelitis (EAE), the leading murine model of MS. Since MS is accompanied
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by motor loss and paralysis, our chamber has not only provided the ability to perform
longitudinal imaging, but also has aided in preventing accidental and potentially
confounding SCI resulting from unavoidable compromised vertebral integrity caused
by laminectomy. As was outlined in Chapter 2, the ability to perform time-lapse
imaging of the spinal cord is invaluable to studies of disease dynamics and therapeutic
efficacy, and our chamber has dramatically improved the ability to achieve this goal. It
is our hope that this chamber will receive widespread use by researchers across a broad
range of spinal cord studies.
Our study on spinal cord blood flow and microvascular architecture is meant
to fill a critical hole in our understanding of both healthy and injured spinal cord.
From an evolutionary biology perspective, the similarities between mouse, rat, rhesus,
and human spinal cords suggests a common evolutionary pressure driving the
network structures we see. In particular, characterization of the network structure
necessarily raises the question of what feature has been optimized, and subject to which
constraints. For example, Corson [1] has presented a generalized flow network model
which minimizes energy dissipation while facing the constraint of a fixed amount of
“material” from which the vasculature is constructed. In his model, he accounted for
fluctuating (as opposed to steady-state) sources and found that, under certain constraint
parameters, the optimal network strongly resembled the tree-like transport structures
found in biological systems. Under different sets of constraint parameters, net-like
structures were observed to optimize the system. Similarly, the spinal cord, like the
brain, requires constant high-rate perfusion and is able to autoregulate this perfusion
[2] across a wide range of systemic blood pressures. However, this perfusion is also
balanced by the high density of neurons requiring perfusion and the limited volume
of the vertebral canal, suggesting that perfusion optimization subject to fixed volume
constraints may apply here as well.
We have systematically mapped the spinal cord microvasculature, quantified vessel
topological connections, and quantified network structure. We have also performed in
vivo measurements of blood flow which have given insights into spinal blood drainage
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and the ischemic susceptibility of the spinal cord to dorsal spinal veinous (DSV)
occlusion. These findings provide a solid baseline and reference for future studies,
which we will discuss in the next section.
To date, we have extensively verified the existence of a nonlinear optical reflection
signal, laying the essential ground work for a new and exciting microscopy. As with
all proposed nonlinear microscopies, the plethora of nonlinear mixing effects that
are possible for a combination of input frequencies requires careful and methodical
identification of any proposed technique. Our preliminary data have verified our
predictions, providing the impetus to evaluate NORM as a true microscopy.
Finally, our work on optoporation brings a new level of understanding and
optimization to a field which has relied primarily on phenomenological studies. We
have systematically mapped transfection efficiency, cell viability, and transport kinetics
across pulse energy for two diverse laser systems. Given the potential of optoporation
for in vivo cellular transfection, it is essential to know optimal laser parameters in a
controlled in vitro setting before proceeding to the complex milieu of tissue. In addition,
the time required for in vivo animal preparations, including cranial or spinal surgery,
plasmid microinjection, and subsequent imaging and transfection makes in vivo studies
cost-prohibitive as an optimization platform. Thus, starting with an optimized system
provides the necessary parameters with which to begin in vivo trials, the subject of
another current PhD student’s thesis.
To answer the question at the beginning of this section, I believe a resounding “yes”
may be answered without special pleading. We have developed robust assays and
experimental platforms for future studies of biological interest. These techniques are
not esoteric findings or isolated to the expertise of one lab, but can be and are being
implemented around the world, as evidenced by the requests we have received for
drawings, parts, and recommendations. Within our own lab, they also serve to have
opened doors to new and exciting studies, upon which I will now offer some insights
and speculations.
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9.2 Future Directions
9.2.1 THG Imaging of Peripheral Nerve
We have demonstrated that THG microscopy is a strong source of contrast for imaging
myelin in the mouse CNS [3](Chapter 4). One surprising outcome of this study was
that THG can be efficiently generated with low-NA objectives in myelin in both the
CNS and peripheral (see Fig. 9.1) nervous system (PNS), enabling a large field of view
(FOV) to be imaged (Fig. 9.1b). Moreover, since low-NA objectives have a large confocal
parameter (∼ 50 µm) compared to large-NA objectives (∼ 1-2 µm), they are much less
sensitive to motion artifact, a feature which is of value in a clinical setting. Nevertheless,
THG can also be generated using large NA objectives, which allow for greater optical
sectioning and detailed resolution (Fig. 9.1d,e) where desired.
One potential application of low-NA THG imaging of PNS myelin is in prostate
cancer surgery. According to the American Cancer Society [5], over 240 000 cases of
prostate cancer (CaP) will be diagnosed in the United States in 2012, resulting in over
28 000 deaths. To date, radical prostatectomy remains the gold standard of care [6].
Unfortunately, this procedure causes damage to or loss of the cavernous nerve, resulting
in erectile dysfunction (ED). Procedures which attempt to spare neurovascular bundles
(NVB) have seen a marked improvement in sparing of erectile function, yet still results
in complete loss of function in nearly 25 % of patients, or limited recovery in almost half
of patients [6] after 18 months of post-operative recovery. Limited recovery was seen
between years 3 and 5, with the greatest improvement seen in cases of total ED [7].
In part, nerve preservation is hindered by the ability of the surgeon to visualize
nerves in real time, as well as the conflicting requirements of NVB sparing and tumor
margin mapping. Recent work using phage display [8] has been shown to robustly label
peripheral nerves fluorescently in mice, although this technique requires considerable
effort in isolation of the correct peptide fragment, and its associated cost of amplification
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Figure 9.1: In vivo imaging of the mouse PNS.
Exposure of a mouse thigh (a) allowed for isolation of the sciatic nerve and its branches
(a; box) [4], making possible low-NA objective imaging (b) of muscle (blue), sciatic nerve
(white), and Texas Red-labeled blood vessels (red; yellow arrows) in vivo. Imaging of
the nerve (c) using high resolution imaging showed collagen from SHG (magenta) and
presumably elastin from THG (cyan) in the perineurium (d). Myelin from THG (white)
and a subset of axons in a transgenic mouse expressing yellow fluorescent protein (YFP)
imaged using 2PEF (green) enabled direct visualization of nerve bundles (e). Diagram
in (a) is reproduced with permission from John Wiley & Sons, initially published as
Weinstein, D. E. and Wu, R. 2001. Isolation and Purification of Primary Schwann Cells.
Current Protocols in Neuroscience. 3.17.13.17.9.
to quantities sufficient for human dosing [4].. Coherent Anti-Stokes Raman Scattering
(CARS) microscopy has also been demonstrated in ex vivo imaging of cavernous nerve
[9] in human tissue. This technique relies on the high lipid content of myelin fibers
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and the lipid-specificity of CARS imaging to outline the nerve. However, the extreme
technical challenges associated with CARS microscopy make its clinical application
difficult. In particular, CARS requires two synchronized, picosecond duration pulsed
laser systems and very tight focusing to generate an image.
Because TH signal is generated from a single laser source, it is easily combined with
other multi-photon imaging modalities such as 2-photon excited fluorescence (2PEF)
and second harmonic generation (SHG). Neither SHG nor THG requires a resonant
energy level to be produced, and both are produced by endogenous tissue structures
without the need for exogenous dyes or labeling strategies. This property also makes
THG non-invasive and cost-effective in a clinical setting. When combined with 2PEF
and tumor-specific fluorescent labeling strategies [10] for margin mapping, a multi-
modal endoscope that included THG for imaging myelin could provide a powerful
surgical tool that both ensured appropriate margin mapping while maximizing NVB
sparing. In fact, this very idea has been the subject of a recent grant proposal in
collaboration with Dr. Chris Xu (Applied and Engineering Physics, Cornell University).
A first step in this process will be to perform imaging of whole mouse prostate and
sciatic nerve in situ using a simultaneous combination of THG, SHG, and 2PEF. Since
THG is produced effectively from myelin in the CNS [3], and we have demonstrated
myelin imaging in the PNS, THG could be used specifically to visualize the cavernous
nerve. However, unlike the CNS, fat storage in the periphery will also provide
strong THG signal [11]. It will therefore be imperative to demonstrate that nerve can
be distinguished morphologically and contextually. To do so, the use of transgenic
animals expressing fluorescent reporter proteins in peripheral nerves would allow
for co-localization of THG with labeled axon bundles. SHG of the surrounding
collagen structures could also provide relevant context, such as the perineurium and/or
muscle. Blinded identification of nerve from THG/SHG images will be compared to
simultaneous 2PEF images with labeled axons.
Since THG is a coherent effect, THG signal does not saturate like 2PEF. However,
it depends critically on laser pulse parameters. In general, THG image contrast is
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improved when lasers with large pulse energy ( 30 nJ) and small (1-10 MHz) pulse
repetition rates are used. In both cases, careful attention must be paid to linear (thermal)
damage by tissue heating occurring at large average powers and nonlinear tissue
ablation, which occurs at large pulse energies. In addition, since for 1040-nm excitation
wavelength, the TH is in the near UV and UV-mediated damage must be considered.
To determine optimum laser parameters for imaging, it will be important to first
evaluate THG contrast in sciatic nerve ex vivo. Characterization would need to include
pulse repetition rates between 1 and 10 MHz with pulse energies up to the NA-
dependent thermal and nonlinear damage thresholds. Pulses should be compressed
to as short as possible to maximize peak power, which will improve signal strength but
will not affect damage thresholds below 1 ps [12].
To evaluate the safety of the laser regimes, in vivo imaging of exposed sciatic
nerve and cavernous nerve by continuously scanning the nerves for 1-hour at each
set of high-contrast laser parameters can be performed. At the end of each session,
exposed tissue could be excised, digested, and examined for DNA fragmentation
using DNA electrophoresis. Positive identification of fragmented DNA is indicative
of phototoxicity. In parallel, gross histopathology of excised tissue could be examined
to look for acute structural photodamage. Laser parameters will then be chosen on the
basis of maximum image contrast with minimal tissue damage.
To demonstrate the value of THG imaging for NVB sparing, studies in which a
surgeon performed partial and radical prostactemoy in mouse models of CaP would
be of value. Two models [13, 14] use simian virus 40 large tumor antigen (SV40-Tag) to
selectively induce neoplasia in mouse prostate, closely resembling human CaP. Since
these sites of neoplasia manifest themselves as early as 10 weeks, straight forward
evaluation of NVB sparing in partial prostatectomies in early onset CaP and radical
prostatectomies in late stage CaP is possible. Anterograde labeling of the cavernous
nerve at the spinal nerve prior to animal sacrifice could be used to assess distal
sparing of the cavernous nerve in both partial and radical prostatectomy models. In
partial resections, quantitative scoring of end-point histological sections will be used to
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determine surgical efficacy in terms of tumor margin mapping. Statistical comparisons
between animals operated on with and without THG imaging will establish the value
of this imaging modality.
Apart from humans, dogs are the only known species to spontaneously acquire
CaP in an age-related manner [15]. For this reason and anatomical similarities, they
have been used as a larger animal model of pre-clinical prostate surgery, especially
with regards to NVB sparing [16–18]. As a follow-up study to mouse models of CaP,
we propose to evaluate THG imaging of cavernous nerve as a surgical tool in canine
models of radical prostatectomy.
9.2.2 Deep In Vivo Imaging in the Mouse Spinal Cord
We have demonstrated longitudinal imaging of the mouse spinal cord using a novel
implanted chamber [19] (Chapter 5). However, due to the short scattering length of
myelin, imaging depth has typically been limited to 50 µm or less. As a consequence,
only axons from the dorsal root ganglia (DRG) in the most superficial layer of the
spinal cord are routinely visible. This particular class of neuron has cell bodies
outside of the spinal cord and sends projections both centrally and peripherally. With
respect to regeneration, the neurons robustly regenerate processes on the peripheral
side but do not on the central side. In fact, lesioning the peripheral projections
of DRG 1-2 weeks prior to lesioning the central projections results in growth of
centrally projected axons past the lesion site [20]. This dualistic nature of the DRG
projections adds a confounding factor to regeneration studies, and raises questions
about the transferability of therapeutic strategies developed for DRG axon regeneration
to “purely central” neurons. Finally, since DRG send afferent, sensory projections only,
treatment of DRG axons does nothing to mitigate the underlying paralysis.
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In contrast, the corticospinal tracts (CSTs) 1 can have cell bodies in layer V of
the primary motor cortex that extend all the way to motor neurons in the ventral
horn of the spinal cord [21], fully contained within the CNS. These tracts are partly
responsible for voluntary motor control and injury results in paralysis, making their
regeneration of primary interest in SCI regeneration studies. For example, in rats,
improved CST sprouting following administration of neurotophin-3 (NT-3) [22] and
olfactory ensheathing cell transplantation have been seen [23]. Another study using
Alzet osmotic pumps to deliver a humanized IN-1 antibody fragment showed CST
regeneration across the lesion site with robust sprouting caudal to the lesion [24]. More
recently, progress has been made in a mouse model of SCI by suppressing PTEN [25],
resulting in regeneration of CSTs across a lesion site and the observation of new synapse
formation. In all cases, these studies have relied on post-mortem histology to assess the
extent of regeneration, losing critical information about the mechanism and dynamic
interactions that have led to these results.
Another critical motor tract is the rubrospinal tract (RST), descending from the
red nucleus and residing in the dorsolateral aspect of the mouse spinal cord [26, 27].
Sparing of these tracts is highly correlated with improved motor outcome [28], and
pre-clinical studies [29–31] have shown that these tracts respond well to neurotrophic
factors following injury.
Clearly, studies of CST and RST regeneration would benefit from the repeated, time-
lapse imaging approach currently accessible to studies of DRG axons. However, the
mouse dorsal corticospinal tracts (dCSTs) are located approximately 300-500 µm below
the dorsal surface of the spinal cord [26] (see Fig. 9.2.2c), making their optical access
without surgical damage to the spinal cord impossible. The RSTs are located more
laterally and slightly closer to the surface (∼200 µm), but still beyond multi photon
imaging ranges. At the same time, invasive surgery would result in experimental
1As a rule, spinal tract nomenclature follows the rule that the first part of the word denotes
the tract origin (i.e. cell body location) and the second part denotes the axonal destination. So,
corticospinal means “from the cortex to the spinal cord”, while spinothalamic tracts refer to
projections of spinal cord neurons to the thalamus.
274
artifacts, including ischemic and inflammatory damage. One possibility for a minimally
invasive surgery has been demonstrated in the rodent cortex by Chia et al. [32]. A right
triangular prism with a mirror on the hypotenuse was inserted into the rodent cortex,
effectively translating the imaging plane from xy to yz. Tissue disruption was limited
to within 100 µm of the prism surface.
We have replicated this technique in the mouse spinal cord (Fig. 9.2.2) in conjunction
with our spinal chamber described elsewhere [19]. Briefly, we used a triangular blade
to create a small incision in the dorsal spinal cord just lateral of the mideline. A 1 mm x
1mm right triangular mirrored prism was inserted (Fig. 9.2.2a) into the spinal cord and
sealed in place with Kwik-Sil elastomer, as for the spinal chamber. Subsequent imaging
(Fig. 9.2.2 b-c) showed intact and well-perfused blood vessels just 50 µm from the site
of insertion (Fig. 9.2.2d).
Using this technique, the maximum depth from the spinal cord surface that can be
imaged is determined by the prism dimensions rather than the scattering length of the
tissue, in this case, 1 mm. The lateral extent of imaging is set by the scattering length
of the local tissue environment, and will vary depending on whether imaging is taking
place in the gray matter or white matter, with the latter being much more scattering
than the former. In our study, we implanted the prism facing the dCSTs. However,
rotation of the prism by 180◦ would allow for similar imaging of the RST. Combining
this technique with our imaging chamber extends the promise of longitudinal imaging
to the more critical motor tracts.
However, this approach is not without its challenges. First, the dCSTs are a highly-
myelinated set of axons in the dorsal spinal cord that sit at the boundary of the gray
commissure. Thus, imaging into the dCST is bound to be limited by the same scattering
limitations as imaging below the dorsal columns. Nevertheless, imaging of at least
superficial dCST axons would present a considerable advance towards understanding
motor pathway regeneration. Similar challenges exist for the RST, but their closer
proximity to the gray matter [26] may allow a more distal placement of the prism, and
thus less disturbance at the imaging site. Careful placement of both the prism position
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Figure 9.2: An implanted prism allows for deeper imaging in the mouse spinal cord.
After exposing a vertebral segment by performing a dorsal laminectomy, a small
incision in the spinal cord is made and a right isosceles triangle is inserted (a).
Subsequent multi-photon microscopy (b) allows for imaging in the yz plane when
scanning in the xy plane (c), potentially enabling access to the dorsal corticospinal tracts
(dCSTs). We have currently demonstrated imaging of intact, perfused blood vessels (d)
1 day post-implantation.
and angle will be critical for optimum imaging.
Second, insertion of the prism itself will result in unavoidable SCI. This tissue
disruption is also likely to carry a secondary injury response, including inflammation
and potentially ischemia. Similar histological studies to those of Chia et al. [32] will
need to be performed to assess the extent of tissue injury in the spinal cord. Any effect
of the implantation on regenerative outcome will similarly need to be assessed.
Despite these challenges, deep imaging in the spinal cord is essential for probing
motor recovery and pursuing therapies targeted at relieving paralysis. Depth
limitations in the brain have been overcome by the use of implanted prisms [32] as well
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as implanted microendoscopes [33], and extension of these techniques to the spinal cord
is a natural and necessary next step for SCI studies.
9.2.3 Angle-Resolved Nonlinear Optical Reflection Microscopy
(AR-NORM)
In our current construction of NORM (Chapter 7), signal is preferentially collected
from normal incidence, with diminishing collection efficiency for off-normal angles of
incidence. As a consequence, we anticipate image “shadows” in curved surfaces. There
are two methods we could use to mitigate this problem.
First, we could introduce a displacement, δ, of the probe beam from the optic axis.
For an objective of effective focal length, f , this would result in an incident angle given
by
θ = arctan(
δ
f
) (9.1)
By scanning over a rage of δ, the extent of shadowing could be reduced, resulting in a
truer representation of tissue structure.
Alternatively, we could replace our existing photodiode with a position-sensitive
photodiode, (PDP90A; Thor Labs, Inc.). This sensor has sub-micron resolution, and any
non-normal incidence would result in a detectable displacement of the reflected beam.
This detection scheme would effectively achieve the same result as our first proposed
scheme, except because we measure displacement, δ, directly, there is no need to scan.
The image intensity, IRN would therefore be renormalized according to
IRN =
I0
cos(θ)
=
I0
cos(δ/f)
(9.2)
where I0 is the reflectance intensity. This change would be easily implemented and
improve the interpretation of NORM images.
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9.2.4 Improved Transfection Efficiency Using Polyethylene
Glycol
In our studies of optoporation, we have experimentally determined the optimum
pulse energies for cellular transfection using two different pulse-repetition rate lasers.
This optimum–for both laser systems– comes as a trade-off between high transfection
efficiency, favoring large holes and thus large pulse energy, and cell viability, favoring
smaller holes and lower pulse energies. One of the paradoxes found in this study was
that simple membrane modeling [34, 35] that balances an edge tension against surface
tension and Laplace pressure predicts that larger holes take longer to close than smaller
holes, while our observations showed that–for holes that closed on acute time scales–
larger holes closed more quickly than small holes.
One resolution of this paradox is that membrane resealing is not a passive
membrane processecently, Spaeth et al. [36] have shown that calcium (Ca2+) mediates
membrane sealing in neurites following transection, and other studies [37] suggest a
Ca2+-dependent mechanism for cell membrane resealing more generally. Thus, since
Ca2+ diffusion into the cell happens more quickly for a large hole, it is plausible that
this activates the sealing process more quickly. Conversely, smaller holes allow a slower
influx of Ca2+, and thus take longer to seal. The diffusion coefficient of Ca2+, D,
is concentration-dependent and ranges between 13 µm2/s and 50 µm2/s for 0.1-0.5
µM free Ca2+ [38]. Using D = 20 µm2/s, we estimate for the larger holes in our
study (r0 ∼ 300 nm; τ ∼ 10 s) that–considering diffusive effects only and ignoring
any intracellular buffering– the concentration of intracellular Ca2+ had completely
equilibrated with the extracellular concentration by the time the hole resealed, while
for smaller holes (r0 ∼ 30 nm; τ ∼ 100 s), the intracellular Ca2+ concentration had only
reached ∼50% of the extracellular concentration. These estimates lend support to the
Ca2+-dependent sealing hypothesis.
In any case, an excess of intracellular Ca2+ will result in activation of cytochrome
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c and initiate the apoptotic cascade. As a caveat, recall that in determining hole
sealing time as a function of hole radius we selected only those cells which did, in fact,
reseal after being permeabilized. However, larger holes had reduced viability, meaning
that we have systematically excluded a large number of holes that did not reseal
on experimental timescales. This selection bias may mask some of true intracellular
dynamics that occur for large holes. Nevertheless, the validity of the Ca2+-dependent
sealing hypothesis could be readily tested by irradiating cells using the optimum laser
pulses in media containing physiological Ca2+ and Ca2+-free media. If our hypothesis
is true, large holes should no longer seal quickly.
While interesting in terms of cellular mechanisms, perhaps of greater practical value
is the discovery of Spaeth et al. [39] that addition of 3.7 mM polyethylene glycol (PEG) to
the extracellular solution can result in much faster axonal resealing following axotomy,
with nearly instantaneous sealing achieved in Ca2+-containing media and 100 % sealing
probability. Since our ultimate goal for optoporation is in vivo transfection, which
requires time-consuming surgery and precise microinjections, any increase in cellular
viability from improved sealing would be an enormous boon. This improvement is
especially important for studies of small-scale neural networks, for which the accidental
killing of neurons during transfection may have confounding effects on subsequent
measurements. In addition, tissue scattering makes the estimation of the incident laser
energy at the cell membrane difficult, since the laser light is attenuated by higher-lying
layers of tissue. In our current study, in the absence of scattering or other complicating
features, laser-permeabilized cells had a maximum viability of approximately 70 %.
Thus, if the addition of PEG to the cellular media results in faster sealing, it is possible
that constraints on laser power could be relaxed while maintaining a much higher
cellular viability.
To test this latter hypothesis, the experiments performed to date should be repeated
with the addition of varying concentrations of PEG. Optimization of PEG concentration
will need to be determined such that cell resealing and viability is increased by
faster membrane sealing while maintaining a window sufficient for DNA transfection.
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Ultimately, these experiments should be demonstrated in vivo.
9.3 Conclusion
With these reflections and future directions in mind, it is time to bring this work to
a close. I have immensely enjoyed and been stimulated by my work in the Schaffer
group over the last few years. Chris has been an incredible mentor, under whom I have
learned a great deal about life in academia, including scientific rigor, academic politics,
and teaching pedagogy. In particular, his willingness to invest time and resources in
projects of mutual interest to him and myself has provided an environment conducive
to true scientific exploration and intellectual growth, and made nearly all of the projects
in this thesis a reality.
To those who follow up on this thesis where I am obliged to leave off, either on one
of the proposed avenues in this chapter or on novel endeavors of their own, I have a
few short pieces of advice which have been helpful to me.
First, avoid tunnel vision. Your project is not that interesting in and of itself. It’s
value is tied, in part, to its perception and impact within a larger scientific community.
Therefore, you must repeatedly present your work as part of a larger whole. In fact, one
of the greatest challenges in presenting your work is to argue that it really is important;
we all abhor “the horror of the same old thing” [40]. This goal cannot be achieved if
you restrict yourself to literature and seminars dealing only within the narrow confines
of your own experiments. Read broadly. Listen broadly. Discuss your work with
colleagues outside of your field, and do not hide behind your lack of formal training.
Your ability to integrate diverse ideas can only improve the quality of your project and
stimulate your thinking to new and interesting ideas.
Second, the principal investigator under whom you work is not, contrary to popular
opinion, infallible (sorry Chris). A professor’s years of experience, depth and breadth of
learning, and collaborative dealings are of immense value to you as a student. However,
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like all human beings, some of his/her ideas are inaccurate, skewed, or just plain
wrong. Part of becoming a mature researcher is your ability to develop your own ideas
and respectfully and professionally disagree. Keep in mind that not all of your ideas
are winners either.
Third, work hard and work smart. There is no substitute for hard work. Period.
However, working smartly can dramatically increase the output of hard work. For
example, taking the time to learn basic Matlab programming can substantially speed
your rate of repetitive and menial data analysis.
Finally, do not be in a great hurry to publish or merely finish your degree. I am not
saying that it is wise to dawdle, but merely that publishing good work and learning a
great deal in the process of doing so is to be preferred to smaller incremental studies.
The most useful (and most cited) papers are those which fully address a key question
by a series of well-thought-out experiments rather than presenting a mere disembodied
result. Moreover, your Ph.D. is a terrific opportunity to interact with the sharpest minds
of our time, both within your field and outside of it. Rushing your Ph.D. simply to be
done sooner is to deny yourself the fullness of higher academic education.
This concludes both this thesis and along with it, the last of my foreseeable formal
education.
And now, O School, thy time has past
’Tis time to say “Farewell”.
But thou, Fair Learning, hold me fast
Be my companion still.
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INTRODUCTION
1. The publisher for this copyrighted material is Elsevier.  By clicking "accept" in connection
with completing this licensing transaction, you agree that the following terms and conditions
apply to this transaction (along with the Billing and Payment terms and conditions established
by Copyright Clearance Center, Inc. ("CCC"), at the time that you opened your Rightslink
account and that are available at any time at http://myaccount.copyright.com).
GENERAL TERMS
2. Elsevier hereby grants you permission to reproduce the aforementioned material subject to
the terms and conditions indicated.
3. Acknowledgement: If any part of the material to be used (for example, figures) has
appeared in our publication with credit or acknowledgement to another source, permission
must also be sought from that source.  If such permission is not obtained then that material may
not be included in your publication/copies. Suitable acknowledgement to the source must be
made, either as a footnote or in a reference list at the end of your publication, as follows:
“Reprinted from Publication title, Vol /edition number, Author(s), Title of article / title of
chapter, Pages No., Copyright (Year), with permission from Elsevier [OR APPLICABLE
SOCIETY COPYRIGHT OWNER].” Also Lancet special credit - “Reprinted from The
Lancet, Vol. number, Author(s), Title of article, Pages No., Copyright (Year), with permission
from Elsevier.”
4. Reproduction of this material is confined to the purpose and/or media for which permission
is hereby given.
5. Altering/Modifying Material: Not Permitted. However figures and illustrations may be
altered/adapted minimally to serve your work. Any other abbreviations, additions, deletions
and/or any other alterations shall be made only with prior written authorization of Elsevier Ltd.
(Please contact Elsevier at permissions@elsevier.com)
6. If the permission fee for the requested use of our material is waived in this instance, please
be advised that your future requests for Elsevier materials may attract a fee.
7. Reservation of Rights: Publisher reserves all rights not specifically granted in the
combination of (i) the license details provided by you and accepted in the course of this
licensing transaction, (ii) these terms and conditions and (iii) CCC's Billing and Payment terms
and conditions. 303
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8. License Contingent Upon Payment: While you may exercise the rights licensed immediately
upon issuance of the license at the end of the licensing process for the transaction, provided
that you have disclosed complete and accurate details of your proposed use, no license is
finally effective unless and until full payment is received from you (either by publisher or by
CCC) as provided in CCC's Billing and Payment terms and conditions.  If full payment is not
received on a timely basis, then any license preliminarily granted shall be deemed
automatically revoked and shall be void as if never granted.  Further, in the event that you
breach any of these terms and conditions or any of CCC's Billing and Payment terms and
conditions, the license is automatically revoked and shall be void as if never granted.  Use of
materials as described in a revoked license, as well as any use of the materials beyond the
scope of an unrevoked license, may constitute copyright infringement and publisher reserves
the right to take any and all action to protect its copyright in the materials.
9. Warranties: Publisher makes no representations or warranties with respect to the licensed
material.
10. Indemnity: You hereby indemnify and agree to hold harmless publisher and CCC, and
their respective officers, directors, employees and agents, from and against any and all claims
arising out of your use of the licensed material other than as specifically authorized pursuant to
this license.
11. No Transfer of License: This license is personal to you and may not be sublicensed,
assigned, or transferred by you to any other person without publisher's written permission.
12. No Amendment Except in Writing: This license may not be amended except in a writing
signed by both parties (or, in the case of publisher, by CCC on publisher's behalf).
13. Objection to Contrary Terms: Publisher hereby objects to any terms contained in any
purchase order, acknowledgment, check endorsement or other writing prepared by you, which
terms are inconsistent with these terms and conditions or CCC's Billing and Payment terms
and conditions.  These terms and conditions, together with CCC's Billing and Payment terms
and conditions (which are incorporated herein), comprise the entire agreement between you
and publisher (and CCC) concerning this licensing transaction.  In the event of any conflict
between your obligations established by these terms and conditions and those established by
CCC's Billing and Payment terms and conditions, these terms and conditions shall control.
14. Revocation: Elsevier or Copyright Clearance Center may deny the permissions described
in this License at their sole discretion, for any reason or no reason, with a full refund payable
to you.  Notice of such denial will be made using the contact information provided by you. 
Failure to receive such notice will not alter or invalidate the denial.  In no event will Elsevier
or Copyright Clearance Center be responsible or liable for any costs, expenses or damage
incurred by you as a result of a denial of your permission request, other than a refund of the
amount(s) paid by you to Elsevier and/or Copyright Clearance Center for denied permissions.
LIMITED LICENSE
The following terms and conditions apply only to specific license types:
15. Translation: This permission is granted for non-exclusive world English rights only
unless your license was granted for translation rights. If you licensed translation rights you
may only translate this content into the languages you requested. A professional translator
must perform all translations and reproduce the content word for word preserving the integrity
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of the article. If this license is to re-use 1 or 2 figures then permission is granted for non-
exclusive world rights in all languages.
16. Website: The following terms and conditions apply to electronic reserve and author
websites:
Electronic reserve: If licensed material is to be posted to website, the web site is to be
password-protected and made available only to bona fide students registered on a relevant
course if:
This license was made in connection with a course,
This permission is granted for 1 year only. You may obtain a license for future website
posting, 
All content posted to the web site must maintain the copyright information line on the bottom
of each image, 
A hyper-text must be included to the Homepage of the journal from which you are licensing at
http://www.sciencedirect.com/science/journal/xxxxx or the Elsevier homepage for books at
http://www.elsevier.com , and
Central Storage: This license does not include permission for a scanned version of the material
to be stored in a central repository such as that provided by Heron/XanEdu.
17. Author website  for journals with the following additional clauses:
All content posted to the web site must maintain the copyright information line on the bottom
of each image, and the permission granted is limited to the personal version of your paper.
You are not allowed to download and post the published electronic version of your article
(whether PDF or HTML, proof or final version), nor may you scan the printed edition to
create an electronic version. A hyper-text must be included to the Homepage of the journal
from which you are licensing at http://www.sciencedirect.com/science/journal/xxxxx . As part
of our normal production process, you will receive an e-mail notice when your article appears
on Elsevier’s online service ScienceDirect (www.sciencedirect.com). That e-mail will include
the article’s Digital Object Identifier (DOI). This number provides the electronic link to the
published article and should be included in the posting of your personal version. We ask that
you wait until you receive this e-mail and have the DOI to do any posting. 
Central Storage: This license does not include permission for a scanned version of the material
to be stored in a central repository such as that provided by Heron/XanEdu.
18. Author website for books with the following additional clauses: 
Authors are permitted to place a brief summary of their work online only.
A hyper-text must be included to the Elsevier homepage at http://www.elsevier.com . All
content posted to the web site must maintain the copyright information line on the bottom of
each image. You are not allowed to download and post the published electronic version of
your chapter, nor may you scan the printed edition to create an electronic version.
Central Storage: This license does not include permission for a scanned version of the material
to be stored in a central repository such as that provided by Heron/XanEdu.
19. Website (regular and for author): A hyper-text must be included to the Homepage of the
journal from which you are licensing at http://www.sciencedirect.com/science/journal/xxxxx. 
or for books to the Elsevier homepage at http://www.elsevier.com
20. Thesis/Dissertation: If your license is for use in a thesis/dissertation your thesis may be305
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submitted to your institution in either print or electronic form. Should your thesis be published
commercially, please reapply for permission. These requirements include permission for the
Library and Archives of Canada to supply single copies, on demand, of the complete thesis
and include permission for UMI to supply single copies, on demand, of the complete thesis.
Should your thesis be published commercially, please reapply for permission.
21. Other Conditions: Permission is granted to submit your article in electronic format. This
license permits you to post this Elsevier article online on your Institution’s website if the
content is embedded within your thesis. You are also permitted to post your Author Accepted
Manuscript online however posting of the final published article is prohibited. Please refer to
Elsevier’s Posting Policy for further information:
http://www.elsevier.com/wps/find/authors.authors/postingpolicy
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